"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A,US 3221228 A,165-274-734-441-764,1965-11-30,1965,US 13828561 A,1961-09-15,US 13828561 A,1961-09-15,Ceramic capacitor and the method of making the same,,CORNELL DUBILIER ELECTRIC,GERARD CARTER;;HODGKINS CHARLES E,,https://lens.org/165-274-734-441-764,Granted Patent,no,4,7,1,1,0,H01G4/008;;Y10T29/435;;Y10T29/435;;H01G4/008,H01G4/008,,0,0,,,,EXPIRED
2,AU,A1,AU 2022/271791 A1,149-290-314-779-267,2024-01-04,2024,AU 2022/271791 A,2022-05-12,US 202163187753 P;;US 2022/0029002 W,2021-05-12,COMBINATIONS FOR TREATMENT OF CANCER,"The present disclosure is directed to combinations of menin inhibitors and Bcl-2 inhibitors, optionally in further combination with hypomethylating agents and/or FLT3 inhibitors for the treatment of cancer. Specifically, menin inhibitors combined with venetoclax are synergistic in the treatment of cancers with a HOX gene signature such as acute myeloid leukemia.",UNIV TEXAS;;SYNDAX PHARMACEUTICALS INC,MCGEEHAN GERARD;;ORDENTLICH PETER;;CARTER BING;;ANDREEFF MICHAEL,,https://lens.org/149-290-314-779-267,Patent Application,no,0,0,5,5,0,A61P35/00;;A61P35/02;;A61K45/06;;A61K31/635;;A61K31/506;;A61K31/497;;A61K31/706,A61P35/00;;A61K31/551;;A61K31/555;;A61P35/02,,0,0,,,,PENDING
3,WO,A1,WO 2022/241122 A1,029-785-605-029-347,2022-11-17,2022,US 2022/0029002 W,2022-05-12,US 202163187753 P,2021-05-12,COMBINATIONS FOR TREATMENT OF CANCER,"The present disclosure is directed to combinations of menin inhibitors and Bcl-2 inhibitors, optionally in further combination with hypomethylating agents and/or FLT3 inhibitors for the treatment of cancer. Specifically, menin inhibitors combined with venetoclax are synergistic in the treatment of cancers with a HOX gene signature such as acute myeloid leukemia.",SYNDAX PHARMACEUTICALS INC;;UNIV TEXAS,MCGEEHAN GERARD;;ORDENTLICH PETER;;CARTER BING;;ANDREEFF MICHAEL,,https://lens.org/029-785-605-029-347,Patent Application,yes,2,0,5,5,0,A61P35/00;;A61P35/02;;A61K45/06;;A61K31/635;;A61K31/506;;A61K31/497;;A61K31/706,A61P35/00;;A61K31/551;;A61K31/555;;A61P35/02,,2,2,100-639-832-648-33X;;077-799-737-319-117,10.1016/j.celrep.2016.12.054;;pmc5263239;;28076791;;29218851;;10.1002/ajh.25000,"JON KERRY, LAURA GODFREY 1, EMMANOUELA REPAPI 2, MARTA TAPIA 1, NEIL P BLACKLEDGE 3, HELEN MA 4, ERICA BALLABIO 1, SORCHA O'BYRNE : ""MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia"", CELL REPORTS, vol. 18, no. 2, 10 January 2017 (2017-01-10), pages 482 - 495, XP093008423;;COURTNEY D. DINARDO, CAITLIN R. RAUSCH, CHRISTOPHER BENTON, TAPAN KADIA, NITIN JAIN, NAVEEN PEMMARAJU, NAVAL DAVER, WENDY COVERT, : ""Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies"", AMERICAN JOURNAL OF HEMATOLOGY, NEW YORK, NY, US, vol. 93, no. 3, 1 March 2018 (2018-03-01), US , pages 401 - 407, XP055744876, ISSN: 0361-8609, DOI: 10.1002/ajh.25000",PENDING
4,US,B1,US 11436339 B1,165-142-947-472-068,2022-09-06,2022,US 202217750378 A,2022-05-22,US 202217750378 A;;US 202263300228 P;;US 202263300240 P;;US 202263296152 P;;US 202163213199 P,2021-06-21,"Systems, methods, and user interfaces for intelligent and expedited generation of cybersecurity artifacts using cybersecurity control data objects","In some embodiments, a cybersecurity data handling and governance service displays a cybersecurity artifact generation object. In some embodiments, while displaying the cybersecurity artifact generation object, the cybersecurity data handling and governance service receives a first input selecting the cybersecurity artifact generation object. In some embodiments, in accordance with a determination that the first input is directed to generating a first cybersecurity artifact corresponding to a first authoritative information security standard and in accordance with a determination that the first user interface is dedicated to displaying information directed to a respective cybersecurity data catalogue, the cybersecurity data handling and governance service generates the first cybersecurity artifact based on a first set of cybersecurity control data objects included in the respective cybersecurity data catalogue in accordance with submittal-criteria defined by the first authoritative information security standard.",RISQ MAN LLC,SCHEITLIN GERARD EDWARD;;SCHEITLIN QUINTIN SCOTT;;SCHEITLIN CHANDLER CARTER,RISQ MANAGEMENT LLC (2022-06-07),https://lens.org/165-142-947-472-068,Granted Patent,yes,4,0,2,2,0,G06F21/577;;G06F2221/034;;G06F21/577,G06F21/57,,0,0,,,,ACTIVE
5,US,A1,US 2017/0051386 A1,103-194-566-028-604,2017-02-23,2017,US 201514830759 A,2015-08-20,US 201514830759 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate positioned on a base plate to a predetermined temperature using a first heater; using a laser to form a melt pool on a surface of the substrate; introducing a superalloy powder to the melt pool; measuring the temperature of the melt pool; receiving the temperature measured at a controller; and using an auxiliary heat source in communication with the controller to adjust the temperature of the melt pool. The predetermined temperature is below the substrate's melting point. The laser and the base plate are movable relative to each other, with the laser being used for direct metal deposition. An apparatus is also generally provided for direct writing of single crystal super alloys and metals.",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,GENERAL ELECTRIC COMPANY (2015-08-07),https://lens.org/103-194-566-028-604,Patent Application,yes,18,22,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,C22F1/10;;B23K26/00;;B23K26/03;;B23K26/14;;B23K26/144;;B23K26/342;;B23K26/70;;B33Y10/00;;B33Y30/00;;B33Y80/00,,0,0,,,,ACTIVE
6,US,A,US 5002387 A,038-661-558-544-523,1991-03-26,1991,US 49815890 A,1990-03-23,US 49815890 A,1990-03-23,Projection synchronization system,"An alternate eye 3-d projection system has a projector projecting alternate eye left and right images, has alternating eye 3-d glasses alternating between left and right lens transmissiveness, and has a phase delay unit synchronizing the left lens transmissiveness to left images and right lens transmissiveness to right images. A timing shutter is driven through a mechanical link to the projector primary mechanism at a frequency proportional to the frequency of the transition between images. A sensor outputs pulses according to the rotationally frequency of the timing shutter. The phase delay unit receives the pulses, a multiplier multiplies the frequency of the pulses, a phase lock loop locks on to the frequency and a counter counts the pulses. After a preset delay the counter outputs a pulse. The delay is adjustable. The counter pulse enables a 60 KHz oscillator. The oscillations are counted by another counter and passed to a transmitter. The 60 KHz oscillations are disabled when the other counter reaches a preset amount. The other counter sets the duty cycle of the transmitter. Each of the components in the unit is duplicated in a back-up section. The back-up section is enabled when the primary phase lock loop is not locked on and the back-up phase locked loop is locked on.",IMAX SYSTEMS CORP,BALJET ANTON L;;CARTER GERARD C;;HARRIS GORDON W,IMAX CORPORATION (1991-05-14);;IMAX SYSTEMS CORPORATION 38 ISABELLA ST. TORONTO ONTARIO CANADA M4Y 1N1 A CORP. OF CANADA (1990-01-31),https://lens.org/038-661-558-544-523,Granted Patent,yes,2,75,1,1,0,G03B35/16;;H04N13/341;;H04N13/161;;H04N13/363;;H04N13/10;;H04N13/398;;G03B35/16;;H04N13/363;;H04N13/341;;H04N13/10;;H04N13/398;;H04N13/161,G03B35/16;;H04N13/00,352/63;;350/132,1,0,,,"Lipton, Lenny, Foundations of the Stereoscopic Cinema: A Study in Depth . Van Nostrand Reinhold: New York, 1982, Chapter 6.",EXPIRED
7,EP,A1,EP 3132885 A1,046-519-365-579-060,2017-02-22,2017,EP 16184982 A,2016-08-19,US 201514830759 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate (23) positioned on a base plate to a predetermined temperature using a first heater; using a laser (26) to form a melt pool (34) on a surface of the substrate (23); introducing a superalloy powder (32) to the melt pool (34); measuring the temperature of the melt pool (34); receiving the temperature measured at a controller (40); and using an auxiliary heat source (41) in communication with the controller (40) to adjust the temperature of the melt pool (34). The predetermined temperature is below the substrate's melting point. The laser (26) and the base plate are movable relative to each other, with the laser (26) being used for direct metal deposition. An apparatus is also generally provided for direct writing of single crystal super alloys and metals.
",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/046-519-365-579-060,Patent Application,yes,3,9,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,B23K26/342;;B23K26/03,,0,0,,,,ACTIVE
8,CN,A,CN 106552939 A,068-157-757-150-135,2017-04-05,2017,CN 201611051382 A,2016-08-20,US 201514830759 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METAL,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate (23) positioned on a base plate (22) to a predetermined temperature using a first heater (24); using a laser (26) to form a melt pool (34) on a surface of the substrate (23); introducing a superalloy powder (32) to the melt pool (34); measuring the temperature of the melt pool (34); receiving the temperature measured at a controller (40); and using an auxiliary heat source (41) in communication with the controller (40) to adjust the temperature of the melt pool (34). The predetermined temperature is below the substrate's melting point. The laser (26) and the base plate (22) are movable relative to each other, with the laser (26) being used for direct metal deposition. An apparatus (20) is also generally provided for direct writing of single crystal super alloys and metals.",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/068-157-757-150-135,Patent Application,no,6,4,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,B22F3/105;;B33Y10/00;;B33Y30/00;;C30B29/52,,0,0,,,,ACTIVE
9,CA,A1,CA 3214990 A1,035-392-665-400-742,2022-11-17,2022,CA 3214990 A,2022-05-12,US 202163187753 P;;US 2022/0029002 W,2021-05-12,COMBINATIONS FOR TREATMENT OF CANCER,"The present disclosure is directed to combinations of menin inhibitors and Bcl-2 inhibitors, optionally in further combination with hypomethylating agents and/or FLT3 inhibitors for the treatment of cancer. Specifically, menin inhibitors combined with venetoclax are synergistic in the treatment of cancers with a HOX gene signature such as acute myeloid leukemia.",SYNDAX PHARMACEUTICALS INC;;UNIV TEXAS,MCGEEHAN GERARD M;;ORDENTLICH PETER;;CARTER BING;;ANDREEFF MICHAEL,,https://lens.org/035-392-665-400-742,Patent Application,no,0,0,5,5,0,A61P35/00;;A61P35/02;;A61K45/06;;A61K31/635;;A61K31/506;;A61K31/497;;A61K31/706,A61P35/02,,0,0,,,,PENDING
10,EP,A2,EP 4234154 A2,185-501-609-379-749,2023-08-30,2023,EP 23168508 A,2016-08-19,US 201514830759 A;;EP 16184982 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate (23) positioned on a base plate (22) to a predetermined temperature using a first heater (24); using a laser (26) to form a melt pool (34) on a surface of the substrate (23); introducing a superalloy powder (32) to the melt pool (34); measuring the temperature of the melt pool (34); receiving the temperature measured at a controller (40); and using an auxiliary heat source (41) in communication with the controller (40) to adjust the temperature of the melt pool (34). The predetermined temperature is below the substrate's melting point. The laser (26) and the base plate (22) are movable relative to each other, with the laser (26) being used for direct metal deposition. An apparatus (20) is also generally provided for direct writing of single crystal super alloys and metals.
",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/185-501-609-379-749,Patent Application,yes,1,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,B23K26/342,,0,0,,,,PENDING
11,US,B2,US 11661644 B2,073-561-778-560-374,2023-05-30,2023,US 201916451430 A,2019-06-25,US 201916451430 A;;US 201514830759 A,2015-08-20,Apparatus and method for direct writing of single crystal super alloys and metals,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate positioned on a base plate to a predetermined temperature using a first heater; using a laser to form a melt pool on a surface of the substrate; introducing a superalloy powder to the melt pool; measuring the temperature of the melt pool; receiving the temperature measured at a controller; and using an auxiliary heat source in communication with the controller to adjust the temperature of the melt pool. The predetermined temperature is below the substrate's melting point. The laser and the base plate are movable relative to each other, with the laser being used for direct metal deposition. An apparatus is also generally provided for direct writing of single crystal super alloys and metals.",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,GENERAL ELECTRIC COMPANY (2015-08-07),https://lens.org/073-561-778-560-374,Granted Patent,yes,31,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,C22F1/10;;B22F5/04;;B22F10/20;;B22F10/30;;B23K26/00;;B23K26/03;;B23K26/14;;B23K26/144;;B23K26/342;;B23K26/70;;B23K101/00;;B23K103/08;;B33Y10/00;;B33Y30/00;;B33Y50/02;;B33Y80/00;;F01D5/18;;F01D5/28;;F01D9/02,,4,0,,,"European Search Report Corresponding to Application No. 16184982 dated Dec. 21, 2016.;;Machine Translated Japanese Search Report Corresponding to Application No. 2016159464 dated Aug. 8, 2017.;;Brazilian Search Report Corresponding to Application No. 102016019180 dated Oct. 9, 2019.;;Indian Search Report Corresponding to Application No. 201644028192 dated Dec. 4, 2019.",ACTIVE
12,EP,A2,EP 0429290 A2,084-921-854-858-515,1991-05-29,1991,EP 90312611 A,1990-11-20,CA 2003496 A,1989-11-21,Projection synchronization system.,"An alternate eye 3-d projection system has a projector (2) projecting alternate eye left and right images, has alternating eye 3-d glasses (7) alternating between left and right lens transmissiveness, and has a phase delay unit (29) synchronizing the left lens trans­missiveness to left images and right lens transmissive­ness to right images. A timing shutter (17) is driven through a mechanical link to the projector primary mechanism at a frequency proportional to the frequency of the transition between images. A sensor (21) outputs pulses according to the rotational frequency of the timing shutter. The phase delay unit receives the pulses, a multiplier (31) multiplies the frequency of the pulses, a phase lock loop (33) locks on to the frequency and a counter (35) counts the pulses. After a preset delay the counter outputs a pulse. The delay is adjustable. The counter pulse enables a 60 KHz oscillator (43). The oscillations are counted by another counter (41) and passed to a transmitter (6). The 60 KHz oscillations are disabled when the other counter (41) reaches a preset amount. The other counter (41) sets the duty cycle of the transmitter. Each of the components in the unit is duplicated in a back-up section. The back-up section is enabled when the primary phase lock loop is not locked on and the back-up phase locked loop is locked on. (Fig. 5)  ",IMAX SYSTEMS CORP,BALJET ANTON L;;CARTER GERARD C;;HARRIS GORDON W,,https://lens.org/084-921-854-858-515,Patent Application,yes,0,4,5,5,0,G03B35/16;;H04N13/341;;H04N13/363;;H04N13/398;;H04N13/363;;G03B35/16,G02B27/22;;G03B21/00;;G03B35/16;;H04N13/363,,0,0,,,,DISCONTINUED
13,US,A1,US 2019/0323111 A1,105-758-233-087-116,2019-10-24,2019,US 201916451430 A,2019-06-25,US 201916451430 A;;US 201514830759 A,2015-08-20,Apparatus and Method for Direct Writing of Single Crystal Super Alloys and Metals,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate positioned on a base plate to a predetermined temperature using a first heater; using a laser to form a melt pool on a surface of the substrate; introducing a superalloy powder to the melt pool; measuring the temperature of the melt pool; receiving the temperature measured at a controller; and using an auxiliary heat source in communication with the controller to adjust the temperature of the melt pool. The predetermined temperature is below the substrate's melting point. The laser and the base plate are movable relative to each other, with the laser being used for direct metal deposition. An apparatus is also generally provided for direct writing of single crystal super alloys and metals.",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,GENERAL ELECTRIC COMPANY (2015-08-07),https://lens.org/105-758-233-087-116,Patent Application,yes,0,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,C22F1/10;;B22F3/105;;B22F5/04;;B23K26/00;;B23K26/03;;B23K26/14;;B23K26/144;;B23K26/342;;B23K26/70;;B33Y10/00;;B33Y30/00;;B33Y50/02;;B33Y80/00,,0,0,,,,ACTIVE
14,CA,C,CA 2939733 C,128-409-916-378-552,2019-09-17,2019,CA 2939733 A,2016-08-18,US 201514830759 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate (23) positioned on a base plate (22) to a predetermined temperature using a first heater (24); using a laser (26) to form a melt pool (34) on a surface of the substrate (23); introducing a superalloy powder (32) to the melt pool (34); measuring the temperature of the melt pool (34); receiving the temperature measured at a controller (40); and using an auxiliary heat source (41) in communication with the controller (40) to adjust the temperature of the melt pool (34). The predetermined temperature is below the substrate's melting point. The laser (26) and the base plate (22) are movable relative to each other, with the laser (26) being used for direct metal deposition. An apparatus (20) is also generally provided for direct writing of single crystal super alloys and metals.",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/128-409-916-378-552,Granted Patent,no,0,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,C30B13/28;;C30B13/24,,0,0,,,,ACTIVE
15,CA,A1,CA 2939733 A1,158-172-960-577-36X,2017-02-20,2017,CA 2939733 A,2016-08-18,US 201514830759 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate (23) positioned on a base plate (22) to a predetermined temperature using a first heater (24); using a laser (26) to form a melt pool (34) on a surface of the substrate (23); introducing a superalloy powder (32) to the melt pool (34); measuring the temperature of the melt pool (34); receiving the temperature measured at a controller (40); and using an auxiliary heat source (41) in communication with the controller (40) to adjust the temperature of the melt pool (34). The predetermined temperature is below the substrate's melting point. The laser (26) and the base plate (22) are movable relative to each other, with the laser (26) being used for direct metal deposition. An apparatus (20) is also generally provided for direct writing of single crystal super alloys and metals.",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/158-172-960-577-36X,Patent Application,no,0,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,C30B13/28;;C30B13/24,,0,0,,,,ACTIVE
16,EP,A3,EP 0429290 A3,065-931-054-072-717,1992-04-29,1992,EP 90312611 A,1990-11-20,CA 2003496 A,1989-11-21,PROJECTION SYNCHRONIZATION SYSTEM,"An alternate eye 3-d projection system has a projector (2) projecting alternate eye left and right images, has alternating eye 3-d glasses (7) alternating between left and right lens transmissiveness, and has a phase delay unit (29) synchronizing the left lens trans­missiveness to left images and right lens transmissive­ness to right images. A timing shutter (17) is driven through a mechanical link to the projector primary mechanism at a frequency proportional to the frequency of the transition between images. A sensor (21) outputs pulses according to the rotational frequency of the timing shutter. The phase delay unit receives the pulses, a multiplier (31) multiplies the frequency of the pulses, a phase lock loop (33) locks on to the frequency and a counter (35) counts the pulses. After a preset delay the counter outputs a pulse. The delay is adjustable. The counter pulse enables a 60 KHz oscillator (43). The oscillations are counted by another counter (41) and passed to a transmitter (6). The 60 KHz oscillations are disabled when the other counter (41) reaches a preset amount. The other counter (41) sets the duty cycle of the transmitter. Each of the components in the unit is duplicated in a back-up section. The back-up section is enabled when the primary phase lock loop is not locked on and the back-up phase locked loop is locked on. (Fig. 5)  ",IMAX SYSTEMS CORPORATION,"BALJET, ANTON L.;;CARTER, GERARD C.;;HARRIS, GORDON W.",,https://lens.org/065-931-054-072-717,Search Report,yes,5,0,5,5,0,G03B35/16;;H04N13/341;;H04N13/363;;H04N13/398;;H04N13/363;;G03B35/16,G02B27/22;;G03B21/00;;G03B35/16;;H04N13/363,,0,0,,,,DISCONTINUED
17,CA,A1,CA 2003496 A1,177-311-305-505-024,1991-05-21,1991,CA 2003496 A,1989-11-21,CA 2003496 A,1989-11-21,PROJECTION SYNCHRONIZATION SYSTEM,,IMAX SYSTEMS CORPORATION,"BALJET, ANTON L.;;CARTER, GERARD C.;;HARRIS, GORDON W.",,https://lens.org/177-311-305-505-024,Patent Application,no,0,0,5,5,0,G03B35/16;;H04N13/341;;H04N13/363;;H04N13/398;;H04N13/363;;G03B35/16,G02B27/22;;G03B21/00;;G03B35/16;;H04N13/363,D20880004    M,0,0,,,,EXPIRED
18,JP,A,JP 2017066023 A,027-099-930-469-220,2017-04-06,2017,JP 2016159464 A,2016-08-16,US 201514830759 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"PROBLEM TO BE SOLVED: To provide an apparatus and method for direct writing of single crystal super alloys and metals.SOLUTION: The method includes: heating a substrate (23) positioned on a base plate (22) to a predetermined temperature using a first heater (24); using a laser (26) to form a melt pool (34) on a surface of the substrate (23); introducing a super alloy powder (32) to the melt pool (34); measuring the temperature of the melt pool (34); receiving the temperature measured at a controller (40); and using an auxiliary heat source (41) in communication with the controller (40) to adjust the temperature of the melt pool (34). The predetermined temperature is below the melting point of the substrate. The laser (26) and the base plate (22) are movable relative to each other, with the laser (26) being used for direct metal deposition. An apparatus (20) is also generally provided for direct writing of single crystal super alloys and metals.SELECTED DRAWING: Figure 1",GENERAL ELECTRIC CO GE,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/027-099-930-469-220,Patent Application,no,4,2,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,C30B29/52;;B22F3/105;;B22F3/16;;C30B7/00;;F01D25/00;;F02C7/00,,0,0,,,,ACTIVE
19,CA,C,CA 2003496 C,188-096-224-619-425,1994-06-07,1994,CA 2003496 A,1989-11-21,CA 2003496 A,1989-11-21,PROJECTION SYNCHRONIZATION SYSTEM,"TITLE: PROJECTION SYNCHRONIZATION SYSTEM INVENTORS: ANTON L. BALJET GERARD C. CARTER GORDON N. HARRIS An alternate eye 3-d projection system has a projector projecting alternate eye left and right images, has alternating eye 3-d glasses alternating between left and right lens transmissiveness, and has a phase delay unit synchronizing the left lens transmissiveness to left images and right lens transmissiveness to right images. A timing shutter is driven through a mechanical link to the projector primary mechanism at a frequency proportional to the frequency of the transistion between images. A sensor outputs pulses according to the rotationally frequency of the timing shutter. The phase delay unit receives the pulses, a multiplier multiplies the frequency of the pulses, a phase lock loop locks on to the frequency and a counter counts the pulses. After a preset delay the counter outputs a pulse. The delay is adjustable. The counter pulse enables a 60 KHz oscillator. The oscillations are counted by another counter and passed to a transmitter. The 60 KHz oscillations are disabled when the other counter reaches a preset amount. The other counter sets the duty cycle of the transmitter. Each of the components in the unit is duplicated in a back-up section. The back-up section is enabled when the primary phase lock loop is not locked on and the backup phase locked loop is locked on.",IMAX CORP,BALJET ANTON L;;CARTER GERARD C;;HARRIS GORDON W,,https://lens.org/188-096-224-619-425,Granted Patent,no,0,0,5,5,0,G03B35/16;;H04N13/341;;H04N13/363;;H04N13/398;;H04N13/363;;G03B35/16,G02B27/22;;G03B21/00;;G03B35/16;;H04N13/363,D20880004    M,0,0,,,,EXPIRED
20,EP,B1,EP 3132885 B1,074-579-438-779-486,2023-05-31,2023,EP 16184982 A,2016-08-19,US 201514830759 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,,GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/074-579-438-779-486,Granted Patent,yes,1,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,B23K26/342;;B23K26/03,,0,0,,,,ACTIVE
21,KR,A,KR 20240006625 A,107-779-310-928-579,2024-01-15,2024,KR 20237042364 A,2022-05-12,US 202163187753 P;;US 2022/0029002 W,2021-05-12,암 치료를 위한 조합물,"본 개시내용은 암 치료를 위한 메닌 억제제 및 Bcl-2 억제제의 조합물, 선택적으로 저메틸화제 및/또는 FLT3 억제제와의 추가 조합물에 관한 것이다. 특히, 베네토클락스와 결합된(combined) 메닌 억제제는 급성 골수성 백혈병과 같은 HOX 유전자 시그니처를 갖는 암 치료에 시너지 효과가 있다.",SYNDAX PHARMACEUTICALS INC;;UNIV TEXAS,MCGEEHAN GERARD M;;ORDENTLICH PETER;;CARTER BING;;ANDREEFF MICHAEL,,https://lens.org/107-779-310-928-579,Patent Application,no,0,0,5,5,0,A61P35/00;;A61P35/02;;A61K45/06;;A61K31/635;;A61K31/506;;A61K31/497;;A61K31/706,A61K31/513;;A61K31/497;;A61K31/635;;A61K31/706;;A61K45/06;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
22,US,A1,US 2022/0405400 A1,151-591-673-732-701,2022-12-22,2022,US 202217874562 A,2022-07-27,US 202217874562 A;;US 202217750378 A;;US 202263300240 P;;US 202263300228 P;;US 202263296152 P;;US 202163213199 P,2021-06-21,"SYSTEMS, METHODS, AND USER INTERFACES FOR INTELLIGENT AND EXPEDITED GENERATION OF CYBERSECURITY ARTIFACTS USING CYBERSECURITY CONTROL DATA OBJECTS","In some embodiments, a cybersecurity data handling and governance service displays a cybersecurity artifact generation object. In some embodiments, while displaying the cybersecurity artifact generation object, the cybersecurity data handling and governance service receives a first input selecting the cybersecurity artifact generation object. In some embodiments, in accordance with a determination that the first input is directed to generating a first cybersecurity artifact corresponding to a first authoritative information security standard and in accordance with a determination that the first user interface is dedicated to displaying information directed to a respective cybersecurity data catalogue, the cybersecurity data handling and governance service generates the first cybersecurity artifact based on a first set of cybersecurity control data objects included in the respective cybersecurity data catalogue in accordance with submittal-criteria defined by the first authoritative information security standard.",RISQ MAN LLC,SCHEITLIN GERARD EDWARD;;SCHEITLIN QUINTIN SCOTT;;SCHEITLIN CHANDLER CARTER,RISQ MANAGEMENT LLC (2022-06-07),https://lens.org/151-591-673-732-701,Patent Application,yes,0,0,2,2,0,G06F21/577;;G06F2221/034;;G06F21/577,G06F21/57,,0,0,,,,PENDING
23,US,B2,US 10443115 B2,090-014-633-898-191,2019-10-15,2019,US 201514830759 A,2015-08-20,US 201514830759 A,2015-08-20,Apparatus and method for direct writing of single crystal super alloys and metals,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate positioned on a base plate to a predetermined temperature using a first heater; using a laser to form a melt pool on a surface of the substrate; introducing a superalloy powder to the melt pool; measuring the temperature of the melt pool; receiving the temperature measured at a controller; and using an auxiliary heat source in communication with the controller to adjust the temperature of the melt pool. The predetermined temperature is below the substrate's melting point. The laser and the base plate are movable relative to each other, with the laser being used for direct metal deposition. An apparatus is also generally provided for direct writing of single crystal super alloys and metals.",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,GENERAL ELECTRIC COMPANY (2015-08-07),https://lens.org/090-014-633-898-191,Granted Patent,yes,21,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,C22F1/10;;B22F3/105;;B22F5/04;;B23K26/00;;B23K26/03;;B23K26/14;;B23K26/144;;B23K26/342;;B23K26/70;;B23K101/00;;B23K103/08;;B33Y10/00;;B33Y30/00;;B33Y50/02;;B33Y80/00;;F01D5/18;;F01D5/28;;F01D9/02,,4,0,,,"Machine Translation and First Office Action and Search issued in connection with corresponding CN Application No. 201611051382.6 datd Feb. 2, 2018.;;European Search Report issued in connection with corresponding EP Application No. EP16184982.3 dated Jan. 16, 2017.;;Machine Translation and Notification of Reasons for Refusal issued in connection with corresponding JP Application No. 2016-159464 dated Aug. 15, 2017.;;Mazumder, J., et al., Apparatus and method for direct writing of single crystal super alloys and metals, GE Co-Pending U.S. Appl. No. 62/041,884, filed Aug. 26, 2014.",ACTIVE
24,BR,A2,BR 102016019180 A2,055-096-514-712-326,2017-02-21,2017,BR 102016019180 A,2016-08-19,US 201514830759 A,2015-08-20,métodos e aparelho para gravação direta de metais e superligas de cristal único,"trata-se de métodos para gravação direta de metais e superligas de cristal único. o método pode incluir: aquecer um substrato (23) posicionado em uma placa de base (22) a uma predeterminada temperatura com o uso de um primeiro aquecedor (24); usar um laser (26) para formar um depósito em fusão (34) em uma superfície do substrato (23); introduzir um pó de superliga (32) para o depósito em fusão (34); medir a temperatura do depósito em fusão (34); receber a temperatura medida em um controlador (40); e usar uma fonte de calor auxiliar (41) em comunicação com o controlador (40) para ajustar a temperatura do depósito em fusão (34). a temperatura predeterminada está abaixo do ponto de fusão do substrato. o laser (26) e a placa de base (22) são móveis um em relação ao outro, em que o laser (26) é usado para direcionar deposição de metal. um aparelho (20) também é geralmente fornecido para gravação direta de metais e superligas de cristal único.",GEN ELECTRIC,DOUGLAS GERARD KONITZER;;TODD JAY ROCKSTROH;;WILLIAM THOMAS CARTER,,https://lens.org/055-096-514-712-326,Patent Application,no,0,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,B23K26/08;;B23K26/00;;B23K26/144,,0,0,,,,PENDING
25,EP,A3,EP 4234154 A3,179-375-692-048-286,2023-09-13,2023,EP 23168508 A,2016-08-19,US 201514830759 A;;EP 16184982 A,2015-08-20,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"Methods for direct writing of single crystal super alloys and metals are provided. The method can include: heating a substrate (23) positioned on a base plate (22) to a predetermined temperature using a first heater (24); using a laser (26) to form a melt pool (34) on a surface of the substrate (23); introducing a superalloy powder (32) to the melt pool (34); measuring the temperature of the melt pool (34); receiving the temperature measured at a controller (40); and using an auxiliary heat source (41) in communication with the controller (40) to adjust the temperature of the melt pool (34). The predetermined temperature is below the substrate's melting point. The laser (26) and the base plate (22) are movable relative to each other, with the laser (26) being used for direct metal deposition. An apparatus (20) is also generally provided for direct writing of single crystal super alloys and metals.
",GEN ELECTRIC,CARTER WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD,,https://lens.org/179-375-692-048-286,Search Report,yes,2,0,15,15,0,B33Y10/00;;B33Y30/00;;C30B29/52;;B22F10/00;;B22F10/368;;B22F12/20;;B22F12/17;;B22F12/45;;B22F10/25;;B22F12/90;;B22F2999/00;;B23K26/034;;B23K26/342;;B22F5/04;;B22F2999/00;;B33Y50/02;;B23K2101/001;;B23K2103/08;;B33Y10/00;;B33Y30/00;;C22F1/10;;B29C64/153;;B22F12/17;;B22F12/20;;B22F10/368;;B22F10/25;;B22F12/45;;B22F12/90;;Y02P10/25;;B23K2101/001;;B23K2103/08;;B23K26/034;;B23K26/342;;B22F2999/00;;B33Y50/02;;B22F5/04;;Y02P10/25;;B22F10/25;;B22F12/17;;B22F12/20;;B22F12/45;;B22F12/90;;B22F10/368;;B22F10/20;;B22F10/30;;B33Y10/00;;B33Y30/00;;B33Y80/00;;B23K26/144;;B23K26/703;;B23K26/0006;;B23K26/1464;;C22F1/10;;F01D5/18;;F01D5/28;;F01D9/02;;F05D2220/32;;F05D2230/30;;F05D2260/20;;F05D2300/175,B23K26/03;;B23K26/342,,0,0,,,,PENDING
26,EP,A1,EP 0132317 A1,173-196-042-278-58X,1985-01-30,1985,EP 84304347 A,1984-06-27,GB 8317499 A,1983-06-28,"The use of dispersing aids in processing aid compositions for vinyl chloride polymer, the production of said compositions and vinyl chloride compositions containing them.","@ The dispersability of processing aids for vinyl chloride polymers is improved by the use of a dispersing aid comprising at least one homopolymer and/or copolymer containing at least 50% by weight of units of one or more of the following monomers: (C 1 -C 8 )-alkyl acrylates, (C 1 -C 9 )-cycloalkyl acrylates, ethylene, propylene, vinyl acetate and butadiene. Preferred processing aid compositions therefor comprise blends of (a) copolymer(s) of methyl methacrylate and, in an amount of less than 50% by weight of the copolymer, (C l -C 4 )-alkyl acrylate(s) and (b) at least one such dispersing aid homopolymer or copolymer wherein the ratio of (a):(b) is 99.5:0.5 to 90:10. The blend may be prepared by intimately mixing components (a) and (b) as latex polymer and subsequently coiso- lated.",ROHM & HAAS,RABINOVIC ISMAIL SAMY;;THOMANN HUBERT;;GUTH GERARD;;CARTER WILLIAM EARL,,https://lens.org/173-196-042-278-58X,Patent Application,yes,1,9,9,12,0,C08L27/06;;C08L33/08,C08L27/06;;C08L33/08,,0,0,,,,EXPIRED
27,AT,T1,AT E87955 T1,060-173-279-311-748,1993-04-15,1993,AT 84304347 T,1984-06-27,EP 84304347 A;;GB 8317499 A,1983-06-28,"VERWENDUNG VON DISPERGIERMITTELN FUER DIE VERBESSERUNG DER HERSTELLUNG VON PVCZUSAMMENSETZUNGEN, HERSTELLUNG SOLCHER ZUSAMMENSETZUNGEN UND DIESE VERBINDUNGEN ENTHALTENDE PVC-ZUSAMMENSETZUNGEN.","The dispersability of processing aids for vinyl chloride polymers is improved by the use of a dispersing aid comprising at least one homopolymer and/or copolymer containing at least 50% by weight of units of one or more of the following monomers: (C1-C8)-alkyl acrylates, (C1-C9)-cycloalkyl acrylates, ethylene, propylene, vinyl acetate and butadiene. Preferred processing aid compositions therefor comprise blends of (a) copolymer(s) of methyl methacrylate and, in an amount of less than 50% by weight of the copolymer, (C1-C4)-alkyl acrylate(s) and (b) at least one such dispersing aid homopolymer or copolymer wherein the ratio of (a):(b) is 99.5:0.5 to 90:10. The blend may be prepared by intimately mixing components (a) and (b) as latex polymer and subsequently coisolated.",ROHM & HAAS,RABINOVIC ISMAIL SAMY;;THOMANN HUBERT;;GUTH GERARD;;CARTER WILLIAM EARL,,https://lens.org/060-173-279-311-748,Granted Patent,no,0,0,9,12,0,C08L27/06;;C08L33/08,C08L27/06;;C08L33/08,,0,0,,,,DISCONTINUED
28,DE,D1,DE 3486125 D1,139-665-279-378-999,1993-05-13,1993,DE 3486125 T,1984-06-27,GB 8317499 A,1983-06-28,"VERWENDUNG VON DISPERGIERMITTELN FUER DIE VERBESSERUNG DER HERSTELLUNG VON PVC-ZUSAMMENSETZUNGEN, HERSTELLUNG SOLCHER ZUSAMMENSETZUNGEN UND DIESE VERBINDUNGEN ENTHALTENDE PVC-ZUSAMMENSETZUNGEN.","The dispersability of processing aids for vinyl chloride polymers is improved by the use of a dispersing aid comprising at least one homopolymer and/or copolymer containing at least 50% by weight of units of one or more of the following monomers: (C1-C8)-alkyl acrylates, (C1-C9)-cycloalkyl acrylates, ethylene, propylene, vinyl acetate and butadiene. Preferred processing aid compositions therefor comprise blends of (a) copolymer(s) of methyl methacrylate and, in an amount of less than 50% by weight of the copolymer, (C1-C4)-alkyl acrylate(s) and (b) at least one such dispersing aid homopolymer or copolymer wherein the ratio of (a):(b) is 99.5:0.5 to 90:10. The blend may be prepared by intimately mixing components (a) and (b) as latex polymer and subsequently coisolated.",ROHM & HAAS,RABINOVIC ISMAIL SAMY;;THOMANN HUBERT;;GUTH GERARD;;CARTER WILLIAM EARL,,https://lens.org/139-665-279-378-999,Granted Patent,no,0,0,9,12,0,C08L27/06;;C08L33/08,C08L27/06;;C08L33/08,,0,0,,,,EXPIRED
29,DE,T2,DE 3486125 T2,092-611-704-709-22X,1993-11-04,1993,DE 3486125 T,1984-06-27,GB 8317499 A,1983-06-28,"VERWENDUNG VON DISPERGIERMITTELN FUER DIE VERBESSERUNG DER HERSTELLUNG VON PVC-ZUSAMMENSETZUNGEN, HERSTELLUNG SOLCHER ZUSAMMENSETZUNGEN UND DIESE VERBINDUNGEN ENTHALTENDE PVC-ZUSAMMENSETZUNGEN.","The dispersability of processing aids for vinyl chloride polymers is improved by the use of a dispersing aid comprising at least one homopolymer and/or copolymer containing at least 50% by weight of units of one or more of the following monomers: (C1-C8)-alkyl acrylates, (C1-C9)-cycloalkyl acrylates, ethylene, propylene, vinyl acetate and butadiene. Preferred processing aid compositions therefor comprise blends of (a) copolymer(s) of methyl methacrylate and, in an amount of less than 50% by weight of the copolymer, (C1-C4)-alkyl acrylate(s) and (b) at least one such dispersing aid homopolymer or copolymer wherein the ratio of (a):(b) is 99.5:0.5 to 90:10. The blend may be prepared by intimately mixing components (a) and (b) as latex polymer and subsequently coisolated.",ROHM & HAAS,RABINOVIC ISMAIL SAMY;;THOMANN HUBERT;;GUTH GERARD;;CARTER WILLIAM EARL,,https://lens.org/092-611-704-709-22X,Granted Patent,no,0,0,9,12,0,C08L27/06;;C08L33/08,C08L27/06;;C08L33/08,,0,0,,,,EXPIRED
30,US,A,US 4460733 A,175-640-268-421-570,1984-07-17,1984,US 44531782 A,1982-11-29,US 44531782 A,1982-11-29,Polycarbonate compositions having low gloss values,The present invention is directed to a polycarbonate composition comprising finely divided silica which composition is characterized by low gloss.,MOBAY CHEMICAL CORP,CARTER JR RUSSELL P;;LIM IN C;;REINERT GERARD E,MOBAY CHEMICAL CORPORATION A NJ CORP (1982-11-10),https://lens.org/175-640-268-421-570,Granted Patent,yes,9,18,1,82,0,C08K3/36;;C08K3/36,C08K3/36,524/493;;524/611,7,0,,,"Min u sil Powder Coating Fillers; Epoxy and Polyester Powders, PGS a Subsidiary of ITT, No. 2072 SM976 CL.;;TS 100, Flatting Agent, Degussa PT 47 2 3 977.;;Technical Bulletin Pigments, Synthetic Silica Auxilaries for the Plastics Industry, Degussa, Pig 13 4 4 779 DD, Jul. 1979.;;The Family of Syloid Silicas; Grace, Davison Chemical Division; PA 59 280.;;Min u sil & Supersil Fillers for Adhesives & Sealants, PGS, a Subsidiary of ITT; 2055 5M1079 CL.;;Min u sil, Micron sized Silica Multi Purpose Filler and Extender, PGS, a Subsidiary of ITT, 2073 SM978 CL.;;Min u sil, PGS, Floridin, a Member of ITT System 2059 5M 1179 CL., p. 610 of 4th Ed Hackh s.",EXPIRED
31,EP,B1,EP 0132317 B1,197-206-536-280-126,1993-04-07,1993,EP 84304347 A,1984-06-27,GB 8317499 A,1983-06-28,"THE USE OF DISPERSING AIDS IN PROCESSING AID COMPOSITIONS FOR VINYL CHLORIDE POLYMER, THE PRODUCTION OF SAID COMPOSITIONS AND VINYL CHLORIDE COMPOSITIONS CONTAINING THEM","The dispersability of processing aids for vinyl chloride polymers is improved by the use of a dispersing aid comprising at least one homopolymer and/or copolymer containing at least 50% by weight of units of one or more of the following monomers: (C1-C8)-alkyl acrylates, (C1-C9)-cycloalkyl acrylates, ethylene, propylene, vinyl acetate and butadiene. Preferred processing aid compositions therefor comprise blends of (a) copolymer(s) of methyl methacrylate and, in an amount of less than 50% by weight of the copolymer, (C1-C4)-alkyl acrylate(s) and (b) at least one such dispersing aid homopolymer or copolymer wherein the ratio of (a):(b) is 99.5:0.5 to 90:10. The blend may be prepared by intimately mixing components (a) and (b) as latex polymer and subsequently coisolated.",ROHM AND HAAS COMPANY,"RABINOVIC, ISMAIL SAMY;;THOMANN, HUBERT;;GUTH, GERARD;;CARTER, WILLIAM EARL",,https://lens.org/197-206-536-280-126,Granted Patent,yes,1,0,9,12,0,C08L27/06;;C08L33/08,C08L27/06;;C08L33/08,,0,0,,,,EXPIRED
32,CA,A,CA 1253641 A,181-147-165-514-772,1989-05-02,1989,CA 457239 A,1984-06-22,GB 8317499 A;;US 61597684 A,1983-06-28,PROCESSING AID COMPOSITIONS,"- iPATENT APPLICATION of ISMAIL SAMY RABINOVIC HUBERT THOMANN GERARD GUTH and WILLIAM EARL CARTER for IMPROVED PROCESSING AID COMPOSITIONS DN 83-36 MSA:plb This invention is directed to improved processing aid compositions for vinylchloride polymers. The improved processing aid compositions are formed from an intimate admixture of a conventional processing aid for vinylchloride polymers and a dispersion aid polymer. The dispersion aid polymer acts to disperse the processing aid polymer in the vinylchloride polymer, reducing the tendency of the processing aid to form lumps or gels in the vinylchloride polymer. The weight ratio of the processing aid polymer to the dispersion aid polymer in the improved processing aid composition ranges from 99.5 to 0.5 to 90 to 10. The vinylchloride polymer contains from about 0.5 to 5 parts by weight of the improved processing aid composition to 99.5 to 95 parts of vinylchloride polymer.",ROHM & HAAS,RABINOVIC ISMAIL S;;GUTH GERARD;;THOMANN HUBERT;;CARTER WILLIAM E,,https://lens.org/181-147-165-514-772,Granted Patent,no,0,1,3,12,0,,C08L27/00;;C08L1/00;;C08L7/00;;C08L9/00;;C08L21/00;;C08L23/00;;C08L23/02;;C08L25/00;;C08L27/06;;C08L31/00;;C08L31/04;;C08L33/00;;C08L33/02;;C08L33/04;;C08L33/08;;C08L51/00;;C08L51/02;;C08L51/04;;C08L101/00,400-100,0,0,,,,EXPIRED
33,ZA,B,ZA 844862 B,001-113-958-107-568,1986-02-26,1986,ZA 844862 A,1984-06-26,GB 8317499 A,1983-06-28,"THE USE OF DISPERSING AIDS IN PROCESSING AID COMPOSITIONS FOR VINYL CHLORIDE POLYMER,THE PRODUCTION OF SAID COMPOSITIONS AND VINYL CHLORIDE COMPOSITIONS CONTAINING THEM","The dispersability of processing aids for vinyl chloride polymers is improved by the use of a dispersing aid comprising at least one homopolymer and/or copolymer containing at least 50% by weight of units of one or more of the following monomers: (C1-C8)-alkyl acrylates, (C1-C9)-cycloalkyl acrylates, ethylene, propylene, vinyl acetate and butadiene. Preferred processing aid compositions therefor comprise blends of (a) copolymer(s) of methyl methacrylate and, in an amount of less than 50% by weight of the copolymer, (C1-C4)-alkyl acrylate(s) and (b) at least one such dispersing aid homopolymer or copolymer wherein the ratio of (a):(b) is 99.5:0.5 to 90:10. The blend may be prepared by intimately mixing components (a) and (b) as latex polymer and subsequently coisolated.",ROHM & HAAS,RABINOVIC ISMAIL SAMY;;THOMANN HUBERT;;GUTH GERARD;;CARTER WILLIAM EARL,,https://lens.org/001-113-958-107-568,Granted Patent,no,0,0,9,12,0,C08L27/06;;C08L33/08,C08L27/06;;C08L33/08,,0,0,,,,EXPIRED
34,EP,A1,EP 0083796 A1,126-894-953-750-084,1983-07-20,1983,EP 82112042 A,1982-12-28,US 33880682 A,1982-01-11,"Flame-resistant moulding masses based on polyethylene terephthalate, process for its preparation and its use in the production of articles.","Flammwidrige Polyethylenterephthalat-Formmassen, die pyrogene Kieselsäure und ein Polymeres enthalten, das bei Temperaturen über 260°C mit Polyethylenterephthalat unter Vernetzung reagiert, zeigen ein außergewöhnlich günstiges Brandverhalten.",BAYER AG;;MOBAY CHEMICAL CORP,BIER PETER DR;;REINERT GERARD E;;CARTER RUSSELL P JR,,https://lens.org/126-894-953-750-084,Patent Application,yes,5,6,2,2,0,C08K3/36;;C08K3/34;;C08L51/00;;C08L67/02,C08L69/00;;C08K3/36;;C08K5/16;;C08K5/52;;C08L7/00;;C08L21/00;;C08L33/00;;C08L33/02;;C08L51/00;;C08L51/02;;C08L67/00;;C08L67/02,,0,0,,,,DISCONTINUED
35,DK,A,DK 494889 A,108-129-923-305-376,1990-04-08,1990,DK 494889 A,1989-10-06,US 25557988 A,1988-10-07,"TOER FILM OG DENS FREMSTILLING SAMT DERI INDGAAENDE MATERIALE, HVORI DER KAN DANNES ET FOTOBILLEDE","A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",THIOKOL MORTON INC,LIPSON MELVIN ALAN;;CARTER THOMAS PAUL;;SHELNUT JAMES GERARD;;ROOS LEO,,https://lens.org/108-129-923-305-376,Patent Application,no,0,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,DISCONTINUED
36,AU,A,AU 1989/042620 A,041-688-141-450-60X,1990-04-12,1990,AU 1989/042620 A,1989-10-05,US 25557988 A,1988-10-07,PHOTOIMAGEABLE COMPOSITION AND DRY FILM FORMED THEREFROM,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",THIOKOL MORTON INC,LIPSON MELVIN ALAN;;SHELNUT JAMES GERARD;;CARTER THOMAS PAUL;;ROOS LEO,,https://lens.org/041-688-141-450-60X,Patent Application,no,0,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,EXPIRED
37,EP,A3,EP 0363210 A3,119-245-854-049-280,1990-12-05,1990,EP 89310232 A,1989-10-05,US 25557988 A,1988-10-07,PHOTOIMAGEABLE COMPOSITION AND DRY FILM FORMED THEREFROM,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.  ","MORTON INTERNATIONAL, INC.","LIPSON, MELVIN ALAN;;CARTER, THOMAS PAUL;;SHELNUT, JAMES GERARD;;ROOS, LEO","MORTON INTERNATIONAL, INC. (1994-07-20)",https://lens.org/119-245-854-049-280,Search Report,yes,3,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,EXPIRED
38,EP,B1,EP 0363210 B1,025-800-495-299-81X,1995-03-22,1995,EP 89310232 A,1989-10-05,US 25557988 A,1988-10-07,Photoimageable composition and dry film formed therefrom.,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",MORTON INT INC,LIPSON MELVIN ALAN;;CARTER THOMAS PAUL;;SHELNUT JAMES GERARD;;ROOS LEO,"MORTON INTERNATIONAL, INC. (1994-07-20)",https://lens.org/025-800-495-299-81X,Granted Patent,yes,3,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,EXPIRED
39,DE,D1,DE 68921836 D1,039-065-584-006-775,1995-04-27,1995,DE 68921836 T,1989-10-05,US 25557988 A,1988-10-07,Lichtempfindliche Bildaufzeichnungszusammensetzung und daraus hergestellter Trockenfilm.,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",MORTON INT INC,LIPSON MELVIN ALAN;;CARTER THOMAS PAUL;;SHELNUT JAMES GERARD;;ROOS LEO,,https://lens.org/039-065-584-006-775,Granted Patent,no,0,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,EXPIRED
40,DE,T2,DE 68921836 T2,006-605-540-850-189,1995-07-27,1995,DE 68921836 T,1989-10-05,US 25557988 A,1988-10-07,Lichtempfindliche Bildaufzeichnungszusammensetzung und daraus hergestellter Trockenfilm.,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",MORTON INT INC,LIPSON MELVIN ALAN;;CARTER THOMAS PAUL;;SHELNUT JAMES GERARD;;ROOS LEO,,https://lens.org/006-605-540-850-189,Granted Patent,no,0,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,EXPIRED
41,AU,B2,AU 610761 B2,151-328-009-839-473,1991-05-23,1991,AU 1989/042620 A,1989-10-05,US 25557988 A,1988-10-07,PHOTOIMAGEABLE COMPOSITION WITH REDUCED COLD FLOW DUE TO SALT-BRIDGING BY METAL IONS AND DRY FILM FORMED THEREFROM,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",THIOKOL MORTON INC,LIPSON MELVIN ALAN;;SHELNUT JAMES GERARD;;CARTER THOMAS PAUL;;ROOS LEO,,https://lens.org/151-328-009-839-473,Granted Patent,no,3,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,EXPIRED
42,DK,D0,DK 494889 D0,101-506-441-808-671,1989-10-06,1989,DK 494889 A,1989-10-06,US 25557988 A,1988-10-07,"TOER FILM OG DENS FREMSTILLING SAMT DERI INDGAAENDE MATERIALE, HVORI DER KAN DANNES ET FOTOBILLEDE","A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",THIOKOL MORTON INC,LIPSON MELVIN ALAN;;CARTER THOMAS PAUL;;SHELNUT JAMES GERARD;;ROOS LEO,,https://lens.org/101-506-441-808-671,Patent Application,no,0,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,DISCONTINUED
43,EP,A2,EP 0363210 A2,105-456-758-045-361,1990-04-11,1990,EP 89310232 A,1989-10-05,US 25557988 A,1988-10-07,Photoimageable composition and dry film formed therefrom.,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.  ",MORTON INT INC,LIPSON MELVIN ALAN;;CARTER THOMAS PAUL;;SHELNUT JAMES GERARD;;ROOS LEO,"MORTON INTERNATIONAL, INC. (1994-07-20)",https://lens.org/105-456-758-045-361,Patent Application,yes,0,3,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,EXPIRED
44,AT,T1,AT E120287 T1,023-089-484-146-346,1995-04-15,1995,AT 89310232 T,1989-10-05,US 25557988 A,1988-10-07,LICHTEMPFINDLICHE BILDAUFZEICHNUNGSZUSAMMENSETZUNG UND DARAUS HERGESTELLTER TROCKENFILM.,"A photoimageable composition of the negative acting type which includes a binder polymer which contains carboxyl groups is provided with a metal chelate in which the coordination number of the metal is 2 or higher. When the photoimageable composition is coated as a layer on a dry film, the metal chelate reacts with the carboxyl groups of the polymer, releasing a metal ion which bridges carboxyl groups of two or more polymer molecules. This bridging reduces cold flow of the photoimageable composition layer of the dry film.",MORTON INT INC,LIPSON MELVIN ALAN;;CARTER THOMAS PAUL;;SHELNUT JAMES GERARD;;ROOS LEO,,https://lens.org/023-089-484-146-346,Granted Patent,no,0,0,17,17,0,G03F7/027;;H05K3/287;;Y10S430/155;;G03C1/00;;G03F7/027;;H05K3/287;;Y10S430/155,G03F7/004;;G03F7/027;;H05K3/28,,0,0,,,,DISCONTINUED
45,CN,A,CN 113841136 A,176-838-918-352-280,2021-12-24,2021,CN 201980096435 A,2019-05-17,US 2019/0032767 W,2019-05-17,"APPARATUS, SYSTEM, AND METHOD FOR MANAGING AN OBJECT-BASED FILE SYSTEM","The present disclosure relates to an apparatus, system, and method for managing an object-based file system, and in particular for providing modifying access to an external application to a file system being managed in a user access restricted state, such as e.g. in the read only state. The apparatus for managing the object-based file system in accordance with the present disclosure includes a network interface configured to communicably connect to one or more client computers via a communication network, and a file system management section, implemented at least in part by processor, configured to manage the object-based file system comprising plural file objects, each file object being associated with a respective file of the file system, the file system management section being configured to serve file access requests of a file serving protocol received via the interface. The file system management section is further configured to provide a block access object of the object-based file system being mountable as a block storage device.",HITACHI VANTARA CORP,POWELL RICHARD;;BENSON MICHAEL;;CARTER MICHAEL;;THORNLEY GERARD;;HANHAM MATTHEW;;NORWOOD DAVID,,https://lens.org/176-838-918-352-280,Patent Application,no,0,0,7,7,0,G06F16/174;;G06F16/1748;;G06F16/18;;G06F16/148;;G06F16/1827;;G06F16/1748;;G06F21/6218,G06F16/174,,0,0,,,,PENDING
46,US,A1,US 2020/0276676 A1,001-493-602-971-790,2020-09-03,2020,US 202016737528 A,2020-01-08,US 202016737528 A;;US 201715439451 A,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF USING CERAMIC CORE WITH WITNESS FEATURE,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/001-493-602-971-790,Patent Application,yes,0,0,11,11,0,F05D2230/211;;B23P15/04;;F05D2230/80;;F05D2300/175;;F05D2230/31;;F01D5/005;;B23P6/007;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B33Y80/00;;B22F2998/10;;B22F7/062;;B22F7/08;;B22C9/04;;B22D29/00;;B22C9/24;;Y02P10/25;;B22F10/28;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F12/41;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F7/062;;B22C9/24;;B22D29/00;;B22F7/08;;B22F2998/10;;B22C9/04;;B23P15/04;;F05D2230/80;;B33Y80/00;;F05D2300/175;;F05D2230/31;;F05D2230/211;;B22F10/28;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F10/32;;B22F10/66,B23P6/04;;B22C9/04;;B22C9/24;;B22D29/00;;B22F5/04;;B22F7/06;;B22F7/08;;B23K20/22;;B23K26/0622;;B23K35/02;;B23P6/00;;B23P15/04;;B33Y80/00;;F01D5/00;;F01D5/14,,0,0,,,,ACTIVE
47,EP,A1,EP 3585556 A1,027-935-068-412-807,2020-01-01,2020,EP 18758399 A,2018-02-15,US 201715439584 A;;US 2018/0018274 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/027-935-068-412-807,Patent Application,yes,0,0,9,9,0,F05D2230/21;;F05D2240/307;;F05D2230/10;;F05D2230/31;;F05D2240/125;;F01D5/005;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F12/41;;B22F10/32;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;F05D2240/12;;F05D2230/31;;F05D2240/125;;F05D2240/307;;F05D2230/21;;F05D2230/10;;F01D5/005;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;F01D5/18,,0,0,,,,ACTIVE
48,CN,A,CN 110520233 A,027-398-142-178-633,2019-11-29,2019,CN 201880026645 A,2018-01-18,US 201715439548 A;;US 2018/0014189 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/027-398-142-178-633,Patent Application,no,7,0,9,9,0,F01D5/005;;F05D2240/307;;F05D2240/125;;F01D5/187;;F05D2230/31;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;Y02P10/25;;Y02T50/60;;B23P6/007;;B23P15/04;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/41;;B22F10/43;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;F01D5/005;;F05D2240/307;;F01D5/187;;F05D2230/31;;F05D2240/125;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/66,B22F3/105;;B22F5/04;;B22F7/06;;B33Y10/00;;B33Y80/00;;F01D5/12,,0,0,,,,ACTIVE
49,EP,A1,EP 3585555 A1,095-769-705-299-815,2020-01-01,2020,EP 18757605 A,2018-02-15,US 201715439451 A;;US 2018/0018277 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF USING CERAMIC CORE WITH WITNESS FEATURE,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/095-769-705-299-815,Patent Application,yes,0,0,11,11,0,F05D2230/211;;B23P15/04;;F05D2230/80;;F05D2300/175;;F05D2230/31;;F01D5/005;;B23P6/007;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B33Y80/00;;B22F2998/10;;B22F7/062;;B22F7/08;;B22C9/04;;B22D29/00;;B22C9/24;;Y02P10/25;;B22F10/28;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F12/41;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F7/062;;B22C9/24;;B22D29/00;;B22F7/08;;B22F2998/10;;B22C9/04;;B23P15/04;;F05D2230/80;;B33Y80/00;;F05D2300/175;;F05D2230/31;;F05D2230/211;;B22F10/28;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F10/32;;B22F10/66,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;F01D5/18,,0,0,,,,ACTIVE
50,EP,A4,EP 3585543 A4,133-053-623-159-117,2020-10-07,2020,EP 18757603 A,2018-01-18,US 201715439548 A;;US 2018/0014189 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/133-053-623-159-117,Search Report,no,6,0,9,9,0,F01D5/005;;F05D2240/307;;F05D2240/125;;F01D5/187;;F05D2230/31;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;Y02P10/25;;Y02T50/60;;B23P6/007;;B23P15/04;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/41;;B22F10/43;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;F01D5/005;;F05D2240/307;;F01D5/187;;F05D2230/31;;F05D2240/125;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/66,B22F3/105;;B22D25/02;;B22D29/00;;B22F5/04;;B22F5/10;;B22F7/06;;B22F7/08;;B23P6/00;;B23P15/04;;B33Y10/00;;B33Y80/00;;F01D5/00;;F01D5/12;;F01D5/18,,1,0,,,See also references of WO 2018156270A1,PENDING
51,US,A1,US 2018/0236557 A1,158-457-012-856-499,2018-08-23,2018,US 201715439548 A,2017-02-22,US 201715439548 A,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/158-457-012-856-499,Patent Application,yes,4,10,9,9,0,F01D5/005;;F05D2240/307;;F05D2240/125;;F01D5/187;;F05D2230/31;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;Y02P10/25;;Y02T50/60;;B23P6/007;;B23P15/04;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/41;;B22F10/43;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;F01D5/005;;F05D2240/307;;F01D5/187;;F05D2230/31;;F05D2240/125;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/66,B22F5/04;;B22D25/02;;B22D29/00;;B22F3/105;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/14;;F01D5/28;;F01D9/04,,0,0,,,,ACTIVE
52,CN,A,CN 110536772 A,072-202-882-193-577,2019-12-03,2019,CN 201880026590 A,2018-02-15,US 201715439584 A;;US 2018/0018274 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/072-202-882-193-577,Patent Application,no,19,0,9,9,0,F05D2230/21;;F05D2240/307;;F05D2230/10;;F05D2230/31;;F05D2240/125;;F01D5/005;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F12/41;;B22F10/32;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;F05D2240/12;;F05D2230/31;;F05D2240/125;;F05D2240/307;;F05D2230/21;;F05D2230/10;;F01D5/005;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;F01D5/18,,0,0,,,,ACTIVE
53,US,B2,US 11179816 B2,085-703-356-290-630,2021-11-23,2021,US 202016737528 A,2020-01-08,US 202016737528 A;;US 201715439451 A,2017-02-22,Method of manufacturing turbine airfoil and tip component thereof using ceramic core with witness feature,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/085-703-356-290-630,Granted Patent,yes,75,0,11,11,0,F05D2230/211;;B23P15/04;;F05D2230/80;;F05D2300/175;;F05D2230/31;;F01D5/005;;B23P6/007;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B33Y80/00;;B22F2998/10;;B22F7/062;;B22F7/08;;B22C9/04;;B22D29/00;;B22C9/24;;Y02P10/25;;B22F10/28;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F12/41;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F7/062;;B22C9/24;;B22D29/00;;B22F7/08;;B22F2998/10;;B22C9/04;;B23P15/04;;F05D2230/80;;B33Y80/00;;F05D2300/175;;F05D2230/31;;F05D2230/211;;B22F10/28;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F10/32;;B22F10/66,F01D5/00;;B22C9/04;;B22C9/24;;B22D29/00;;B22F3/105;;B22F5/04;;B22F7/06;;B22F7/08;;B22F10/20;;B23K20/22;;B23K26/0622;;B23K26/34;;B23K35/02;;B23K101/00;;B23K103/08;;B23K103/18;;B23P6/00;;B23P6/04;;B23P15/04;;B33Y80/00;;F01D5/14,,22,0,,,"English Translation of Chinese office action for application 201880026574.2 dated Nov. 6, 2020 (17 pages).;;English Translation of Chinese office action for application 201880026590.1 dated Dec. 1, 2020 (18 pages).;;European Extended Search Report for EP Application No. 18757104.7 dated Nov. 16, 2020 (7 pages).;;European Extended Search Report for EP Application No. 18758285.3 dated Nov. 26, 2020 (11 pages).;;English Translation of Japanese office action for application 2019-546040 dated Dec. 23, 2020 (4 pages).;;English Translation of Japanese office action for application 2019-545942 dated Dec. 23, 2020 (4 pages).;;English Translation of Japanese office action for application 2019-546034 dated Oct. 16, 2020 (5 pages).;;English Translation of Japanese office action for application 2019-546039 dated Oct. 16, 2020 (8 pages).;;English Translation of Japanese office action for application 2019-545949 dated Oct. 9, 2020 (9 pages).;;English Translation of Japanese office action for application 2019-545941 dated Oct. 19, 2020 (4 pages).;;European Extended Search Report for EP Application No. 18758399.2 dated Oct. 21, 2020 (9 pages).;;European Extended Search Report for EP Application No. 18757603.8 dated Sep. 9, 2020 (12 pages).;;European Extended Search Report for EP Application No. 18757605.3 dated Oct. 23, 2020 (7 pages).;;English Translation of Chinese office action for application 201880026659.0 dated Aug. 5, 2020 (14 pages).;;European Extended Search Report for EP Application No. 18756847.2 dated Sep. 3, 2020 (8 pages).;;PCT International Search Report and Opinion Corresponding to PCT/US2018/013386 dated Apr. 27, 2018.;;PCT International Search Report Corresponding to PCT/US2018/013388 dated May 4, 2018.;;PCT International Search Report Corresponding to PCT/US2018/018274 dated May 31, 2018.;;PCT International Written Opinion Corresponding to PCT/US2018/018274 dated May 31, 2018.;;PCT International Search Report and Opinion Corresponding to PCT/US2018/018276 dated May 31, 2018.;;PCT International Search Report and Opinion Corresponding to PCT/US2018/018277 dated May 31, 2018.;;PCT International Written Opinion Corresponding to PCT/US2018/014189 dated Jul. 2, 2018.",ACTIVE
54,US,A1,US 2018/0236558 A1,189-861-605-339-752,2018-08-23,2018,US 201715439592 A,2017-02-22,US 201715439592 A,2017-02-22,Method of repairing turbine component,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/189-861-605-339-752,Patent Application,yes,4,20,9,9,0,F05D2230/22;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F10/368;;B22F12/43;;B22F10/50;;B22F10/64;;B22F10/36;;B22F10/60;;B22F10/40;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;F05D2230/22;;B22F10/28;;B22F12/43;;B22F10/40;;B22F10/36;;B22F10/368;;B22F10/50;;B22F10/60;;B22F10/64,B22F5/04;;B22D25/02;;B22D29/00;;B22F3/105;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/00;;F01D9/04,,0,0,,,,ACTIVE
55,US,B2,US 10610933 B2,104-887-973-266-173,2020-04-07,2020,US 201715439529 A,2017-02-22,US 201715439529 A,2017-02-22,Method of manufacturing turbine airfoil with open tip casting and tip component thereof,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/104-887-973-266-173,Granted Patent,yes,42,0,9,9,0,F05D2230/14;;F05D2230/211;;F01D5/20;;F05D2240/307;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/43;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F10/66;;B22F12/41;;B22F10/32;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;F01D5/20;;F05D2230/14;;F05D2230/211;;F05D2240/307;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B22F5/04;;B22D25/02;;B22D29/00;;B22F3/105;;B22F5/10;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/20,,13,0,,,"US 9,987,684 B1, 06/2018, Redding et al. (withdrawn);;International Search Report and Written Opinion issued in connection with corresponding PCT Application No. PCT/US2018/013386 dated Apr. 27, 2018.;;Garay, G.T., et al., Method of Manufacturing Turbine Airfoil and Tip Component Thereof Using Ceramic Core With Witness Feature, GE Co-Pending U.S. Appl. No. 15/439,451, filed Feb. 22, 2017.;;Garay, G.T., et al., Method of Manufacturing Turbine Airfoil and Tip Component Thereof, GE Co-Pending U.S. Appl. No. 15/439,584, filed Feb. 22, 2017.;;Garay, G.T., et al., Method of Manufacturing Turbine Airfoil and Tip Component Thereof, GE Co-Pending U.S. Appl. No. 15/439,548, filed Feb. 22, 2017.;;Garay, G.T., et al., Method of repairing turbine component, GE Co-Pending U.S. Appl. No. 15/439,592, filed Feb. 22, 2017.;;Garay, G.T. et al., Method of repairing turbine component using ultra-thin plate, GE Co-pending U.S. Appl. No. 15/439,643, filed Feb. 22, 2017.;;PCT International Search Report Corresponding to Application No. PCT/US2018/013388 dated May 4, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Written Opinion Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018276 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018277 dated May 31, 2018.;;PCT International Written Opinion Corresponding to Application No. PCT/US2018/014189 dated Jul. 2, 2018.",ACTIVE
56,US,B2,US 10702958 B2,168-594-426-055-96X,2020-07-07,2020,US 201715439451 A,2017-02-22,US 201715439451 A,2017-02-22,Method of manufacturing turbine airfoil and tip component thereof using ceramic core with witness feature,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/168-594-426-055-96X,Granted Patent,yes,64,2,11,11,0,F05D2230/211;;B23P15/04;;F05D2230/80;;F05D2300/175;;F05D2230/31;;F01D5/005;;B23P6/007;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B33Y80/00;;B22F2998/10;;B22F7/062;;B22F7/08;;B22C9/04;;B22D29/00;;B22C9/24;;Y02P10/25;;B22F10/28;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F12/41;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F7/062;;B22C9/24;;B22D29/00;;B22F7/08;;B22F2998/10;;B22C9/04;;B23P15/04;;F05D2230/80;;B33Y80/00;;F05D2300/175;;F05D2230/31;;F05D2230/211;;B22F10/28;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F10/32;;B22F10/66,F01D5/00;;B22C9/04;;B22C9/24;;B22D29/00;;B22F3/105;;B22F5/04;;B22F7/06;;B22F7/08;;B23K20/22;;B23K26/0622;;B23K26/34;;B23K35/02;;B23K101/00;;B23K103/08;;B23K103/18;;B23P6/00;;B23P6/04;;B23P15/04;;B33Y80/00;;F01D5/14,,7,0,,,"PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/013386 dated Apr. 27, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/013388 dated May 4, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Written Opinion Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018276 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018277 dated May 31, 2018.;;International Written Opinion Corresponding to PCT Application No. PCT/US2018/014189 dated Jul. 2, 2018.",ACTIVE
57,US,B2,US 11154956 B2,187-824-043-429-936,2021-10-26,2021,US 201715439643 A,2017-02-22,US 201715439643 A,2017-02-22,Method of repairing turbine component using ultra-thin plate,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/187-824-043-429-936,Granted Patent,yes,81,5,9,9,0,F05D2230/30;;F01D5/187;;F01D9/065;;F05D2230/22;;F05D2240/307;;F05D2230/31;;F05D2240/125;;F01D5/005;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B22F7/062;;B22F7/08;;B22F2003/245;;C30B29/52;;B22F2998/10;;B22F2999/00;;B22F5/009;;C30B29/66;;C30B13/24;;Y02P10/25;;B33Y10/00;;B23P6/002;;B22F10/28;;B22F12/17;;B22F10/66;;B22F10/38;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;F05D2240/125;;C30B29/66;;C30B13/24;;B22F2998/10;;F05D2230/31;;F05D2240/307;;B22F7/062;;F01D9/065;;B22F2999/00;;F01D5/187;;B22F7/08;;F05D2230/22;;B22F5/009;;C30B29/52;;F05D2230/30;;B22F2003/245;;B22F10/28;;B22F12/17;;B22F10/32;;B22F10/38;;B22F10/66,B23P6/04;;B22F3/105;;B22F3/24;;B22F5/00;;B22F5/04;;B22F7/06;;B22F7/08;;B22F10/20;;B23K20/22;;B23K26/0622;;B23K26/34;;B23K35/02;;B23K101/00;;B23K103/08;;B23K103/18;;B23P6/00;;C30B13/24;;C30B29/52;;C30B29/60;;C30B29/66;;F01D5/00;;F01D5/14;;F01D5/18;;F01D9/06,,22,0,,,"International Search Report and Written Opinion issued in connection with corresponding PCT Application No. PCT/US2018/013388 dated May 4, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/013386 dated Apr. 27, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Written Opinion Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018276 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018277 dated May 31, 2018.;;PCT International Written Opinion Corresponding to PCT Application No. PCT/US2018/014189 dated Jul. 2, 2018.;;English Translation of Chinese office action for application 201880026659.0 dated Aug. 5, 2020 (14 pages).;;English Translation of Chinese office action for application 201880026574.2 dated Nov. 6, 2020 (17 pages).;;English Translation of Chinese office action for application 201880026590.1 dated Dec. 1, 2020 (18 pages).;;European Extended Search Report for EP Application No. 18757104.7 dated Nov. 16, 2020 (7 pages).;;European Extended Search Report for EP Application No. 18758285.3 dated Nov. 26, 2020 (11 pages).;;English Translation of Japanese office action for application 2019-546040 dated Dec. 23, 2020 (4 pages).;;English Translation of Japanese office action for application 2019-545942 dated Dec. 23, 2020 (4 pages).;;English Translation of Japanese office action for application 2019-546034 dated Oct. 16, 2020 (5 pages).;;English Translation of Japanese office action for application 2019-546039 dated Oct. 16, 2020 (8 pages).;;English Translation of Japanese office action for application 2019-545949 dated Oct. 9, 2020 (9 pages).;;English Translation of Japanese office action for application 2019-545941 dated Oct. 19, 2020 (4 pages).;;European Extended Search Report for EP Application No. 18758399.2 dated Oct. 21, 2020 (9 pages).;;European Extended Search Report for EP Application No. 18757603.8 dated Sep. 9, 2020 (12 pages).;;European Extended Search Report for EP Application No. 18757605.3 dated Oct. 23, 2020 (7 pages).;;European Extended Search Report for EP Application No. 18756847.2 dated Sep. 3, 2020 (8 pages).",ACTIVE
58,US,B2,US 10717130 B2,007-753-019-184-972,2020-07-21,2020,US 201715439548 A,2017-02-22,US 201715439548 A,2017-02-22,Method of manufacturing turbine airfoil and tip component thereof,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/007-753-019-184-972,Granted Patent,yes,64,1,9,9,0,F01D5/005;;F05D2240/307;;F05D2240/125;;F01D5/187;;F05D2230/31;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;Y02P10/25;;Y02T50/60;;B23P6/007;;B23P15/04;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/41;;B22F10/43;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;F01D5/005;;F05D2240/307;;F01D5/187;;F05D2230/31;;F05D2240/125;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/66,B22F5/04;;B22D25/02;;B22D29/00;;B22F3/105;;B22F5/10;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/00;;F01D5/18,,7,0,,,"PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/013386 dated Apr. 27, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/013388 dated May 4, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Written Opinion Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018276 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018277 dated May 31, 2018.;;PCT International Written Opinion Corresponding to PCT Application No. PCT/US2018/014189 dated Jul. 2, 2018.",ACTIVE
59,US,A1,US 2018/0236616 A1,115-428-540-639-815,2018-08-23,2018,US 201715439643 A,2017-02-22,US 201715439643 A,2017-02-22,METHOD OF REPAIRING TURBINE COMPONENT USING ULTRA-THIN PLATE,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/115-428-540-639-815,Patent Application,yes,12,12,9,9,0,F05D2230/30;;F01D5/187;;F01D9/065;;F05D2230/22;;F05D2240/307;;F05D2230/31;;F05D2240/125;;F01D5/005;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B22F7/062;;B22F7/08;;B22F2003/245;;C30B29/52;;B22F2998/10;;B22F2999/00;;B22F5/009;;C30B29/66;;C30B13/24;;Y02P10/25;;B33Y10/00;;B23P6/002;;B22F10/28;;B22F12/17;;B22F10/66;;B22F10/38;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;F05D2240/125;;C30B29/66;;C30B13/24;;B22F2998/10;;F05D2230/31;;F05D2240/307;;B22F7/062;;F01D9/065;;B22F2999/00;;F01D5/187;;B22F7/08;;F05D2230/22;;B22F5/009;;C30B29/52;;F05D2230/30;;B22F2003/245;;B22F10/28;;B22F12/17;;B22F10/32;;B22F10/38;;B22F10/66,B23P6/04;;B22F5/04;;B23K20/22;;B23K26/34;;B23K35/02;;B23P6/00;;F01D5/00;;F01D5/14,,0,0,,,,ACTIVE
60,WO,A1,WO 2018/156406 A1,163-964-124-493-386,2018-08-30,2018,US 2018/0018274 W,2018-02-15,US 201715439584 A,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/163-964-124-493-386,Patent Application,yes,5,0,9,9,0,F05D2230/21;;F05D2240/307;;F05D2230/10;;F05D2230/31;;F05D2240/125;;F01D5/005;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F12/41;;B22F10/32;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;F05D2240/12;;F05D2230/31;;F05D2240/125;;F05D2240/307;;F05D2230/21;;F05D2230/10;;F01D5/005;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B22D23/00;;B23P15/02;;B22F3/105;;B22F7/06;;F01D5/18,,0,0,,,,PENDING
61,EP,A1,EP 3969977 A1,009-835-243-101-862,2022-03-23,2022,EP 19930036 A,2019-05-17,US 2019/0032767 W,2019-05-17,"APPARATUS, SYSTEM, AND METHOD FOR MANAGING AN OBJECT-BASED FILE SYSTEM",,HITACHI VANTARA LLC,POWELL RICHARD;;BENSON MICHAEL;;CARTER MICHAEL;;THORNLEY GERARD;;HANHAM MATTHEW;;NORWOOD DAVID,,https://lens.org/009-835-243-101-862,Patent Application,yes,0,0,7,7,0,G06F16/174;;G06F16/1748;;G06F16/18;;G06F16/148;;G06F16/1827;;G06F16/1748;;G06F21/6218,G06F/,,0,0,,,,PENDING
62,EP,A1,EP 3585543 A1,112-820-136-435-666,2020-01-01,2020,EP 18757603 A,2018-01-18,US 201715439548 A;;US 2018/0014189 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/112-820-136-435-666,Patent Application,yes,0,0,9,9,0,F01D5/005;;F05D2240/307;;F05D2240/125;;F01D5/187;;F05D2230/31;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;Y02P10/25;;Y02T50/60;;B23P6/007;;B23P15/04;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/41;;B22F10/43;;B22F5/04;;B22F7/08;;B22F7/062;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/22;;F01D5/005;;F05D2240/307;;F01D5/187;;F05D2230/31;;F05D2240/125;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/66,B22F3/105;;B22F5/04;;B22F7/06;;B33Y10/00;;B33Y80/00;;F01D5/12,,0,0,,,,PENDING
63,EP,A1,EP 3585554 A1,147-732-658-478-524,2020-01-01,2020,EP 18756847 A,2018-02-15,US 201715439592 A;;US 2018/0018276 W,2017-02-22,METHOD OF REPAIRING TURBINE COMPONENT,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/147-732-658-478-524,Patent Application,yes,0,0,9,9,0,F05D2230/22;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F10/368;;B22F12/43;;B22F10/50;;B22F10/64;;B22F10/36;;B22F10/60;;B22F10/40;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;F05D2230/22;;B22F10/28;;B22F12/43;;B22F10/40;;B22F10/36;;B22F10/368;;B22F10/50;;B22F10/60;;B22F10/64,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;C04B35/626;;F01D5/18,,0,0,,,,PENDING
64,US,A1,US 2018/0236556 A1,171-680-192-925-078,2018-08-23,2018,US 201715439529 A,2017-02-22,US 201715439529 A,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL WITH OPEN TIP CASTING AND TIP COMPONENT THEREOF,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/171-680-192-925-078,Patent Application,yes,8,24,9,9,0,F05D2230/14;;F05D2230/211;;F01D5/20;;F05D2240/307;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/43;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F10/66;;B22F12/41;;B22F10/32;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;F01D5/20;;F05D2230/14;;F05D2230/211;;F05D2240/307;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B22F5/04;;B22D25/02;;B22D29/00;;B22F3/105;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/12,,0,0,,,,ACTIVE
65,US,A1,US 2022/0188277 A1,007-496-402-462-889,2022-06-16,2022,US 201917605307 A,2019-05-17,US 2019/0032767 W,2019-05-17,"APPARATUS, SYSTEM, AND METHOD FOR MANAGING AN OBJECT-BASED FILE SYSTEM","An apparatus, system, and method for managing an object-based file system, and in particular for providing modifying access to an external application to a file system being managed in a user access restricted state, such as e.g. in the read only state. The apparatus including a network interface configured to communicably connect to one or more client computers via a communication network, and a file system management section, implemented at least in part by processor, configured to manage the object-based file system comprising plural file objects, each file object being associated with a respective file of the file system, the file system management section being configured to serve file access requests of a file serving protocol received via the interface. The file system management section is further configured to provide a block access object of the object-based file system being mountable as a block storage device.",HITACHI VANTARA LLC,POWELL RICHARD;;BENSON MICHAEL;;CARTER MICHAEL;;THORNLEY GERARD;;HANHAM MATTHEW;;NORWOOD DAVID,HITACHI VANTARA LLC (2019-05-16),https://lens.org/007-496-402-462-889,Patent Application,yes,5,0,7,7,0,G06F16/174;;G06F16/1748;;G06F16/18;;G06F16/148;;G06F16/1827;;G06F16/1748;;G06F21/6218,G06F16/182;;G06F16/14;;G06F16/174;;G06F21/62,,1,0,,,"Creating and attaching a block storage disk to your Windows Server instance in Amazon Lightsail. https://lightsail.aws.amazon.com/ls/docs/en_us/articles/create-and-attach-additional-block-storage-disks-windows, pp. 1-6, 2018. (Year: 2018)",PENDING
66,WO,A1,WO 2018/156408 A1,010-887-448-128-17X,2018-08-30,2018,US 2018/0018277 W,2018-02-15,US 201715439451 A,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF USING CERAMIC CORE WITH WITNESS FEATURE,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/010-887-448-128-17X,Patent Application,yes,13,1,11,11,0,F05D2230/211;;B23P15/04;;F05D2230/80;;F05D2300/175;;F05D2230/31;;F01D5/005;;B23P6/007;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B33Y80/00;;B22F2998/10;;B22F7/062;;B22F7/08;;B22C9/04;;B22D29/00;;B22C9/24;;Y02P10/25;;B22F10/28;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F12/41;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F7/062;;B22C9/24;;B22D29/00;;B22F7/08;;B22F2998/10;;B22C9/04;;B23P15/04;;F05D2230/80;;B33Y80/00;;F05D2300/175;;F05D2230/31;;F05D2230/211;;B22F10/28;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F10/32;;B22F10/66,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;F01D5/18,,1,0,,,See also references of EP 3585555A4,PENDING
67,US,A1,US 2003/0202199 A1,053-931-585-397-865,2003-10-30,2003,US 13276502 A,2002-04-25,US 13276502 A,2002-04-25,Black-and-white lock mode for printer,"
   A color printer having a black-and-white lock mode is provided by the present application. The color printer has firmware programming that is accessed through an operator panel menu that allows selected personnel to place the printer in a lock mode such that the printer will only print in black-and-white. An access code is utilized to access the lock mode such that only individuals that are provided the access code can lock and unlock the color printing function of the printer. Once the printer is in lock mode, the printer will only print in black-and-white no matter what the user's intent or the print job's source. The invention is equally applicable to all types of printers and copiers including ink jet and laser type devices. 
",CARTER BARBARA BURKLIN;;MURPHY DAVID WILLIAM;;WALLIN PETER ERIC;;YORKEY TIMOTHY GERARD,CARTER BARBARA BURKLIN;;MURPHY DAVID WILLIAM;;WALLIN PETER ERIC;;YORKEY TIMOTHY GERARD,LEXMARK INTERNATIONAL INC (2002-04-25),https://lens.org/053-931-585-397-865,Patent Application,yes,16,36,1,1,0,G06F3/1205;;G06F3/1219;;G06F3/1222;;G06F3/1238;;G06F3/1239;;G06F3/1285;;G06F3/1205;;G06F3/1285;;G06F3/1219;;G06F3/1238;;G06F3/1239;;G06F3/1222,G06F3/12,358/1.13;;358/1.14;;X7132,0,0,,,,DISCONTINUED
68,EP,A4,EP 3585556 A4,094-681-048-217-281,2020-11-18,2020,EP 18758399 A,2018-02-15,US 201715439584 A;;US 2018/0018274 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/094-681-048-217-281,Search Report,no,3,0,9,9,0,F05D2230/21;;F05D2240/307;;F05D2230/10;;F05D2230/31;;F05D2240/125;;F01D5/005;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F12/41;;B22F10/32;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;F05D2240/12;;F05D2230/31;;F05D2240/125;;F05D2240/307;;F05D2230/21;;F05D2230/10;;F01D5/005;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B23P15/02;;B22D23/00;;B22D25/02;;B22D29/00;;B22F3/105;;B22F5/04;;B22F7/06;;B22F7/08;;B23P6/00;;B33Y10/00;;F01D5/00;;F01D5/14;;F01D5/18;;F01D5/28,,0,0,,,,ACTIVE
69,CN,A,CN 110520244 A,101-964-781-455-137,2019-11-29,2019,CN 201880026574 A,2018-02-15,US 201715439592 A;;US 2018/0018276 W,2017-02-22,Method of repairing turbine component,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/101-964-781-455-137,Patent Application,no,5,1,9,9,0,F05D2230/22;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F10/368;;B22F12/43;;B22F10/50;;B22F10/64;;B22F10/36;;B22F10/60;;B22F10/40;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;F05D2230/22;;B22F10/28;;B22F12/43;;B22F10/40;;B22F10/36;;B22F10/368;;B22F10/50;;B22F10/60;;B22F10/64,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;C04B35/626;;F01D5/18,,0,0,,,,ACTIVE
70,EP,A4,EP 3585545 A4,164-987-138-840-658,2020-12-30,2020,EP 18758285 A,2018-01-11,US 201715439643 A;;US 2018/0013388 W,2017-02-22,METHOD OF REPAIRING TURBINE COMPONENT USING ULTRA-THIN PLATE,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/164-987-138-840-658,Search Report,no,3,0,9,9,0,F05D2230/30;;F01D5/187;;F01D9/065;;F05D2230/22;;F05D2240/307;;F05D2230/31;;F05D2240/125;;F01D5/005;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B22F7/062;;B22F7/08;;B22F2003/245;;C30B29/52;;B22F2998/10;;B22F2999/00;;B22F5/009;;C30B29/66;;C30B13/24;;Y02P10/25;;B33Y10/00;;B23P6/002;;B22F10/28;;B22F12/17;;B22F10/66;;B22F10/38;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;F05D2240/125;;C30B29/66;;C30B13/24;;B22F2998/10;;F05D2230/31;;F05D2240/307;;B22F7/062;;F01D9/065;;B22F2999/00;;F01D5/187;;B22F7/08;;F05D2230/22;;B22F5/009;;C30B29/52;;F05D2230/30;;B22F2003/245;;B22F10/28;;B22F12/17;;B22F10/32;;B22F10/38;;B22F10/66,B22F3/105;;B22D29/00;;B22F3/24;;B22F5/00;;B22F5/04;;B22F7/06;;B22F7/08;;B23K26/34;;B23K35/02;;B23K101/00;;B23K103/08;;B23K103/18;;B23P6/00;;B33Y10/00;;B33Y80/00;;C30B13/24;;C30B29/52;;C30B29/60;;C30B29/66;;F01D5/00;;F01D5/18;;F01D9/06,,1,0,,,See also references of WO 2018156256A1,PENDING
71,EP,A4,EP 3585555 A4,018-282-270-243-769,2020-11-25,2020,EP 18757605 A,2018-02-15,US 201715439451 A;;US 2018/0018277 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF USING CERAMIC CORE WITH WITNESS FEATURE,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/018-282-270-243-769,Search Report,no,3,0,11,11,0,F05D2230/211;;B23P15/04;;F05D2230/80;;F05D2300/175;;F05D2230/31;;F01D5/005;;B23P6/007;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B33Y80/00;;B22F2998/10;;B22F7/062;;B22F7/08;;B22C9/04;;B22D29/00;;B22C9/24;;Y02P10/25;;B22F10/28;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F12/41;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F7/062;;B22C9/24;;B22D29/00;;B22F7/08;;B22F2998/10;;B22C9/04;;B23P15/04;;F05D2230/80;;B33Y80/00;;F05D2300/175;;F05D2230/31;;F05D2230/211;;B22F10/28;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F10/32;;B22F10/66,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;F01D5/18,,1,0,,,See also references of WO 2018156408A1,ACTIVE
72,US,A1,US 2018/0236615 A1,052-715-672-281-956,2018-08-23,2018,US 201715439451 A,2017-02-22,US 201715439451 A,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF USING CERAMIC CORE WITH WITNESS FEATURE,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/052-715-672-281-956,Patent Application,yes,3,7,11,11,0,F05D2230/211;;B23P15/04;;F05D2230/80;;F05D2300/175;;F05D2230/31;;F01D5/005;;B23P6/007;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B33Y80/00;;B22F2998/10;;B22F7/062;;B22F7/08;;B22C9/04;;B22D29/00;;B22C9/24;;Y02P10/25;;B22F10/28;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F12/41;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F7/062;;B22C9/24;;B22D29/00;;B22F7/08;;B22F2998/10;;B22C9/04;;B23P15/04;;F05D2230/80;;B33Y80/00;;F05D2300/175;;F05D2230/31;;F05D2230/211;;B22F10/28;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F10/32;;B22F10/66,B23P6/04;;B22F5/04;;B23K20/22;;B23K35/02;;B23P6/00;;F01D5/00;;F01D5/14,,0,0,,,,ACTIVE
73,WO,A1,WO 2020/236130 A1,146-127-451-972-136,2020-11-26,2020,US 2019/0032767 W,2019-05-17,US 2019/0032767 W,2019-05-17,"APPARATUS, SYSTEM, AND METHOD FOR MANAGING AN OBJECT-BASED FILE SYSTEM","The present disclosure relates to an apparatus, system, and method for managing an object-based file system, and in particular for providing modifying access to an external application to a file system being managed in a user access restricted state, such as e.g. in the read only state. An apparatus for managing an object-based file system in accordance with the present disclosure includes a network interface configured to communicably connect to one or more client computers via a communication network, and a file system management section, implemented at least in part by processor, configured to manage the object-based file system comprising plural file objects, each file object being associated with a respective file of the file system, the file system management section being configured to serve file access requests of a file serving protocol received via the interface. The file system management section is further configured to provide a block access object of the object-based file system being mountable as a block storage device.",HITACHI VANTARA LLC,POWELL RICHARD;;BENSON MICHAEL;;CARTER MICHAEL;;THORNLEY GERARD;;HANHAM MATTHEW;;NORWOOD DAVID,,https://lens.org/146-127-451-972-136,Patent Application,yes,3,0,7,7,0,G06F16/174;;G06F16/1748;;G06F16/18;;G06F16/148;;G06F16/1827;;G06F16/1748;;G06F21/6218,G06F15/16,,4,0,,,"WANG ET AL.: ""OBFS: A File System for Object-Based Storage Devices"", 21ST IEEE / 12TH NASA GODDARD CONFERENCE ON MASS STORAGE SYSTEMS AND TECHNOLOGIES (MSST2004, April 2004 (2004-04-01), pages 1 - 18, XP055852022;;POOJARY: ""Understanding Object Storage and Block Storage Use Cases"", CLOUD ACADEMY, 12 March 2019 (2019-03-12), XP055761749, Retrieved from the Internet <URL:https://cloudacademy.com/blog/object-storage-block-storage> [retrieved on 20190715];;VANTARA.H.: ""Hitachi Content Platform Architecture Fundamentals"", HITACHI, June 2020 (2020-06-01), pages 1 - 34, XP055852023, Retrieved from the Internet <URL:https://www.hitachivantara.com/en-us/pdfd/white-paper/content-platform-architecture-fundamentals-whitepaper.pdf> [retrieved on 20190715];;See also references of EP 3969977A4",PENDING
74,EP,A4,EP 3585554 A4,140-382-048-273-298,2020-10-07,2020,EP 18756847 A,2018-02-15,US 201715439592 A;;US 2018/0018276 W,2017-02-22,METHOD OF REPAIRING TURBINE COMPONENT,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/140-382-048-273-298,Search Report,no,3,0,9,9,0,F05D2230/22;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F10/368;;B22F12/43;;B22F10/50;;B22F10/64;;B22F10/36;;B22F10/60;;B22F10/40;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;F05D2230/22;;B22F10/28;;B22F12/43;;B22F10/40;;B22F10/36;;B22F10/368;;B22F10/50;;B22F10/60;;B22F10/64,B22F3/105;;B22D25/02;;B22D29/00;;B22F5/04;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/00,,1,0,,,See also references of WO 2018156407A1,PENDING
75,EP,A4,EP 3969977 A4,158-669-163-351-054,2022-12-21,2022,EP 19930036 A,2019-05-17,US 2019/0032767 W,2019-05-17,"APPARATUS, SYSTEM, AND METHOD FOR MANAGING AN OBJECT-BASED FILE SYSTEM",,HITACHI VANTARA LLC,POWELL RICHARD;;BENSON MICHAEL;;CARTER MICHAEL;;THORNLEY GERARD;;HANHAM MATTHEW;;NORWOOD DAVID,,https://lens.org/158-669-163-351-054,Search Report,no,1,0,7,7,0,G06F16/174;;G06F16/1748;;G06F16/18;;G06F16/148;;G06F16/1827;;G06F16/1748;;G06F21/6218,G06F16/18;;G06F16/174,,2,0,,,"SYMANTEC CRAIG HARMER: ""Object-Based File Systems: An Overview"", 2009, XP055980199, Retrieved from the Internet <URL:https://www.snia.org/sites/default/education/tutorials/2009/fall/file/CraigHarmer_Object-based_File_Systems_An_Overview.pdf> [retrieved on 20221110];;See also references of WO 2020236130A1",PENDING
76,US,A1,US 2018/0238173 A1,188-327-279-164-38X,2018-08-23,2018,US 201715439584 A,2017-02-22,US 201715439584 A,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/188-327-279-164-38X,Patent Application,yes,5,25,9,9,0,F05D2230/21;;F05D2240/307;;F05D2230/10;;F05D2230/31;;F05D2240/125;;F01D5/005;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F12/41;;B22F10/32;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;F05D2240/12;;F05D2230/31;;F05D2240/125;;F05D2240/307;;F05D2230/21;;F05D2230/10;;F01D5/005;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,F01D5/14;;B22D25/02;;B22D29/00;;B22F3/105;;B22F5/04;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/28;;F01D9/04,,0,0,,,,DISCONTINUED
77,US,B2,US 10625342 B2,044-410-162-047-839,2020-04-21,2020,US 201715439592 A,2017-02-22,US 201715439592 A,2017-02-22,Method of repairing turbine component,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,GENERAL ELECTRIC COMPANY (2017-01-30),https://lens.org/044-410-162-047-839,Granted Patent,yes,48,0,9,9,0,F05D2230/22;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F10/368;;B22F12/43;;B22F10/50;;B22F10/64;;B22F10/36;;B22F10/60;;B22F10/40;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;F05D2230/22;;B22F10/28;;B22F12/43;;B22F10/40;;B22F10/36;;B22F10/368;;B22F10/50;;B22F10/60;;B22F10/64,B22F5/04;;B22D25/02;;B22D29/00;;B22F3/105;;B22F7/06;;B22F7/08;;B33Y10/00;;B33Y80/00;;F01D5/00,,7,0,,,"PCT International Search Report Corresponding to Application No. PCT/US2018/013386 dated Apr. 27, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/013388 dated May 4, 2018.;;PCT International Search Report Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Written Opinion Corresponding to Application No. PCT/US2018/018274 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018276 dated May 31, 2018.;;PCT International Search Report and Written Opinion Corresponding to Application No. PCT/US2018/018277 dated May 31, 2018.;;PCT International Written Opinion Corresponding to Application No. PCT/US2018/014189 dated Jul. 2, 2018.",ACTIVE
78,EP,B1,EP 3585556 B1,057-581-312-319-296,2023-10-04,2023,EP 18758399 A,2018-02-15,US 201715439584 A;;US 2018/0018274 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL AND TIP COMPONENT THEREOF,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/057-581-312-319-296,Granted Patent,yes,8,0,9,9,0,F05D2230/21;;F05D2240/307;;F05D2230/10;;F05D2230/31;;F05D2240/125;;F01D5/005;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/43;;B22F12/17;;B22F10/66;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F12/41;;B22F10/32;;F01D5/147;;B22F5/04;;B22F7/08;;B22D25/02;;B22D29/002;;B33Y10/00;;B33Y80/00;;F01D5/284;;B22F2007/068;;F05D2230/22;;F05D2240/12;;F05D2230/31;;F05D2240/125;;F05D2240/307;;F05D2230/21;;F05D2230/10;;F01D5/005;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B22F10/28;;B22D25/02;;B22D29/00;;B22F5/04;;B22F7/06;;B22F7/08;;B22F10/62;;B22F12/17;;B23P6/00;;B33Y10/00;;F01D5/00;;F01D5/14;;F01D5/28,,0,0,,,,ACTIVE
79,EP,A1,EP 3585545 A1,123-118-241-825-323,2020-01-01,2020,EP 18758285 A,2018-01-11,US 201715439643 A;;US 2018/0013388 W,2017-02-22,METHOD OF REPAIRING TURBINE COMPONENT USING ULTRA-THIN PLATE,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/123-118-241-825-323,Patent Application,yes,0,0,9,9,0,F05D2230/30;;F01D5/187;;F01D9/065;;F05D2230/22;;F05D2240/307;;F05D2230/31;;F05D2240/125;;F01D5/005;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B22F7/062;;B22F7/08;;B22F2003/245;;C30B29/52;;B22F2998/10;;B22F2999/00;;B22F5/009;;C30B29/66;;C30B13/24;;Y02P10/25;;B33Y10/00;;B23P6/002;;B22F10/28;;B22F12/17;;B22F10/66;;B22F10/38;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;F05D2240/125;;C30B29/66;;C30B13/24;;B22F2998/10;;F05D2230/31;;F05D2240/307;;B22F7/062;;F01D9/065;;B22F2999/00;;F01D5/187;;B22F7/08;;F05D2230/22;;B22F5/009;;C30B29/52;;F05D2230/30;;B22F2003/245;;B22F10/28;;B22F12/17;;B22F10/32;;B22F10/38;;B22F10/66,B22F3/105;;B22D29/00;;B22F5/04;;B22F7/06;;B33Y10/00;;B33Y80/00;;F01D5/12,,0,0,,,,PENDING
80,CN,A,CN 110520234 A,123-308-018-876-926,2019-11-29,2019,CN 201880026666 A,2018-01-11,US 201715439643 A;;US 2018/0013388 W,2017-02-22,Method of repairing turbine component using ultra-thin plate,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY THOMAS;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/123-308-018-876-926,Patent Application,no,9,0,9,9,0,F05D2230/30;;F01D5/187;;F01D9/065;;F05D2230/22;;F05D2240/307;;F05D2230/31;;F05D2240/125;;F01D5/005;;B23K35/0244;;B23K26/34;;B23K26/0624;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B22F5/04;;B22F7/062;;B22F7/08;;B22F2003/245;;C30B29/52;;B22F2998/10;;B22F2999/00;;B22F5/009;;C30B29/66;;C30B13/24;;Y02P10/25;;B33Y10/00;;B23P6/002;;B22F10/28;;B22F12/17;;B22F10/66;;B22F10/38;;B22F10/32;;B23P6/045;;F01D5/005;;B22F5/04;;B23P6/007;;B23K20/22;;B23K35/0244;;B23K26/34;;B22F3/105;;B23K26/0624;;F01D5/147;;B23K2101/001;;B23K2103/08;;B23K2103/26;;F05D2240/125;;C30B29/66;;C30B13/24;;B22F2998/10;;F05D2230/31;;F05D2240/307;;B22F7/062;;F01D9/065;;B22F2999/00;;F01D5/187;;B22F7/08;;F05D2230/22;;B22F5/009;;C30B29/52;;F05D2230/30;;B22F2003/245;;B22F10/28;;B22F12/17;;B22F10/32;;B22F10/38;;B22F10/66,B22F3/105;;B22D29/00;;B22F5/04;;B22F7/06;;B33Y10/00;;B33Y80/00;;F01D5/12,,0,0,,,,ACTIVE
81,EP,A1,EP 3585534 A1,136-849-863-465-677,2020-01-01,2020,EP 18757104 A,2018-01-11,US 201715439529 A;;US 2018/0013386 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL WITH OPEN TIP CASTING AND TIP COMPONENT THEREOF,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/136-849-863-465-677,Patent Application,yes,0,0,9,9,0,F05D2230/14;;F05D2230/211;;F01D5/20;;F05D2240/307;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/43;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F10/66;;B22F12/41;;B22F10/32;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;F01D5/20;;F05D2230/14;;F05D2230/211;;F05D2240/307;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B22C9/06;;B22C9/10;;B22D23/00;;B22D29/00;;B22F3/105;;B22F5/04;;B22F7/06;;B33Y10/00;;F01D5/12,,0,0,,,,PENDING
82,EP,A4,EP 3585534 A4,028-851-842-659-963,2020-12-16,2020,EP 18757104 A,2018-01-11,US 201715439529 A;;US 2018/0013386 W,2017-02-22,METHOD OF MANUFACTURING TURBINE AIRFOIL WITH OPEN TIP CASTING AND TIP COMPONENT THEREOF,,GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/028-851-842-659-963,Search Report,no,3,0,9,9,0,F05D2230/14;;F05D2230/211;;F01D5/20;;F05D2240/307;;B22F2005/103;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F12/44;;B22F12/17;;B22F12/43;;B22F12/30;;B22F10/73;;B22F10/62;;B22F10/36;;B22F10/66;;B22F12/41;;B22F10/32;;B22F5/04;;B22F7/08;;B22F7/062;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;B22F2007/068;;F05D2230/31;;F05D2300/607;;F05D2300/175;;F01D5/20;;F05D2230/14;;F05D2230/211;;F05D2240/307;;B22F2005/103;;B22F10/28;;B22F10/73;;B22F12/17;;B22F12/30;;B22F12/41;;B22F12/43;;B22F12/44;;B22F10/32;;B22F10/36;;B22F10/62;;B22F10/66,B22C9/06;;B22C9/10;;B22D23/00;;B22D29/00;;B22F3/105;;B22F5/04;;B22F7/06;;B33Y10/00;;F01D5/12,,1,0,,,See also references of WO 2018156255A1,PENDING
83,WO,A1,WO 2018/156407 A1,042-221-714-757-076,2018-08-30,2018,US 2018/0018276 W,2018-02-15,US 201715439592 A,2017-02-22,METHOD OF REPAIRING TURBINE COMPONENT,"Methods of manufacturing or repairing a turbine blade or vane are described. The airfoil portions of these turbine components are typically manufactured by casting in a ceramic mold, and a surface made up of the cast airfoil and at the least the ceramic core serves as a build surface for a subsequent process of additively manufacturing the tip portions. The build surface is created by removing a top portion of the airfoil and the core, or by placing an ultra-thin shim on top of the airfoil and the core. The overhang projected by the shim is subsequently removed. These methods are not limited to turbine engine applications, but can be applied to any metallic object that can benefit from casting and additive manufacturing processes. The present disclosure also relates to finished and intermediate products prepared by these methods.",GEN ELECTRIC,GARAY GREGORY TERRENCE;;MEYER MARK KEVIN;;KONITZER DOUGLAS GERARD;;CARTER WILLIAM THOMAS,,https://lens.org/042-221-714-757-076,Patent Application,yes,5,0,9,9,0,F05D2230/22;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;Y02P10/25;;B23P6/007;;B22F10/28;;B22F10/368;;B22F12/43;;B22F10/50;;B22F10/64;;B22F10/36;;B22F10/60;;B22F10/40;;B22F5/04;;B22F7/062;;B22F7/08;;B22D29/002;;B22D25/02;;B33Y10/00;;B33Y80/00;;F01D5/005;;B22F2007/068;;F05D2240/307;;F05D2240/125;;F05D2230/80;;F05D2230/21;;F05D2230/22;;B22F10/28;;B22F12/43;;B22F10/40;;B22F10/36;;B22F10/368;;B22F10/50;;B22F10/60;;B22F10/64,B23P15/02;;B22D23/00;;B22F3/105;;B22F7/06;;C04B35/626;;F01D5/18,,1,0,,,See also references of EP 3585554A4,PENDING
84,WO,A1,WO 2014/137749 A1,125-582-924-000-453,2014-09-12,2014,US 2014/0019067 W,2014-02-27,US 201313786358 A,2013-03-05,SMART PHONE ON A CHIP AND METHOD MAKING SAME,"Method and apparatuses for making a smart phone on a chip (SPOC) are described. Active components (210) are embedded into a copper core (212). In an aspect, and optionally, passive components may also be embedded into the copper core. Printed circuit board (PCB) laminate (224, 225) is layered above and below the copper core. A copper ground plane (214) is fixed underneath the layer of PCB laminate (225) below, and furthest from, the copper core. One or more additional components (218, 220) are surface mounted on top of the PCB laminate layers (224) above the copper core. A conformal coating is applied to completely and thinly encase the one or more surface mounted additional components. The conformal coating includes trenching and a copper sputter coating finish.",QUALCOMM INC,CARTER MARK ANTHONY;;ZHANG YANG;;PENG YONGSHENG;;STEENSTRA JACK BRIAN;;BARRETT MICHAEL GERARD,,https://lens.org/125-582-924-000-453,Patent Application,yes,4,4,3,3,0,H01L23/3121;;H05K1/0206;;H05K1/0209;;H05K1/0218;;H05K1/141;;H05K1/185;;H05K3/0097;;H05K3/284;;H05K3/4608;;H05K2201/068;;H05K2201/09872;;H01L23/3677;;H01L2924/0002;;H01L23/5389;;H01L23/552;;H01L2924/19105;;Y10T29/4913;;H05K7/205;;H05K3/30;;H05K9/00;;Y10T29/4913;;H05K1/0218;;H05K3/4608;;H01L23/3121;;H05K1/185;;H05K3/284;;H01L23/3677;;H05K3/0097;;H05K1/0209;;H05K1/0206;;H01L2924/0002;;H05K1/141;;H05K2201/068;;H05K2201/09872;;H01L2924/19105;;H01L23/5389;;H01L23/552,H05K1/18;;H01L23/31;;H01L23/373;;H01L25/00;;H05K1/02;;H05K1/14;;H05K3/00;;H05K3/28;;H05K3/46,,0,0,,,,PENDING
85,US,A1,US 2005/0033261 A1,141-835-621-345-764,2005-02-10,2005,US 83320004 A,2004-04-27,US 83320004 A;;US 85036501 A;;US 57548000 A;;US 20441700 P;;US 26261401 P;;US 26246101 P;;US 26380601 P;;US 26397901 P,2000-05-12,Drug/drug delivery systems for the prevention and treatment of vascular disease,"A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.",FALOTICO ROBERT;;SIEKIERKA JOHN;;LLANOS GERARD H.;;KOPIA GREGORY A.;;CARTER ANDREW J.,FALOTICO ROBERT;;SIEKIERKA JOHN;;LLANOS GERARD H;;KOPIA GREGORY A;;CARTER ANDREW J,CORDIS CORPORATION (2004-09-13);;WYETH (2007-12-12),https://lens.org/141-835-621-345-764,Patent Application,yes,99,5,6,6,0,A61L31/16;;A61L31/16;;A61F2/91;;A61F2/91;;A61F2/915;;A61F2/915;;A61F2002/91541;;A61F2002/91541;;A61F2250/0067;;A61F2250/0067;;A61F2250/0068;;A61F2250/0068;;A61K31/436;;A61K31/436;;A61K31/727;;A61K31/727;;A61K45/06;;A61K45/06;;A61L2300/416;;A61L2300/416;;A61L2300/434;;A61L2300/434;;A61L2300/608;;A61L2300/608;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,A61K9/00;;A61F2/00;;A61F2/06;;A61F2/84;;A61F2/90;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61M37/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,6045,0,0,,,,EXPIRED
86,US,B2,US 8236048 B2,082-112-332-363-125,2012-08-07,2012,US 83320004 A,2004-04-27,US 83320004 A;;US 85036501 A;;US 57548000 A;;US 20441700 P;;US 26261401 P;;US 26246101 P;;US 26380601 P;;US 26397901 P,2000-05-12,Drug/drug delivery systems for the prevention and treatment of vascular disease,"A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.",FALOTICO ROBERT;;SIEKIERKA JOHN;;LLANOS GERARD H;;KOPIA GREGORY A;;CARTER ANDREW J;;CORDIS CORP;;WYETH CORP,FALOTICO ROBERT;;SIEKIERKA JOHN;;LLANOS GERARD H;;KOPIA GREGORY A;;CARTER ANDREW J,CORDIS CORPORATION (2004-09-13);;WYETH (2007-12-12),https://lens.org/082-112-332-363-125,Granted Patent,yes,108,2,6,6,0,A61L31/16;;A61L31/16;;A61F2/91;;A61F2/91;;A61F2/915;;A61F2/915;;A61F2002/91541;;A61F2002/91541;;A61F2250/0067;;A61F2250/0067;;A61F2250/0068;;A61F2250/0068;;A61K31/436;;A61K31/436;;A61K31/727;;A61K31/727;;A61K45/06;;A61K45/06;;A61L2300/416;;A61L2300/416;;A61L2300/434;;A61L2300/434;;A61L2300/608;;A61L2300/608;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,A61F2/06;;A61K9/00;;A61F2/00;;A61F2/84;;A61F2/90;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61M37/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,623/1.42;;623/1.44;;623/1.45;;623/1.46,99,65,128-044-663-875-278;;186-775-038-277-267;;075-317-984-832-498;;040-275-397-694-577;;060-036-214-673-456;;005-549-265-309-514;;055-032-401-559-983;;002-667-862-909-292;;032-521-944-239-129;;036-891-396-319-518;;040-143-318-240-426;;020-124-984-510-150;;074-758-221-608-073;;042-963-304-032-876;;031-637-367-055-482;;041-760-109-802-891;;104-204-140-439-847;;129-542-324-589-523;;090-256-931-603-859;;086-767-970-192-159;;011-126-029-770-176;;025-626-836-247-575;;037-396-959-071-017;;007-227-997-843-49X;;045-027-873-726-71X;;027-363-365-994-611;;088-771-146-446-67X;;036-481-547-353-202;;068-391-276-116-572;;008-001-912-909-934;;042-889-086-920-476;;053-926-658-298-731;;025-335-773-148-528;;064-757-156-175-541;;016-277-641-378-496;;043-050-150-570-419;;101-629-566-752-288;;026-949-417-579-703;;106-761-851-868-757;;169-123-655-792-862;;139-669-050-528-459;;071-593-217-109-544;;035-474-310-460-841;;046-454-029-725-386;;041-753-324-074-713;;048-541-795-726-837;;004-580-504-771-714;;097-327-630-840-770;;069-714-074-911-201;;008-661-288-318-404;;080-363-648-611-002;;030-874-897-085-673;;035-085-198-762-786;;043-499-185-019-088;;049-397-380-407-669;;139-500-862-702-13X;;078-514-363-120-123;;066-875-374-977-569;;070-194-000-631-361;;047-129-110-573-698;;030-555-366-735-608;;008-149-683-968-375;;038-442-569-497-11X;;012-605-254-328-565;;195-847-593-549-686,10.1148/radiology.170.3.2916065;;2916065;;10.1007/978-1-4684-7239-4_2;;10.1016/0168-3659(88)90029-6;;10.1093/oxfordjournals.eurheartj.a014750;;8922915;;10.1016/0168-3659(85)90002-1;;10.1016/0735-1097(91)90946-7;;2016469;;9822578;;10.1016/s0960-9822(07)00535-0;;10.1055/s-2007-1010510;;1505489;;10.1002/jps.2600721019;;6644569;;10.1016/0014-4800(85)90023-1;;3884359;;pmc185876;;10.1172/jci118281;;7593612;;10.1148/radiology.161.2.3763891;;3763891;;10.1016/0092-8674(92)90643-q;;1377606;;3719930;;10.1161/01.res.58.6.839;;4040189;;10.1161/01.res.56.1.139;;3967343;;10.1038/265625a0;;859561;;1538508;;10.1016/0741-5214(92)90190-j;;10.1067/mva.1992.32078;;6304813;;10.1148/radiology.148.1.6304813;;6828742;;10.1148/radiology.147.1.6828742;;10468521;;10.1161/01.cir.100.9.918;;5346893;;10.1097/00004424-196909000-00008;;10.1148/radiology.162.1.3786778;;3786778;;10.1161/01.cir.98.18.1875;;9799207;;11196150;;10.1056/nejm199812033392304;;9834304;;10.1097/00004424-198805000-00008;;2968328;;9118485;;10.1161/01.res.80.4.542;;10.1126/science.1653454;;1653454;;8041414;;10.1056/nejm199408253310802;;8087933;;10.1161/01.cir.90.3.1239;;10.1097/00019501-199303000-00003;;8269217;;9519320;;10.1053/euhj.1997.0614;;1909221;;10.1161/01.cir.84.3.1266;;6766491;;6978049;;10.2214/ajr.138.4.771;;9603954;;10.1074/jbc.273.23.14424;;10.1016/s0735-1097(99)00254-5;;10483953;;6827458;;10.1002/jps.2600720105;;pmc279979;;3258426;;10.1073/pnas.85.7.2303;;10.1056/nejm199602293340903;;8569823;;10.1016/0167-7799(84)90007-6;;6353438;;10.1016/0163-7258(83)90066-9;;10.1021/bk-1982-0186.ch008;;10.1038/263797a0;;995197;;2951767;;10.1148/radiology.163.2.2951767;;10.1016/0735-1097(91)90949-a;;1673136;;6463245;;10.1148/radiology.152.3.6463245;;10.1161/01.res.61.2.296;;3621492;;8804735;;pmc2359376;;11514367;;10.1161/01.cir.104.8.852;;10.1161/01.res.76.3.412;;7532117;;10.1016/0735-1097(96)00083-6;;8636553;;10.1148/radiology.170.3.2916054;;2916054;;10.1161/01.cir.77.1.188;;3335067;;10149123;;2539459;;2601819;;10.1097/00006123-198912000-00007;;10.1227/00006123-198912000-00007;;10.1148/radiology.160.3.2942964;;2942964;;10.2214/ajr.150.6.1263;;3285649;;10.1148/radiology.156.1.3159043;;3159043;;2935960;;10.1148/radiology.164.3.2956628;;2956628;;10.1053/euhj.1999.1947;;11052843;;10.1007/bf01893139,"European Search Report EP 05 25 2466 dated Jul. 26, 2005.;;European Search Report EP 05 25 2631 dated Jul. 26, 2005.;;European Search Report EP 05 25 2478 dated Jul. 26, 2005.;;Search from Mexican Patent Office mailed Jun. 11, 2009 for corresponding Patent Application No. PA/A/2005/005471.;;European Search Report dated Aug. 2, 2005 corresponding Patent Application No. 05252478.2-2107.;;Reasons for Rejection dated Nov. 2, 2010 from the Japanese Patent Office for corresponding Japanese Patent Application No. 2005-128379.;;U.S. Appl. No. 07/819,314, Jan. 9, 1992, Morris.;;U.S. Appl. No. 08/424,884, Apr. 19, 1995, Helmus et al.;;U.S. Appl. No. 08/526,273, Sep. 11, 1995, Ding.;;U.S. Appl. No. 08/730,542, Oct. 11, 1996, Helmus.;;U.S. Appl. No. 09/575,480, May 19, 2000, Kopia.;;U.S. Appl. No. 10/431,059, May 7, 2003, Falotico.;;U.S. Appl. No. 10/951,385, Sep. 28, 2004, Wright et al.;;Abraham, R.T., ""Mammalian target of rapamycin: Immunosupressive drugs offer new insight into cell growth regulation,"" Progress in Inflammation Research, 2000, 53-66, Switzerland.;;Alvarado, R. et al., ""Evaluation of Polymer-coated Balloon-expandable Stents in Bile Ducts,"" Radiology, 1989, 170, 975-978.;;Badimon, J. J. et al., ""Inhibitory Effects of Rapamycin on Intimal Hyperplasia After PTCA . . . ,"" JACC, Feb. 1998.;;Bailey et al., ""Polymer Coating of Palmaz-Schatz Stent Attenuates Vascular Spasm after Stent Placement,"" Circulation, 82:III-541 (1990).;;Baker, et al., Controlled Release: Mechanisms and Rates, 15-71 (1974).;;Baker, Controlled Release of Biologically Active Agents (1987) pp. 1-275.;;Bauters, C. et al., ""Restenosis after coronary angioplasty for rapidly progressive coronary stenosis,"" European Heart Journal, 1996, 17, 1671-1677.;;Bawa et al., An Explanation for the Controlled Release of Macromolecules from Polymers, Journal of Controlled Release, 1985, pp. 259-267, vol. 1 Elsevier Science BV Amsterdam.;;Berk, B. C. et al., ""Pharmacologic Roles of Heparin and Glucocorticoids to Prevent Restenosis After Coronary Angioplasty,"" JACC, May 1991, 17(6), 111B-117B.;;Bertram, P. G. et al., ""The 14-3-3 proteins positively regulate rapamycin-sensitive signaling,"" Current Biology, 1998, 8, 1259-1267.;;Binmoeller, et al., Silicone-Covered Expandable Metallic Stents in the Esophagus: An Experimental Study, Endoscopy, 1992, pp. 416-420, vol. 24, Georg Thieme Verlag Stuttgart New York.;;Brown et al., In Vivo and In Vitro Release of Macromolecules from Polymeric Drug Delivery Systems, Journal of Pharmaceutical Sciences, 1983, pp. 1181-1185, vol. 72, No. 10.;;Campbell and Campbell, ""Recent Advances in Molecular Pathology"", Experimental and Molecular Pathology 42, 139-162, 1985.;;Campbell, G. R. et al., ""Phenotypic Modulation of Smooth Muscle Cells in Primary Culture, Vascular Smooth Muscle Cells in Culture,"" CRC Press, 1987, 39-55.;;Chandrasekaran, S. et al., ""Methods to Achieve Controlled Drug Delivery,"" Sustained and Controlled Release Drug Delivery Systems, ED. Joseph R. Robinson, Marcel Dekker, Inc. NY, 1978, Chp. 7, 557-593.;;Chang, M. W. et al., ""Adenovirus-mediated Over-expression of the Cyclin/Cyclin-dependent Kinase inhibitor, p21 inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat Carotid Artery Model of Balloon Angioplasty,"" J. Clin. Invest., 1995, 96, 2260-2268.;;Charnsangavej et al., Article ""Stenosis of the Vena Cava: Preliminary Assessment of Treatment with Expandable Metallic Stents,"" Radiology, vol. 161, pp. 295-298, 1986.;;Charnsangavej et al., Article: ""A New Expandable Metallic Stent for Dilation of Stenotic Tubular Structures: Experimental and Clinical Evaluation,"" Houston Medical Journal, vol. 3, pp. 41-51, Jun. 1987.;;Chien, Y., ""Methods to Achieve Sustained Drug Delivery,"" Sustained and Controlled Release Drug Delivery Systems, ED. Joseph R. Robinson, Marcel Dekker, Inc., NY, 1978, Chp. 4, 211-349.;;Chung, J. et al., ""Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases,"" Cell, Jun. 26, 1992, 69(7), 1227-1236.;;Clowes, A. W. et al., ""Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration,"" Circ. Res., 1986, 58(6), 839-845.;;Clowes, A. W. et al., Kinetics of Cellular Proliferation after Arterial Injury, Laboratory Investigation, 1985, 52(6), 611-616.;;Clowes, A. W. et al., ""Significance of quiescent smooth muscle migration in the injured rat carotid artery,"" Circ Res. 1985, 56(1), 139-145.;;Clowes, A. W., ""Suppression by heparin of smooth muscle cell proliferation in injured arteries,"" Nature, 1977, 265, 625-626.;;Colburn, M. D. et al., ""Dose responsive suppression of myointimal hyperplasia by dexamethasone,"" J. Vasc. Surg., 1992, 15, 510-518.;;Coons et. al., Article: ""Large-Bore, Long Biliary Endoprosthesis (Biliary Stents) for Improved Drainage,"" Radiology, vol. 148, pp. 89-94, 1983.;;Cragg et al, Nonsurgical Placement of Arterial Endoprostheses: A New Technique Using Nitinol Wire, Radiology, vol. 147, pp. 261-263, Apr., 1983.;;Currier, J. W. et al., ""Colchicine Inhibits Restenosis After Iliac Angioplasty in the Atherosclerotic Rabbit,"" Circ., 1989, 80(4), 11-66.;;Dirschinger, J. et al., ""Influence of Balloon Pressure During Stent Placement in Native Coronary Arteries on Early and Late Angiographic and Clinical Outcome,"" Circulation, 1999, 100, 918-923 (Abstract).;;Dotter, Transluminally-placed Coilspring Endarterial Tube Grafts, Investigative Radiology, vol. 4, Sep.-Oct., pp. 329-332, 1969.;;Duprat et. al., Article: Flexible Balloon-Expandable Stent for Small Vessels Duprat et. al. Radiology, vol. 162, pp. 276-278, 1987.;;Elezi, S. et al., ""Vessel Size and Long-Term Outcome After Coronary Stent Placement,"" Circulation, 1998, 98, 1875-1880.;;End, D.W., et al., Characterization of the Antitumor Effects of the Selective Farnesyl Protein Transferase Inhibitor R115777 in Vivo and in Vitro, American Assn. for Cancer Research, Jan. 1, 2001, Cancer Research 61, 131-137.;;Erbel, R. et al., ""Coronary Artery Stenting Compared With Balloon Angioplasty for Restenosis After Initial Balloon Angioplasty,"" The New England Journal of Med, Dec. 3, 1998, 1672-1678.;;Fallone et al., ""Elastic Characteristics of the Self-Expanding Metallic Stents,"" Investigative Radiology, vol. 23, pp. 370-376, 1988.;;Farb, A. et al., ""Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein,"" Circ. Res., 1997, 80, 542-550.;;Ferns, G. A. A. et al., ""Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF,"" Science, 1991, 253, 1129-1132.;;Fischman, D. L. et al., ""A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease,"" N. Eng. J. Med., Aug. 25, 1994, 331(8), 496-501.;;Foley, D.P. et al., ""Influence of Coronary Vessel Size on Renarrowing Process and Late Angiographic Outcome After Successful Balloon Angioplasty,"" Circulation, 1994, 90, 1239-1251.;;Franklin, S. M. et al., ""Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials,"" Coronary Artery Disease Mar. 1993, 4(3), 232-242.;;Haase, H.D. et al., ""Acute and one year follow-up vessel size adapted PTCA using intracoronary ultrasound,"" European Heart Journal, 1998, 19, 263-272.;;Hansson, G. K. et al., ""Interferon-gamma Inhibits Arterial Stenosis After Injury,"" Circ., 1991, 84, 1266-1272.;;Hanson, et al., In Vivo Evaluation of Artificial Surfaces with a Nonhum Primate Model of Arterial Thrombosis,/ Lab Clin. Med., Feb. 1980, pp. 289-304.;;Harries-Jones, et al., Article: ""Repositioning of Biliary Endoprosthesis with Gruntzig Balloon Catheters,"" AJR, vol. 138, pp. 771-772, 1982. (AVE 153).;;Hashemolhosseini, S. et al., ""Rapamycin Inhibition of the G1 to S Transition Is Mediated by Effects on Cyclin D1 mRNA and Protein Stability,"" J Biol Chem, Jun. 5, 1998, 273, 14424-14429.;;Höher, M. et al., ""A randomized trial of elective stenting after balloon recanalization of chronic total occlusions,"" J. Am. Coll. Cardiol., 1993, vol. 34, No. 31, 722-729.;;Honickman et al., Article: ""Malpositioned Biliary Endoprosthesis, Technical Developments and Instrumentation,"" vol. 144, No. 2, 1982.;;Hsieh, et al., Zero-Order Controlled-Release Polymer Matrices for Micro-and-Macromolecules, Journal of Pharmaceutical Sciences, 1983 pp. 17-22, vol. 72, No. 1.;;Jonasson, J. et al., ""Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury,"" Proc. Natl., Acad. Sci., 1988, 85, 2303-2306.;;Kimura, T. et al., ""Three-year follow-up after implantation of metallic coronary-artery stents,"" N. Engl. J. Med., 1996, 334, 561-566.;;Gina Kolata, News Article: NY Times, ""Devices That Opens Clogged Arteries Gets a Falling Grade in a New Study"", pp. 16-18, Jan. 3, 1991.;;Kost et al., Controlled Release of Bioactive Agents, Trends in Biotechnology, 1984, pp. 47-51, vol. 2, No. 2, Elsevier BV Amsterdam.;;Langer, Controlled Release Systems, Chemical Engineering Education, Chemical Engineering Education, MIT, Cambridge, MA, pp. 115-124.;;Langer et al., Applications of Polymeric Delivery Systems for Macromolecules and Factors Controlling Release Kinetics.;;Langer, Implantable Controlled Release Systems, Pharmac. Ther., 1983, pp. 35-51, vol. 21, printed in Great Britain.;;Langer, New Drug Delivery Systems: What the Clinician Can Expect, Drug Therapy, 1983, pp. 217-231.;;Langer, Polymeric Delivery Systems for Controlled Drug Release, Chem. Eng. Commun. 1980, pp. 1-48, vol. 6, Gordon and breach Science Pubs. Inc. USA.;;Langer, R. et al., ""Polymeric Delivery Systems for Macromolecules: Approaches for Studying In Vivo Release Kinetics and Designing Constant Rate System,"" Am. Chem. Society, 1982, 95-105.;;Langer, Polymeric Delivery Systems, ""Targeting of Drugs 2 Optimization Strategies"", 1989, pp. 165-174, Plenum Press, New York and London.;;Langer, Polymers and Drug Delivery Systems, Long-Acting Contraceptive Delivery Systems, 1983, pp. 23-32, Harper & Row, Phila., PA.;;Langer, R. et al., ""Polymers for the Sustained Release of Proteins and other Macromolecules,"" Nature, 1976, 263, 797-800.;;Langer et al., Polymers for the Sustained Release of Macromolecules: Controlled and Magnetically Modulated Systems, Better Therapy With Existing Drugs: New Uses and Delivery Systems; 1981, pp. 179-216, Merck Sharp & Dohme International, Rahway, NJ.;;Lawrence et al., ""Percutaneous Endovascular Graft: Experimental Evaluation."" Radiology, vol. 163, pp. 357-360, 1987.;;Lundergan, C. F. et al., ""Peptide inhibition of Myointimal Proliferation by Angiopeptin, a Somatostatin Analogue,"" JACC, May 1991, 17(6), 132B-136B.;;Maass et al., Radiological Follow-up of Transluminally Inserted Vascular Endoprostheses: An Experimental Study Using Expanding Spirals, Radiology, vol. 152, pp. 659-663, 1984.;;Majesky, M. W. et al., ""Heparin regulates smooth muscle S phase entry in the injured rat carotid artery,"" Circ. Res., 1987, 61, 296-300.;;Marks, A., ""Attacking Heart Disease with Novel Molecular Tools,"" NY Acad. Med., 1996, 23-36.;;Marx, S. et al., ""Bench to Bedside: The Development of Rapamycin and its Application to Stent Resenosis,"" Circulation, 2001, 104, 852-855.;;Marx, S. O. et al., ""Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells,"" Circ. Res., 1995, 76, 412-417.;;Mintz et al., Intravascular Ultrasound Predictors of Restenosis After Percutaneous Transcatheter Coronary Revascularization, JACC vol. 27, No. 7, 1996, 1678-1687.;;Mirich et al., Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study, Radiology, vol. 170, pp. 1033-1037, 1989.;;Mullins et al., Article: ""Implantation of balloon-expandable intravascular grafts by catherization in pulmonary arteries and systemic veins,"" Circulation, vol. 77, No. 1, pp. 188-199, 1988.;;Murphy, J. et al., ""Polymeric Stents: Modern Alchemy or the Future,"" J. of Invasive Cardio., 1991, vol. 3, No. 3, 144-148.;;Nemecek, G. M. et al., ""Terbinafine Inhibits the Mitogenic Response to Platelet-Derived Growth Factor in Vitro and Neoinimal Proliferation in Vivo,"" J. Pharmacol. Exp. Thera., 1989, vol. 248, No. 3, 1167-1174.;;Okada, T. et al., ""Localized Release of Perivascular Heparin Inhibits Intimal Proliferation after Endothelial Injury without Systemic Anticoagulation,"" Neurosurgery, 1989, vol. 25, No. 6, 892-898.;;Palmaz et al., Atheroscierotic Rabbit Aortas: Expandable Intraluminal Grafting, Radiology, vol. 168, pp. 723-726, 1986.;;Palmaz et al., Abstract: Expandable Intraluminal Graft: A Preliminary Study, Radiology, vol. 153 (P), Nov. 1983: 70th Scientific Assembly and Annual Meeting, p. 329.;;Palmaz, Balloon-Expandable Intravascular Stent, AJR, vol. 1510, pp. 1263-1269, 1988.;;Julio C. Palmaz, et al., Expandable intraluminal vascular graft: a feasibility study. Nov. 17-22, 1985, Radiology, vol. 156, pp. 73-77, 1985.;;Julio C. Palmaz, et al., ""Expandable intraluminal graft: a feasibility study. Surgery, 1986: 99:199-205."".;;Palmaz, The Current Status of Vascular Prostheses; Rosch et al., Gianturco, Expandable Stents in Experimental and Clinical Use, SCIVR, pp. 118-124, 1987.;;J. Palmaz: The Current Status of Vascular Prostheses, published by SCIR in the Twelfth Annual Course on Diagnostic Angiography and Interventional Radiology Mar. 23-26, 1987.;;Palmaz, et al., Article: ""Normal and Stenotic Renal Arteries: Experimental Balloon Expandable Intraluminal Stenting"", Radiology, Sep. pp. 705-708, 1987.;;Palmaz Paper Entitled ""Research Project Expandable Vascular Endoprosthesis"" May 18, 1983.;;Park, S.-W. et al., ""Randomized Comparison of Coronary Stenting with Optimal balloon Angioplasty for Treatment of Lesions in Small Coronary Arteries,"" Europ. Heart J., 2000, 21, 1785-1789.;;Papanicolaou et al., Insertion of A Biliary Endoprosthesis Using a Balloon Dilatation Catheter, Gastrointest Radiology, vol. 10, pp. 394-396, 1985.",EXPIRED
87,US,B2,US 6776796 B2,005-529-509-209-459,2004-08-17,2004,US 85023201 A,2001-05-07,US 85023201 A;;US 57548000 A;;US 26397901 P;;US 26380601 P;;US 26261401 P;;US 26246101 P;;US 20441700 P,2000-05-12,Antiinflammatory drug and delivery device,"
    A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity. 
",CORDIS CORPORTATION,FALOTICO ROBERT;;KOPIA GREGORY A;;LLANOS GERARD H;;SIEKIERKA JOHN;;CARTER ANDREW J,CORDIS CORPORATION (2003-06-11);;WYETH (2007-12-12),https://lens.org/005-529-509-209-459,Granted Patent,yes,101,151,48,255,0,A61F2/91;;A61F2/915;;A61F2002/91541;;A61F2250/0067;;A61F2250/0068;;A61F2310/0097;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61L2300/41;;A61L2300/416;;A61L2300/602;;A61L2300/606;;A61P21/00;;A61P29/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61F2/91;;A61F2/915;;A61F2002/91541;;A61F2250/0067;;A61F2250/0068;;A61F2310/0097;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61L2300/41;;A61L2300/416;;A61L2300/602;;A61L2300/606;;A61L31/10,A61B17/00;;A61K47/32;;A61F2/00;;A61F2/06;;A61F2/82;;A61F2/84;;A61F2/90;;A61K31/365;;A61K31/4353;;A61K31/436;;A61K31/453;;A61K31/553;;A61K31/727;;A61K38/00;;A61K45/00;;A61K45/06;;A61K47/30;;A61K47/48;;A61K48/00;;A61L31/00;;A61L31/16;;A61M31/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61P21/00;;A61P29/00;;A61P43/00;;C07D401/04;;C07D498/18;;C07D498/22,623/1.46,1,1,049-561-368-313-661,10.1161/01.cir.100.6.659;;10441105,"Ruef, Johannes Md, et al.; ""Flavopiridol Inhibits Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo After Carotid Injury In the Rat""; From the Division of Cardiology and Sealy Center for Molecular Cardiology, University of Texas Medical Branch, Galveston; Accepted Apr. 9, 1999; Circulation Aug. 10, 1999; pp 659-665.",EXPIRED
88,BR,A,BR 0012251 A,087-865-898-767-135,2002-03-26,2002,BR 0012251 A,2000-06-28,US 34905499 A;;US 0017841 W,1999-07-07,"Polìmero zwiteriÈnico solúvel em água de alto peso molecular, e, métodos para aumentar a retenção e a drenagem em suspensões de polpa fibrosas durante o processamento da referida polpa, para remover sólidos suspensos e clarificar água branca no processo de fabricação de papel, e para aumentar a retenção de carga","""POLìMERO ZWITERIÈNICO SOLúVEL EM áGUA DE ALTO PESO MOLECULAR, E, MéTODOS PARA AUMENTAR A RETENçãO E A DRENAGEM EM SUSPENSõES DE POLPA FIBRO SAS DURANTE O PROCESSAMENTO DA REFERIDA POLPA, PARA REMOVER SóLIDOS SUSPENSOS E CLARIFICAR áGUA BRANCA NO PROCESSO DE FABRICAçãO DE PAPEL, E PARA AUMENTAR A RETENçãO DE CARGA"". Esta invenção é dirigida a polímeros zwiteriónicos de alto peso molecular derivados a partir de unidades de monómero zwiteriónicas e não-iónicas, e ao uso dos polímeros em processos de fabricação de papel.",NALCO CHEMICAL CO,CARTER PHILLIP W;;MURRAY PATRICK GERARD;;BRAMMER LARRY E JR;;DUNHAM ANDREW J,,https://lens.org/087-865-898-767-135,Patent Application,no,0,0,22,22,0,C02F1/56;;C08F2/32;;D21H17/41;;D21H21/10;;C08F220/56;;C08F220/54;;D21H21/10;;C02F1/56;;C08F2/32;;C08F220/54;;C08F220/56;;D21H17/41;;D21H21/10;;C08F2/32;;D21H17/41;;C02F1/56;;C08F220/54;;C08F220/56,B01D21/01;;C02F1/56;;C02F11/14;;C08F218/08;;C08F220/28;;C08F220/54;;C08F226/10;;C08F228/02;;C08F246/00;;D21F1/82;;D21H17/41;;D21H17/46;;D21H17/68;;D21H21/10,,0,0,,,,DISCONTINUED
89,CA,A1,CA 2505469 A1,069-128-100-564-660,2005-10-27,2005,CA 2505469 A,2005-04-27,US 83320004 A,2004-04-27,DRUG/DRUG DELIVERY SYSTEMS FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASE,,CORDIS CORP,CARTER ANDREW J;;LLANOS GERARD H;;KOPIA GREGORY A;;SIEKIERKA JOHN;;FALOTICO ROBERT,,https://lens.org/069-128-100-564-660,Patent Application,no,0,0,6,6,0,A61L31/16;;A61L31/16;;A61F2/91;;A61F2/91;;A61F2/915;;A61F2/915;;A61F2002/91541;;A61F2002/91541;;A61F2250/0067;;A61F2250/0067;;A61F2250/0068;;A61F2250/0068;;A61K31/436;;A61K31/436;;A61K31/727;;A61K31/727;;A61K45/06;;A61K45/06;;A61L2300/416;;A61L2300/416;;A61L2300/434;;A61L2300/434;;A61L2300/608;;A61L2300/608;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,A61K9/00;;A61F2/00;;A61F2/06;;A61F2/84;;A61F2/90;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61M37/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,,0,0,,,,ACTIVE
90,JP,A,JP 2005312967 A,055-727-554-057-221,2005-11-10,2005,JP 2005128379 A,2005-04-26,US 83320004 A,2004-04-27,MEDICINE AND MEDICINE DISTRIBUTION SYSTEM FOR PREVENTING AND TREATING VASAL DISEASE,"<P>PROBLEM TO BE SOLVED: To provide a medicine and medicine distribution system which can be used for treating a vasal disease. <P>SOLUTION: A topical distribution system is covered by rapamycin or other suitable medicines, and a substance or a compound. It is distributed through a lumen for the treatment and prevention of neointimal hyperplasia after percutaneous and percutaneous luminal coronary angioplasty. The topical distribution of this medicine or substance increases these operational effects and reduces the toxicity of a general system. <P>COPYRIGHT: (C)2006,JPO&NCIPI",CORDIS CORP,FALOTICO ROBERT;;SIEKIERKA JOHN;;LLANOS GERARD H;;KOPIA GREGORY A;;CARTER ANDREW J,,https://lens.org/055-727-554-057-221,Patent Application,no,5,1,6,6,0,A61L31/16;;A61L31/16;;A61F2/91;;A61F2/91;;A61F2/915;;A61F2/915;;A61F2002/91541;;A61F2002/91541;;A61F2250/0067;;A61F2250/0067;;A61F2250/0068;;A61F2250/0068;;A61K31/436;;A61K31/436;;A61K31/727;;A61K31/727;;A61K45/06;;A61K45/06;;A61L2300/416;;A61L2300/416;;A61L2300/434;;A61L2300/434;;A61L2300/608;;A61L2300/608;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,A61K9/00;;A61F2/00;;A61F2/06;;A61F2/84;;A61F2/90;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61M37/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,,0,0,,,,PENDING
91,EP,A1,EP 1591135 A1,144-326-133-234-698,2005-11-02,2005,EP 05252631 A,2005-04-27,US 83320004 A,2004-04-27,Drug/drug delivery systems for the prevention and treatment of vascular disease,"A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.",CORDIS CORP,FALOTICO ROBERT;;SIEKIERKA JOHN;;LLANOS GERARD H;;KOPIA GREGORY A;;CARTER ANDREW J,,https://lens.org/144-326-133-234-698,Patent Application,yes,2,0,6,6,0,A61F2/91;;A61F2/915;;A61F2002/91541;;A61F2250/0067;;A61F2250/0068;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61L2300/416;;A61L2300/434;;A61L2300/608;;A61P41/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61L31/16;;A61K31/436;;A61L2300/434;;A61F2/915;;A61F2250/0068;;A61F2/91;;A61F2002/91541;;A61F2250/0067;;A61K31/727;;A61L2300/608;;A61K45/06;;A61L2300/416,A61F2/00;;A61K9/00;;A61F2/06;;A61F2/84;;A61F2/90;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61M37/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,,0,0,,,,DISCONTINUED
92,CA,C,CA 2505469 C,162-096-877-789-639,2014-06-17,2014,CA 2505469 A,2005-04-27,US 83320004 A,2004-04-27,DRUG DELIVERY DEVICE COMPRISING A BILAYERED POLYMERIC COATING HAVING A CELL CYCLE INHIBITOR THAT ACTS SELECTIVELY AT THE G1 PHASE OF THE CELL CYCLE INCORPORATED INTO THE FIRST POLYMER COATING LAYER,"There is provided herein a drug delivery device comprising an intraluminal medical device, the intraluminal medical device including a stent having a fenestrated structure, the stent comprising a plurality of bands and links defining a substantially tubular device with openings. The device further comprises a polymeric coating affixed to the bands and links of the fenestrated structure, the polymeric coating having first and second layers; and a therapeutic dosage of rapamycin incorporated into the polymeric coating for treatment of intimil hyperplasia, constrictive vascular remodeling, and inflammation caused by injury. The rapamycin is incorporated into the first layer of the polymeric coating, the first layer comprising a solution of ethylene-co-vinylacetate and polybutylmethacrylate. The second layer, comprising polybutylmethacrylate, acts as a diffusion layer. The first layer has a thickness in the range from about eight microns to about twelve microns and the second layer has a thickness in the range from about one micron to about two microns, the rapamycin being configured for release over a period of about seven to thirty days and having a dosage in the range from about 35 to 430 micrograms per 15 to 18 mm length stents thereby producing a peak 50 to 55 percent reduction in neointimal hyperplasia of about 175 micrograms for a 3.5 mm by 18 mm stent.",CORDIS CORP,FALOTICO ROBERT;;SIEKIERKA JOHN;;LLANOS GERARD H;;KOPIA GREGORY A;;CARTER ANDREW J,,https://lens.org/162-096-877-789-639,Granted Patent,no,0,0,6,6,0,A61F2/91;;A61F2/915;;A61F2002/91541;;A61F2250/0067;;A61F2250/0068;;A61K31/436;;A61K31/727;;A61K45/06;;A61L31/16;;A61L2300/416;;A61L2300/434;;A61L2300/608;;A61P41/00;;A61P43/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61L31/16;;A61K31/436;;A61L2300/434;;A61F2/915;;A61F2250/0068;;A61F2/91;;A61F2002/91541;;A61F2250/0067;;A61K31/727;;A61L2300/608;;A61K45/06;;A61L2300/416,A61K9/00;;A61L27/54;;A61F2/00;;A61F2/06;;A61F2/84;;A61F2/90;;A61K31/436;;A61K31/727;;A61K45/06;;A61K47/30;;A61L27/34;;A61L31/16;;A61M25/00;;A61M37/00;;A61P7/02;;A61P9/00;;A61P9/10;;A61P41/00;;A61P43/00,,0,0,,,,ACTIVE
93,US,A1,US 2016/0258045 A1,011-563-840-103-036,2016-09-08,2016,US 201514836494 A,2015-08-26,US 201514836494 A;;US 201462041884 P,2014-08-26,APPARATUS AND METHOD FOR DIRECT WRITING OF SINGLE CRYSTAL SUPER ALLOYS AND METALS,"Apparatus and methods for direct writing of single crystal super alloys and metals are provided. In one method, a substrate is heated to a pretermined temperature below its melting point, and a laser is used to form a melt pool on a surface of a substrate. The substrate is positioned on a base plate, and the laser and the base plate are movable relative to each other, with the laser being used for direct metal deposition and the substrate is heated to a temperature below its melting point. A superalloy powder is introduced to the melt pool, and the temperature of the melt pool is controlled to maintain a predetermined thermal gradient on a solid and liquid interface of the melt pool so as to form a single crystal deposit on the substrate.",GEN ELECTRIC;;UNIV MICHIGAN REGENTS,CARTER JR WILLIAM THOMAS;;ROCKSTROH TODD JAY;;KONITZER DOUGLAS GERARD;;MAZUMDER JYOTIRMOY;;CHOI JEONGYONG,,https://lens.org/011-563-840-103-036,Patent Application,yes,0,36,9,9,0,B23K26/034;;B23K26/083;;B23K26/0869;;B23K26/34;;B23K26/702;;B23K26/144;;B23P15/04;;B23K26/354;;B23K2101/001;;B23K2103/08;;B23K2103/26;;C22F1/10;;B23K26/354;;B23K2101/001;;B23K2103/08;;B23K2103/26;;B23K26/034;;B23K26/083;;B23K26/0869;;B23K26/34;;B23K26/702;;B23K26/144;;B23P15/04;;B33Y10/00;;B33Y30/00;;B33Y50/02;;B33Y80/00;;B23K26/342;;B23K26/703;;B23K26/0006;;B23K26/0861;;B23K26/0884;;C22F1/10;;B23K26/346,B23K26/00;;C22F1/10;;B23K26/08;;B23K26/144;;B23K26/342;;B23K26/70,,0,0,,,,DISCONTINUED
94,WO,A1,WO 2023/223263 A1,036-071-463-145-623,2023-11-23,2023,IB 2023055138 W,2023-05-18,US 202263343510 P,2022-05-18,METHODS OF SELECTIVELY TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS,"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG,BRUIN GERARD;;CARTER SHEA;;KOLBINGER FRANK;;MILLAR NEAL;;MCINNES IAIN;;SCHIEKER MATTHIAS;;WEBER ECKHARD,,https://lens.org/036-071-463-145-623,Patent Application,yes,17,0,1,1,30,C07K16/244;;A61K39/395;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K2317/21;;A61K39/3955;;C07K2317/34;;A61P19/02;;A61P37/06;;A61P29/00;;A61P37/00;;A61P19/04;;A61P21/00,A61K39/395;;A61P19/02;;A61P19/04;;A61P21/00;;A61P29/00;;A61P37/00;;A61P37/06;;C07K16/24,,39,31,093-990-281-584-267;;051-768-589-697-937;;114-671-605-982-467;;023-085-533-008-428;;048-689-917-720-46X;;021-999-425-086-750;;054-877-551-583-346;;016-359-464-119-74X;;067-345-384-259-032;;029-674-503-318-947;;060-574-304-002-048;;090-979-226-546-341;;118-411-811-653-60X;;082-637-772-418-785;;003-841-753-797-786;;018-504-469-081-008;;051-768-589-697-937;;002-949-058-829-297;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;086-372-208-493-818;;056-201-471-905-934;;015-331-172-172-345;;009-567-903-968-245;;063-974-546-378-605;;015-331-172-172-345;;171-241-165-257-460;;009-494-529-890-905;;098-913-887-217-915;;041-145-889-666-450,10.1038/srep27149;;pmc4893609;;27263531;;28119539;;10.1038/nrrheum.2016.213;;10.1136/annrheumdis-2021-eular.45;;10.1093/rheumatology/keab784;;34730795;;pmc9258542;;10.1017/s1462399405008963;;15796783;;18235537;;10.1038/ncprheum0700;;10.1080/15459620590929635;;15788381;;10.1097/01.csmr.0000306421.85919.9c;;16934204;;24149868;;pmc3761855;;16464123;;10.2165/00007256-200636020-00005;;10.1016/s0278-5919(03)00004-8;;14560540;;10.1111/j.1600-0838.2007.00746.x;;18294189;;10.1007/s11999-016-5002-1;;27469590;;pmc5174041;;10.1016/s0140-6736(10)61160-9;;20970844;;10.1177/0363546512472975;;23328738;;20068208;;10.1001/jama.2009.1986;;28119539;;10.1038/nrrheum.2016.213;;10.1016/s0030-5898(20)32343-9;;4783891;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;15059275;;pmc400429;;10.1186/ar1038;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1186/s13018-014-0128-x;;pmc4278262;;25519001;;10.1097/00042752-200303000-00004;;12629425;;22958838;;10.1016/s1058-2746(09)80019-0;;10.1186/s13018-014-0128-x;;pmc4278262;;25519001;;pmc3500791;;10.1259/bjr/45423226;;23091289;;pmc3769589;;10.1007/s00330-013-2897-8;;23760303;;10.1055/s-0031-1281742;;21986866;;23443185;;10.7863/jum.2013.32.3.449,"NEAL L. MILLAR ET AL: ""IL-17A mediates inflammatory and tissue remodelling events in early human tendinopathy"", SCIENTIFIC REPORTS, vol. 6, no. 1, 6 June 2016 (2016-06-06), XP055537883, DOI: 10.1038/srep27149;;NEAL L. MILLAR ET AL: ""Inflammatory mechanisms in tendinopathy - towards translation"", NATURE REVIEWS RHEUMATOLOGY, vol. 13, no. 2, 1 February 2017 (2017-02-01), GB, pages 110 - 122, XP055537888, ISSN: 1759-4790, DOI: 10.1038/nrrheum.2016.213;;MILLAR N L ET AL: ""Interleukin 17A - a Tranlational Target to Treat Supraspinatus Tendinopathy"", ARTHRITIS RHEUMATOL., 21 October 2018 (2018-10-21), XP055537989, Retrieved from the Internet <URL:https://acrabstracts.org/abstract/interleukin-17a-a-translational-target-totreat- supraspinatus-tendinopathy/> [retrieved on 20190102];;MILLAR NL: ""EFFICACY AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY: A 24-WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, PHASE II PROOF-OF-CONCEPT TRIAL"", ANNALS OF THE RHEUMATIC DISEASES, vol. 80, no. Suppl 1, 1 June 2021 (2021-06-01), GB, pages 211.1 - 211, XP093047650, ISSN: 0003-4967, Retrieved from the Internet <URL:https://ard.bmj.com/content/annrheumdis/80/Suppl_1/211.2.full.pdf> DOI: 10.1136/annrheumdis-2021-eular.3593;;BEHRENS FRANK ET AL: ""Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial"", RHEUMATOLOGY, vol. 61, no. 7, 3 November 2021 (2021-11-03), GB, pages 2856 - 2866, XP093080716, ISSN: 1462-0324, Retrieved from the Internet <URL:https://academic.oup.com/rheumatology/article-pdf/61/7/2856/44473086/keab784.pdf> DOI: 10.1093/rheumatology/keab784;;RILEY G, EXPERT REV MOL MED, vol. 7, 2005, pages 1 - 25;;RILEY G, NAT CLIN PRACT RHEUMATOL, vol. 4, 2008, pages 82 - 9;;FORDE ET AL., J. OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE, vol. 2, 2005, pages 203 - 12;;SCOTTASHE, CURRENT SPORTS MEDICINE REPORTS, vol. 5, 2006, pages 233 - 241;;LITTLEWOOD ET AL., PHYSIOTHERAPY, vol. 98, 2013, pages 101 - 9;;KAUX ET AL., J SPORTS SCI MED, vol. 10, 2011, pages 238 - 253;;HUME ET AL., SPORTS MEDICINE, vol. 36, 2006, pages 151 - 170;;MAFFULLI ET AL., CLINICS IN SPORTS MEDICINE, vol. 22, 2003, pages 675 - 692;;FREDBERG USTENGAARD-PEDERSEN K, SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, vol. 18, 2008, pages 3 - 15;;ALFREDSONCOOK, BR J SPORTS MED, vol. 41, no. 8, 2007, pages 211 - 216;;MOHAMADI ET AL., CLIN. ORTHOP. RELAT. RES., vol. 475, 2017, pages 232 - 243;;COOMBES ET AL., LANCET, vol. 376, 2010, pages 1751 - 67;;KROGH TP ET AL., AM J SPORTS MED, vol. 41, 2013, pages 625 - 35;;DE VOS RJ ET AL., JAMA, vol. 303, 2010, pages 144 - 9;;MILLAR ET AL., NAT REV RHEUMATOL, vol. 13, 2017, pages 110 - 122;;BLAZINA ET AL., ORTHOP. CLIN. NORTH AM., vol. 4, 1973, pages 665 - 678;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 5879 - 5883;;HWANG ET AL., ARTHRITIS RES THER, vol. 6, 2004, pages R120 - 128;;ALTSHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410;;NEEDLEMAN ET AL., J. MOL. BIOL., vol. 48, 1970, pages 444 - 453;;MEYERS ET AL., COMPUT. APPL. BIOSCI., vol. 4, 1988, pages 11 - 17;;E. MEYERSW. MILLER, CABIOS, vol. 4, 1989, pages 11 - 17;;BAUER ET AL., J ORTHOP SURG RES, vol. 9, 2014, pages 128;;O'KANETORESDAHL, CURR SPORTS MED REP, vol. 13, no. 5, 2014, pages 307 - 13;;KIRKLEY ET AL., CLIN J SPORT MED, vol. 13, 2003, pages 84 - 92;;RICHARDS ET AL., J SHOULDER ELBOW SURG, vol. 3, 1994, pages 347 - 352;;BAUER ET AL., J. ORTHOPAEDIC SURG. RES, vol. 9, 2014, pages 128;;HODGSON ET AL., BR. J. RADIOLOGY, vol. 85, 2012, pages 1482 - 1487;;JURAS ET AL., EUR RADIOL, vol. 23, 2013, pages 2814 - 2822;;SYHA ET AL., FORTSCHR RONTGENSTRA, vol. 183, 2011, pages 1043 - 1050;;CHEN ET AL., J ULTRASOUND MED, vol. 32, 2013, pages 449 - 455;;MCGONAGLE DBENJAMIN M, REPORTS ON RHEUMATIC DISEASES SERIES, vol. 6, no. 4, 2009, pages 1 - 6",PENDING
95,AU,A1,AU 2022/200690 A1,036-844-125-790-47X,2022-02-24,2022,AU 2022/200690 A,2022-02-02,AU 2022/200690 A;;AU 2018/361975 A;;US 201762580715 P;;IB 2018058599 W,2017-11-02,Method of treating tendinopathy using interleukin-17 (IL-17) antagonists,"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL 17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/036-844-125-790-47X,Patent Application,no,0,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,0,0,,,,ACTIVE
96,CA,A1,CA 3080665 A1,090-222-598-390-101,2019-05-09,2019,CA 3080665 A,2018-11-01,US 201762580715 P;;IB 2018058599 W,2017-11-02,METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS,"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/090-222-598-390-101,Patent Application,no,0,0,16,16,31,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,0,0,,,,PENDING
97,US,A1,US 2023/0331834 A1,022-767-197-747-900,2023-10-19,2023,US 202318152139 A,2023-01-09,US 202318152139 A;;US 202016760605 A;;IB 2018058599 W;;US 201762580715 P,2017-11-02,METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17),"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists. e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,BRUIN GERARD;;CARTER SHEA;;KOLBINGER FRANK;;MCINNES IAIN;;MILLAR NEAL;;MINDEHOLM LINDA;;SCHIEKER MATTHIAS;;WEBER ECKHARD,UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (2017-12-21);;NOVARTIS AG (2018-01-18);;NOVARTIS PHARMA AG (2017-12-05),https://lens.org/022-767-197-747-900,Patent Application,yes,0,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,C07K16/24;;A61P19/04,,0,0,,,,PENDING
98,WO,A8,WO 2019/087133 A8,097-527-841-939-769,2019-06-27,2019,IB 2018058599 W,2018-11-01,US 201762580715 P,2017-11-02,METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS,"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/097-527-841-939-769,Amended Application,yes,0,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,0,0,,,,PENDING
99,US,A1,US 2021/0179702 A1,039-774-084-626-531,2021-06-17,2021,US 201816760605 A,2018-11-01,US 201816760605 A;;US 201762580715 P;;IB 2018058599 W,2017-11-02,METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17),"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,BRUIN GERARD;;CARTER SHEA;;KOLBINGER FRANK;;MCINNES IAIN;;MILLAR NEAL;;MINDEHOLM LINDA;;SCHIEKER MATTHIAS;;WEBER ECKHARD,UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (2017-12-21);;NOVARTIS AG (2018-01-18);;NOVARTIS PHARMA AG (2017-12-05),https://lens.org/039-774-084-626-531,Patent Application,yes,0,1,16,16,31,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,C07K16/24;;A61P19/04,,5,5,074-990-706-582-242;;114-671-605-982-467;;068-731-287-366-567;;053-636-889-568-326;;137-558-501-988-039,27747518;;pmc4999581;;10.1007/s40744-016-0031-5;;10.1136/annrheumdis-2021-eular.45;;24078497;;10.1002/bdrc.21041;;pmc4041869;;22809137;;10.1146/annurev-bioeng-071811-150122;;10.1007/s40257-015-0162-4;;26649440,"Mease et al, Rheumatology Therapy, 04/2016; Vol. 3, pages 5-29.;;Millar et al, , Ann Rheum Dis, 2021, 80(1): pages 211-212, POS0020;;Yang el al, Birth Defects Research Part C-Embryo Today; 2013; 99 (3), pages 203-222.;;Voleti et al, The Annual Review of Biomedical Engineering, 2012; Vol. 14; pages 47-71.;;Canavan et al, American Journal of Clinical Dermatology; 2016; Vol.17; pages 33-47.",DISCONTINUED
100,EP,A1,EP 3703819 A1,060-372-189-726-191,2020-09-09,2020,EP 18808497 A,2018-11-01,US 201762580715 P;;IB 2018058599 W,2017-11-02,METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS,,NOVARTIS AG;;UNIV GLASGOW COURT,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/060-372-189-726-191,Patent Application,yes,0,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,0,0,,,,PENDING
101,CN,A,CN 111344043 A,133-236-695-119-685,2020-06-26,2020,CN 201880070897 A,2018-11-01,US 201762580715 P;;IB 2018058599 W,2017-11-02,Method of treating tendinopathy by using interleukin-17 (il-17) antagonist,"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, by using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the discloseduses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/133-236-695-119-685,Patent Application,no,4,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,3,1,001-990-504-683-59X,28968735;;pmc5850284;;10.1093/rheumatology/kex301,"NEAL L. MILLAR ET AL.: ""Inflammatory mechanisms in tendinopathy – towards translation"", 《NATURE REVIEWS》, vol. 13, pages 110 - 122, XP055537888, DOI: 10.1038/nrrheum.2016.213;;IAIN B. MCINNES ET AL: ""Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study"", 《RHEUMATOLOGY》, vol. 56, pages 1993 - 2003, XP055537906, DOI: 10.1093/rheumatology/kex301;;NEAL L. MILLAR ET AL.: ""IL-17A mediates inflammatory and tissue remodelling events in early human tendinopathy"", 《SCIENTIFIC REPORTS》, vol. 6, no. 27149, pages 1 - 11",PENDING
102,IN,B,IN 175944 B,027-711-269-202-379,1995-11-18,1995,IN 999CA1990 A,1990-11-27,IN 999CA1990 A,1990-11-27,A method of manufacturing a substrate having a bond coat adhered thereto undamaged after removal of the top coat coated on the bond coat,,UNITED TECHNOLOGIES CORP,MCCOMAS CHARLES CARTER;;APPLEBY JOHN WAYNE JR;;SILEO GERARD ALBERT;;BARRIGNER HERBERT RUSSELL;;PATRY MICHAEL JAMES,,https://lens.org/027-711-269-202-379,Granted Patent,no,0,0,1,1,0,,B23P6/00;;B24D3/00,,0,0,,,,EXPIRED
103,KR,A,KR 20200083996 A,036-220-372-754-067,2020-07-09,2020,KR 20207015011 A,2018-11-01,US 201762580715 P;;IB 2018058599 W,2017-11-02,인터류킨-17(IL-17)을 사용하여 건병증을 치료하는 방법,"본 발명은 IL-17 길항제, 예를 들어 세쿠키누맙을 사용하여 건병증, 예를 들어 회전근개 건병증을 치료하는 방법에 관한 것이다. 건병증 환자를 치료하기 위한 IL-17 길항제, 예를 들어 IL-17 항체, 예컨대 세쿠키누맙, 및 개시된 용도 및 방법에 사용하기 위한 약제, 투약 섭생, 약학적 제제, 투여형 및 키트가 본원에 또한 개시된다.",NOVARTIS AG;;UNIV GLASGOW COURT,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/036-220-372-754-067,Patent Application,no,0,0,16,16,62,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,C07K16/24;;A61K39/00;;A61P19/04,,0,0,,,,DISCONTINUED
104,AU,A1,AU 2018/361975 A1,159-252-969-648-968,2020-05-07,2020,AU 2018/361975 A,2018-11-01,US 201762580715 P;;IB 2018058599 W,2017-11-02,Method of treating tendinopathy using interleukin-17 (IL-17) antagonists,"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/159-252-969-648-968,Patent Application,no,0,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,0,0,,,,DISCONTINUED
105,AU,B2,AU 2022/200690 B2,032-309-388-451-840,2024-01-25,2024,AU 2022/200690 A,2022-02-02,AU 2022/200690 A;;AU 2018/361975 A;;US 201762580715 P;;IB 2018058599 W,2017-11-02,Method of treating tendinopathy using interleukin-17 (IL-17) antagonists,"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL 17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/032-309-388-451-840,Granted Patent,no,0,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,0,0,,,,ACTIVE
106,WO,A1,WO 2019/087133 A1,094-677-821-650-436,2019-05-09,2019,IB 2018058599 W,2018-11-01,US 201762580715 P,2017-11-02,METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17),"The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,MCINNES IAIN;;MILLAR NEAL;;KOLBINGER FRANK;;BRUIN GERARD;;SCHIEKER MATTHIAS;;MINDEHOLM LINDA;;WEBER ECKHARD;;CARTER SHEA,,https://lens.org/094-677-821-650-436,Patent Application,yes,17,1,16,16,31,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61P19/04;;C07K16/24,,41,33,001-990-504-683-59X;;093-990-281-584-267;;051-768-589-697-937;;062-037-128-124-095;;048-689-917-720-46X;;021-999-425-086-750;;054-877-551-583-346;;016-359-464-119-74X;;067-345-384-259-032;;029-674-503-318-947;;060-574-304-002-048;;090-979-226-546-341;;058-468-154-085-341;;118-411-811-653-60X;;082-637-772-418-785;;003-841-753-797-786;;018-504-469-081-008;;051-768-589-697-937;;002-949-058-829-297;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;086-372-208-493-818;;056-201-471-905-934;;015-331-172-172-345;;009-567-903-968-245;;063-974-546-378-605;;044-311-819-415-170;;015-331-172-172-345;;171-241-165-257-460;;009-494-529-890-905;;098-913-887-217-915;;041-145-889-666-450,28968735;;pmc5850284;;10.1093/rheumatology/kex301;;10.1038/srep27149;;pmc4893609;;27263531;;28119539;;10.1038/nrrheum.2016.213;;28851983;;pmc5575127;;10.1038/s41598-017-09875-x;;10.1017/s1462399405008963;;15796783;;18235537;;10.1038/ncprheum0700;;10.1080/15459620590929635;;15788381;;10.1097/01.csmr.0000306421.85919.9c;;16934204;;24149868;;pmc3761855;;16464123;;10.2165/00007256-200636020-00005;;10.1016/s0278-5919(03)00004-8;;14560540;;10.1111/j.1600-0838.2007.00746.x;;18294189;;pmc2658946;;10.1136/bjsm.2007.035543;;17311806;;10.1007/s11999-016-5002-1;;27469590;;pmc5174041;;10.1016/s0140-6736(10)61160-9;;20970844;;10.1177/0363546512472975;;23328738;;20068208;;10.1001/jama.2009.1986;;28119539;;10.1038/nrrheum.2016.213;;10.1016/s0030-5898(20)32343-9;;4783891;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;15059275;;pmc400429;;10.1186/ar1038;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1186/s13018-014-0128-x;;pmc4278262;;25519001;;10.1097/00042752-200303000-00004;;12629425;;22958838;;10.1016/s1058-2746(09)80019-0;;pmc2465433;;17289860;;10.1136/bjsm.2006.034421;;10.1186/s13018-014-0128-x;;pmc4278262;;25519001;;pmc3500791;;10.1259/bjr/45423226;;23091289;;pmc3769589;;10.1007/s00330-013-2897-8;;23760303;;10.1055/s-0031-1281742;;21986866;;23443185;;10.7863/jum.2013.32.3.449,"IAIN B MCINNES ET AL: ""Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study"", RHEUMATOLOGY, vol. 56, no. 11, 16 August 2017 (2017-08-16), GB, pages 1993 - 2003, XP055537906, ISSN: 1462-0324, DOI: 10.1093/rheumatology/kex301;;NEAL L. MILLAR ET AL: ""IL-17A mediates inflammatory and tissue remodelling events in early human tendinopathy"", SCIENTIFIC REPORTS, vol. 6, no. 1, 6 June 2016 (2016-06-06), XP055537883, DOI: 10.1038/srep27149;;NEAL L. MILLAR ET AL: ""Inflammatory mechanisms in tendinopathy - towards translation"", NATURE REVIEWS RHEUMATOLOGY, vol. 13, no. 2, 1 February 2017 (2017-02-01), GB, pages 110 - 122, XP055537888, ISSN: 1759-4790, DOI: 10.1038/nrrheum.2016.213;;NEAL L. MILLAR ET AL: ""Interleukin 17A- a Translational Target to Treat Supraspinatus Tendinopathy"", ARTHRITIS RHEUMATOL., 21 October 2018 (2018-10-21), XP055537989, Retrieved from the Internet <URL:https://acrabstracts.org/abstract/interleukin-17a-a-translational-target-totreat- supraspinatus-tendinopathy/> [retrieved on 20190102];;MEAGHAN STOLK ET AL: ""New insights into tenocyte-immune cell interplay in an in vitro model of inflammation"", SCIENTIFIC REPORTS, vol. 7, no. 1, 29 August 2017 (2017-08-29), XP055537887, DOI: 10.1038/s41598-017-09875-x;;RILEY G, EXPERT REV MOL MED, vol. 7, 2005, pages 1 - 25;;RILEY G, NAT CLIN PRACT RHEUMATOL, vol. 4, 2008, pages 82 - 9;;FORDE ET AL., J. OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE, vol. 2, 2005, pages 203 - 12;;SCOTT; ASHE, CURRENT SPORTS MEDICINE REPORTS, vol. 5, 2006, pages 233 - 241;;LITTLEWOOD ET AL., PHYSIOTHERAPY, vol. 98, 2013, pages 101 - 9;;KAUX ET AL., J SPORTS SCI MED, vol. 10, 2011, pages 238 - 253;;HUME ET AL., SPORTS MEDICINE, vol. 36, 2006, pages 151 - 170;;MAFFULLI ET AL., CLINICS IN SPORTS MEDICINE, vol. 22, 2003, pages 675 - 692;;FREDBERG U; STENGAARD-PEDERSEN K, SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, vol. 18, 2008, pages 3 - 15;;ALFREDSON; COOK, BR J SPORTS MED, vol. 41, 2007, pages 211 - 216;;MOHAMADI ET AL., CLIN. ORTHOP. RELAT. RES., vol. 475, 2017, pages 232 - 243;;COOMBES ET AL., LANCET, vol. 376, 2010, pages 1751 - 67;;KROGH TP ET AL., AM J SPORTS MED, vol. 41, 2013, pages 625 - 35;;DE VOS RJ ET AL., JAMA, vol. 303, 2010, pages 144 - 9;;MILLAR ET AL., NAT REV RHEUMATOL, vol. 13, 2017, pages 110 - 122;;BLAZINA ET AL., ORTHOP. CLIN. NORTH AM., vol. 4, 1973, pages 665 - 678;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 5879 - 5883;;HWANG ET AL., ARTHRITIS RES THER, vol. 6, 2004, pages 120 - 128;;ALTSHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 410;;NEEDLEMAN ET AL., J. MOL. BIOL., vol. 48, 1970, pages 444 453;;MEYERS ET AL., COMPUT. APPL. BIOSCI., vol. 4, 1988, pages 11 17;;E. MEYERS; W. MILLER, CABIOS, vol. 4, 1989, pages 11 - 17;;KABAT E.A. ET AL.: ""Sequences of Proteins of Immunological Interest"", US DEPARTMENT OF HEALTH AND HUMAN SERVICES;;BAUER ET AL., J ORTHOP SURG RES., vol. 9, 2014, pages 128;;O'KANE; TORESDAHL, CURR SPORTS MED REP., vol. 13, no. 5, 2014, pages 307 - 13;;KIRKLEY ET AL., CLIN J SPORT MED, vol. 13, 2003, pages 84 - 92;;RICHARDS ET AL., J SHOULDER ELBOW SURG, vol. 3, 1994, pages 347 - 352;;SEIN ET AL., BR J SPORTS MED, vol. 41, no. 8, 2007, pages e9;;BAUER ET AL., J. ORTHOPAEDIC SURG. RES, vol. 9, 2014, pages 128;;HODGSON ET AL., BR. J. RADIOLOGY, vol. 85, 2012, pages 1482 - 1487;;JURAS ET AL., EUR RADIOL, vol. 23, 2013, pages 2814 - 2822;;SYHA ET AL., FORTSCHR RONTGENSTRA, vol. 183, 2011, pages 1043 - 1050;;CHEN ET AL., J ULTRASOUND MED, vol. 32, 2013, pages 449 - 455;;MCGONAGLE D; BENJAMIN M, REPORTS ON RHEUMATIC DISEASES, vol. 4, 2009, pages 1 - 6",PENDING
107,JP,A,JP 2023138982 A,082-517-863-908-687,2023-10-03,2023,JP 2023106622 A,2023-06-29,JP 2020524075 A;;US 201762580715 P;;IB 2018058599 W,2017-11-02,METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17) ANTAGONIST,"To provide methods for inducing tendon tissue regeneration in tendinopathy patients or promoting tendon repair.SOLUTION: The present disclosure relates to uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.SELECTED DRAWING: Figure 1",NOVARTIS AG;;UNIV COURT UNIV OF GLASGOW,IAIN MCINNES;;NEAL MILLAR;;FRANK KOLBINGER;;GERARD BRUIN;;MATTIAS SCHIEKER;;LINDA MINDEHOLM;;ECKHARD WEBER;;SHEA CARTER,,https://lens.org/082-517-863-908-687,Patent Application,no,0,0,16,16,0,C07K16/244;;C07K2317/76;;A61P19/04;;A61P19/04;;C07K16/244;;C07K2317/76;;C07K16/244;;A61P19/04;;C07K2317/76;;A61K2039/505;;A61P19/04;;A61K2039/505;;C07K16/244;;C07K2317/92;;C07K2317/94,A61K39/395;;A61K45/00;;A61P19/04;;A61P29/00;;A61P43/00,,0,0,,,,PENDING
108,WO,A2,WO 1998/023260 A2,157-802-394-260-778,1998-06-04,1998,GB 9703235 W,1997-11-26,GB 9624536 A,1996-11-26,NON-IONIC SURFACTANT VESICLES AS A DELIVERY AGENT FOR NUCLEIC ACID,The present invention provides an aqueous formulation (especially an injectable formulation) comprising a polynucleotide and a carrier component suspended in an aqueous delivery vehicle. The formulation though not exclusively comprises DNA or RNA in combination with vesicles comprised of non-ionic surfactants.,UNIV STRATHCLYDE;;UNIV EDINBURGH;;COMMON SERVICES AGENCY;;CARTER KATHARINE CHRISTINE;;MULLEN ALEXANDER BALFOUR;;BAILLIE ALAN JAMES;;ANSELL JOHN DOUGLAS;;MURPHY WILLIAM GERARD;;SAMUEL KAY,CARTER KATHARINE CHRISTINE;;MULLEN ALEXANDER BALFOUR;;BAILLIE ALAN JAMES;;ANSELL JOHN DOUGLAS;;MURPHY WILLIAM GERARD;;SAMUEL KAY,,https://lens.org/157-802-394-260-778,Patent Application,no,0,4,5,5,0,A61K9/1272;;A61K48/00,A61K9/127;;A61K31/708;;A61K31/7088;;A61K31/7105;;A61K31/711;;A61K48/00,,0,0,,,,PENDING
109,EP,A2,EP 0946148 A2,079-950-634-528-129,1999-10-06,1999,EP 97945945 A,1997-11-26,GB 9703235 W;;GB 9624536 A,1996-11-26,NON-IONIC SURFACTANT VESICLES AS A DELIVERY AGENT FOR NUCLEIC ACID,,UNIV STRATHCLYDE;;UNIV EDINBURGH;;COMMON SERVICES AGENCY,CARTER KATHARINE CHRISTINE;;MULLEN ALEXANDER BALFOUR;;BAILLIE ALAN JAMES;;ANSELL JOHN DOUGLAS;;MURPHY WILLIAM GERARD;;SAMUEL KAY,,https://lens.org/079-950-634-528-129,Patent Application,yes,0,0,5,5,0,A61K9/1272;;A61K48/00,A61K9/127;;A61K31/708;;A61K31/7088;;A61K31/7105;;A61K31/711;;A61K48/00,,1,0,,,See references of WO 9823260A3,DISCONTINUED
110,WO,A3,WO 1998/023260 A3,053-114-218-220-515,1998-08-27,1998,GB 9703235 W,1997-11-26,GB 9624536 A,1996-11-26,NON-IONIC SURFACTANT VESICLES AS A DELIVERY AGENT FOR NUCLEIC ACID,The present invention provides an aqueous formulation (especially an injectable formulation) comprising a polynucleotide and a carrier component suspended in an aqueous delivery vehicle. The formulation though not exclusively comprises DNA or RNA in combination with vesicles comprised of non-ionic surfactants.,UNIV STRATHCLYDE;;UNIV EDINBURGH;;COMMON SERVICES AGENCY;;CARTER KATHARINE CHRISTINE;;MULLEN ALEXANDER BALFOUR;;BAILLIE ALAN JAMES;;ANSELL JOHN DOUGLAS;;MURPHY WILLIAM GERARD;;SAMUEL KAY,CARTER KATHARINE CHRISTINE;;MULLEN ALEXANDER BALFOUR;;BAILLIE ALAN JAMES;;ANSELL JOHN DOUGLAS;;MURPHY WILLIAM GERARD;;SAMUEL KAY,,https://lens.org/053-114-218-220-515,Search Report,yes,2,0,5,5,0,A61K9/1272;;A61K48/00,A61K9/127;;A61K31/708;;A61K31/7088;;A61K31/7105;;A61K31/711;;A61K48/00,,0,0,,,,PENDING
111,WO,A1,WO 2019/133168 A1,107-080-353-681-781,2019-07-04,2019,US 2018/0062993 W,2018-11-29,EP 17290170 A,2017-12-29,METHOD FOR PREPARING POLYOLEFIN-ACRYLIC PARTICLES,"Provided is a process for making a dispersion of composite particles comprising (i) providing a dispersion of crosslinked polyolefin particles in an aqueous medium, (ii) performing emulsion polymerization on one or more vinyl monomers in the presence of the crosslinked polyolefin particles to produce the dispersion of composite particles.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;JANCO MIROSLAV;;CRUZ CARLOS A;;SAINT-GERARD YANNICK,,https://lens.org/107-080-353-681-781,Patent Application,yes,5,2,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/24;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,PENDING
112,US,B2,US 11401404 B2,181-760-647-345-938,2022-08-02,2022,US 201816765338 A,2018-11-29,EP 17290170 A;;US 2018/0062993 W,2017-12-29,Method for preparing polyolefin-acrylic particles,"Provided is a process for making a dispersion of composite particles comprising (i) providing a dispersion of crosslinked polyolefin particles in an aqueous medium,(ii) performing emulsion polymerization on one or more vinyl monomers in the presence of the crosslinked polyolefin particles to produce the dispersion of composite particles.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;JANCO MIROSLAV;;CRUZ CARLOS A;;SAINT-GERARD YANNICK,DOW GLOBAL TECHNOLOGIES LLC (2018-11-28);;ROHM AND HAAS COMPANY (2018-12-01),https://lens.org/181-760-647-345-938,Granted Patent,yes,10,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/24;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815,C08L23/08,,0,0,,,,ACTIVE
113,EP,A1,EP 3732206 A1,080-371-041-811-227,2020-11-04,2020,EP 18815093 A,2018-11-29,EP 17290170 A;;US 2018/0062993 W,2017-12-29,METHOD FOR PREPARING POLYOLEFIN-ACRYLIC PARTICLES,,DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;JANCO MIROSLAV;;CRUZ CARLOS A;;SAINT-GERARD YANNICK,,https://lens.org/080-371-041-811-227,Patent Application,yes,0,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/24;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,PENDING
114,CN,A,CN 111727205 A,053-292-042-036-782,2020-09-29,2020,CN 201880079478 A,2018-11-29,EP 17290170 A;;US 2018/0062993 W,2017-12-29,Method for preparing polyolefin-acrylic particles,"Provided is a process for making a dispersion of composite particles comprising (i) providing a dispersion of crosslinked polyolefin particles in an aqueous medium, (ii) performing emulsion polymerization on one or more vinyl monomers in the presence of the crosslinked polyolefin particles to produce the dispersion of composite particles.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;JANCO MIROSLAV;;CRUZ CARLOS A;;SAINT-GERARD YANNICK,,https://lens.org/053-292-042-036-782,Patent Application,no,4,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/24;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,ACTIVE
115,BR,A2,BR 112020010952 A2,031-920-225-956-991,2021-03-30,2021,BR 112020010952 A,2018-11-29,US 2018/0062993 W;;EP 17290170 A,2017-12-29,processo para produzir uma dispersão de partículas compósitas.,"trata-se de um processo para produzir uma dispersão de partículas compósitas que compreende (i) fornecer uma dispersão de partículas de poliolefina reticuladas em um meio aquoso, (ii) realizar polimerização em emulsão em um ou mais monômeros de vinila na presença de partículas de poliolefinas reticuladas para produzir a dispersão de partículas compósitas.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,ANDY JUN LI;;CARLOS A CRUZ;;LIANG CHEN;;MATTHEW CARTER;;MIROSLAV JANCO;;RALPH C EVEN;;ROBERT S MOGLIA;;YANNICK SAINT-GERARD,,https://lens.org/031-920-225-956-991,Patent Application,no,0,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/24;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,PENDING
116,US,A1,US 2020/0354553 A1,176-403-515-167-109,2020-11-12,2020,US 201816765338 A,2018-11-29,EP 17290170 A;;US 2018/0062993 W,2017-12-29,METHOD FOR PREPARING POLYOLEFIN-ACRYLIC PARTICLES,"Provided is a process for making a dispersion of composite particles comprising (i) providing a dispersion of crosslinked polyolefin particles in an aqueous medium,(ii) performing emulsion polymerization on one or more vinyl monomers in the presence of the crosslinked polyolefin particles to produce the dispersion of composite particles.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;JANCO MIROSLAV;;CRUZ CARLOS A;;SAINT-GERARD YANNICK,DOW GLOBAL TECHNOLOGIES LLC (2018-11-28);;ROHM AND HAAS COMPANY (2018-12-01),https://lens.org/176-403-515-167-109,Patent Application,yes,0,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/24;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815,C08L23/08,,0,0,,,,ACTIVE
117,KR,A,KR 20200104861 A,121-194-512-059-491,2020-09-04,2020,KR 20207017939 A,2018-11-29,EP 17290170 A;;US 2018/0062993 W,2017-12-29,폴리올레핀 아크릴 입자의 제조 방법,"본원은, 복합 입자의 분산액을 제조하는 방법을 제공하며, 상기 방법은, (i) 수성 매질 중의 가교 폴리올레핀 입자의 분산액을 제공하는 단계, (ii) 상기 가교 폴리올레핀 입자의 존재하에 하나 이상의 비닐 단량체에 대해 유화 중합을 수행하여 복합 입자의 분산액을 생성하는 단계를 포함한다.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;JANCO MIROSLAV;;CRUZ CARLOS A;;SAINT GERARD YANNICK,,https://lens.org/121-194-512-059-491,Patent Application,no,4,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/24;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815,C08F285/00;;C08F2/24;;C08F220/18;;C08F299/00;;C08K5/3492;;C08L23/08;;C08L51/06;;C08L69/00,,0,0,,,,ACTIVE
118,AU,B2,AU 755154 B2,129-817-223-098-784,2002-12-05,2002,AU 1998/074943 A,1998-05-15,US 4659597 P;;US 9810088 W,1997-05-15,Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods,,CYTOGEN CORP;;ELAN CORP PLC,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A;;CARTER JOHN M;;CAGNEY GERARD M,,https://lens.org/129-817-223-098-784,Granted Patent,no,2,0,10,15,0,A61K38/09;;A61K9/5153;;A61K38/28;;A61K47/62;;A61K47/6937;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,0,0,,,,EXPIRED
119,NZ,A,NZ 501110 A,122-186-406-125-850,2001-10-26,2001,NZ 50111098 A,1998-05-15,US 4659597 P;;US 9810088 W,1997-05-15,Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related drug delivery methods,"Proteins (e.g., random peptides and peptide motifs) capable of facilitating transport of an active agent through human or animal gastro-intestinal tissue, and derivatives (e.g., fragments and functionally active analogues) thereof, and nucleotide sequences coding for said proteins and derivatives are disclosed. The proteins facilitate transport of active agents from the lumenal side of the gastro-intestinal tract (GIT) into the systemic blood system and/or in targeting active agents to the GIT. Thus, by binding (covalently or noncovalently) a protein disclosed to an orally administered drug, the drug can be targeted to specific receptors, such as, HPT1, hEPT1, D2H and hSI, or transport pathways which are known to operate in the human GIT.",ELAN CORP PLC;;CYTOGEN CORP,CAGNEY GERARD M;;ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A;;CARTER JOHN M,,https://lens.org/122-186-406-125-850,Patent Application,no,0,0,10,15,0,A61K38/09;;A61K9/5153;;A61K38/28;;A61K47/62;;A61K47/6937;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,0,0,,,,PENDING
120,AU,A,AU 1998/074943 A,014-609-563-451-349,1998-12-08,1998,AU 1998/074943 A,1998-05-15,US 4659597 P;;US 9810088 W,1997-05-15,Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods,,CYTOGEN CORP;;ELAN CORP PLC,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A;;CARTER JOHN M;;CAGNEY GERARD M,,https://lens.org/014-609-563-451-349,Patent Application,no,0,0,10,15,0,A61K38/09;;A61K9/5153;;A61K38/28;;A61K47/62;;A61K47/6937;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,0,0,,,,EXPIRED
121,US,B1,US 7053177 B1,127-774-218-466-861,2006-05-30,2006,US 7967898 A,1998-05-15,US 7967898 A;;US 4659597 P,1997-05-15,Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods,"This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastrointestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastrointestinal tract, thus facilitating its absorption into the systemic system.",CYTOGEN CORP,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA JR BENJAMIN A;;CARTER JOHN M;;CAGNEY GERARD M,CYTOGEN CORPROATION (2004-07-27);;ELAN CORPORATION PLC (1998-08-12);;CYTOGEN CORPORATION (1998-10-22),https://lens.org/127-774-218-466-861,Granted Patent,yes,8,8,2,15,407,A61K38/28;;A61K38/28;;A61K47/58;;A61K47/58;;A61K47/593;;A61K47/593;;A61K47/60;;A61K47/60;;A61K47/62;;A61K47/62;;A61K47/6937;;A61K47/6937,A61K38/00,530/324;;514/21;;424/185.1,32,29,136-206-156-591-915;;026-623-017-714-89X;;023-581-408-570-254;;010-740-280-665-96X;;009-186-473-238-939;;000-577-316-851-722;;009-069-193-386-694;;014-935-196-346-195;;019-278-757-718-935;;065-117-941-135-263;;060-459-542-715-007;;134-798-310-918-904;;037-412-520-623-943;;011-962-497-035-168;;027-396-041-217-200;;008-721-226-627-596;;013-242-768-882-463;;023-100-238-103-724;;083-771-782-040-353;;020-855-322-534-259;;030-630-100-818-462;;052-798-596-323-654;;042-787-507-181-37X;;058-927-415-617-378;;052-747-811-670-668;;044-798-306-702-833;;181-995-345-726-803;;078-075-414-981-82X;;018-407-315-416-616,10.1073/pnas.90.22.10638;;pmc47832;;7504273;;10.1002/prot.340080405;;1708882;;10.1016/0014-5793(92)80903-t;;1639197;;1404385;;10.1016/0022-2836(92)90219-a;;10.1073/pnas.87.16.6378;;2201029;;pmc54537;;2450091;;10.1016/s0021-9258(18)68927-6;;2143033;;10.1126/science.2143033;;8961139;;10.1021/js960158a;;1990438;;10.1126/science.1990438;;10.1002/ddr.430330203;;10.1021/jm00035a001;;8176700;;10.1016/0022-2836(91)90354-9;;1880799;;10.1038/354084a0;;1719428;;10.1093/nar/19.15.4133;;pmc328552;;1908075;;10.1073/pnas.88.10.4363;;1903540;;pmc51659;;10.1016/0378-1119(93)90153-t;;8508960;;10.1038/354082a0;;1944576;;10.1074/jbc.270.12.6456;;7896779;;10.1021/bi00109a004;;1932005;;1748994;;10.1016/0022-2836(91)90498-u;;10.1038/348552a0;;2247164;;10.1016/0378-1119(88)90495-7;;3149606;;2481962;;10.1007/978-1-4757-2046-4_21;;10.1242/jcs.102.3.581;;1506435;;2095213;;10.1021/bc00002a001;;9299407;;10.1006/bbrc.1997.7129;;1696028;;10.1126/science.1696028;;4001944;;10.1126/science.4001944;;7504274;;10.1073/pnas.90.22.10643;;pmc47833,"Balass et al., 1993, ""Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library"", Proc. Natl. Acad. Sci. USA 90:10638-10642.;;Bass et al., 1990, ""Hormone phage: an enrichment method for variant proteins with altered binding properties"", Proteins: Struct. Func. Genet. 8:309-314.;;Cesareni, 1992, ""Peptide display on filamentous phage capsids"", FEBS Lett. 307:66-70.;;Christian et al., 1992, ""Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage"", J. Mol. Biol. 227:711-718.;;Cwirla et al., 1990, ""Peptides on phage: A vast library of peptides for identifying ligands"", Proc. Natl. Acad. Sci. USA 87:6378-6382.;;Davis and Jllum, 1994, ""Particulate systems for site specific drug delivery"", In: Targeting of Drugs 4 (Eds), Gregoriadis, McCormack and Poste, 183-194.;;De la Cruz et al., 1988, ""Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage"", J. Biol. Chem. 263:4318-4322.;;Devlin et al., 1990, ""Random peptide libraries: a source of specific protein binding molecules"", Science 249:404-406.;;Evers, 1995, Developments in Drug Delivery: Technology and Markets, Financial Times Management Report, p. 1-26.;;Fix, 1996, ""Strategies for delivery of peptides utilizing absorption-enhancing agents"", J. Pharmac. Sci. 85:1282-1285.;;Fodor et al., 1991, ""Light-directed, spatially addressable parallel chemical synthesis"", Science 251:767-773.;;Fong et al., 1994, ""Scanning whole cells with phage-display libraries: identification of peptide ligands that modulate cell function"", Drug Development Research 33:64-70.;;Gallop et al., 1994, ""Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries"", J. Med. Chem. 37:1233-1251.;;Greenwood et al., 1991, ""Multiple display of foreign peptides on a filamentous bacteriophage"", J. Mol. Biol. 220:821-827.;;Houghten et al., 1991, ""Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery"", Nature 354:84-86.;;Hoogenboom et al., 1991, ""Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) haevy and light chains"", Nucleic Acids Res. 19:4133-4137.;;Kang et al., 1991, ""Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces"", Proc. Natl. Acad. Sci. USA 88:4363-4366.;;Kay et al., 1993, ""An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to select targets"", Gene 128:59-65.;;Lam et al, ""A new type of synthetic peptide library for identifying ligand-binding activity"", Nature 354:82-84.;;Liang et al., 1995, ""Human intestinal H<SUP>+</SUP>/peptide cotransporter: cloning, functional expression, and chromosomal localization,"" J. Biol. Chem. 270:6456-6463.;;Lowman et al., 1991, ""Selecting high-affinity binding proteins by monovalent phage display"", Biochemistry 30:10832-10838.;;Marks et al., 1991, ""By-passing immunization: human antibodies from V-gene libraries displayed on phage"", J. Mol. Biol. 222:581-597.;;McCafferty et al., 1990, ""Phage antibodies: filamentous phage displaying antibody variable domains"", Nature 348:552-554.;;Parmley and Smith, 1988, ""Antibody-selectable filamentous fd phage vectors: affinity purification of target genes"", Gene 73:305-318.;;Parmley and Smith, 1989, ""Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines"", Adv. Exp. Med. Biol. 251:215-218.;;Peterson and Mooseker, 1992, ""Characterization of the enterocyte-like brush border cytoskeleton of the C2<SUB>BBe </SUB>clones of the human intestinal cell line, Caco-2"", J. Cell Science 102:581-600.;;Pietersz, 1990, ""The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer"", Bioconjugate Chem. 1:89-95.;;Saito et al., 1997, ""Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H+/peptide cotransporter, PEPT1,"" Biochem. and Biophys. Res. Commun. 237:577-582.;;Scott and Smith, 1990, ""Searching for peptide ligands with an epitope library"", Science 249:386-390.;;Smith, 1985, ""Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface"", Science 228:1315-1317.;;Stevenson et al., 1995, ""Permeability screen for synthetic peptide combinatorial libraries using CACO-2 cell monolayers and LC/MS/MS"", Pharmaceutical Res. 12(9), S94.;;Yayon et al., 1993, ""Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library"", Proc. Natl. Acad. Sci. USA 90:10643-10647.",EXPIRED
122,US,A1,US 2007/0010441 A1,118-493-444-186-596,2007-01-11,2007,US 35645206 A,2006-02-17,US 35645206 A;;US 7967898 A;;US 4659597 P,1997-05-15,Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods,"This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastrointestinal tract, thus facilitating its absorption into the systemic system.",CYTOGEN CORP,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A JR;;CARTER JOHN M;;CAGNEY GERARD M,,https://lens.org/118-493-444-186-596,Patent Application,yes,0,0,2,15,407,A61K38/28;;A61K38/28;;A61K47/58;;A61K47/58;;A61K47/593;;A61K47/593;;A61K47/60;;A61K47/60;;A61K47/62;;A61K47/62;;A61K47/6937;;A61K47/6937,A61K38/17;;C07K14/47,514/12;;530/324;;530/326;;514/13,0,0,,,,DISCONTINUED
123,CA,A1,CA 2290756 A1,121-101-401-228-445,1998-11-19,1998,CA 2290756 A,1998-05-15,US 4659597 P;;US 9810088 W,1997-05-15,RANDOM PEPTIDES THAT BIND TO GASTRO-INTESTINAL TRACT (GIT) TRANSPORT RECEPTORS AND RELATED METHODS,"This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastro-intestinal tract, thus facilitating its absorption into the systemic system.",ELAN CORP PLC;;CYTOGEN CORP,BELINKA BENJAMIN A JR;;SINGLETON JUDITH;;CARTER JOHN M;;PATTERSON CATHERINE A;;LAMBKIN IMELDA J;;ALVAREZ VERNON L;;CAGNEY GERARD M;;O'MAHONY DANIEL J,,https://lens.org/121-101-401-228-445,Patent Application,no,0,0,10,15,407,A61K9/5153;;A61K38/09;;A61K38/28;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00;;A61K47/62;;A61K47/6937;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,0,0,,,,DISCONTINUED
124,US,B1,US 6703362 B1,075-112-247-619-225,2004-03-09,2004,US 7972398 A,1998-05-15,US 7972398 A;;US 4659597 P,1997-05-15,Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods,"
    This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastrointestinal tract, thus facilitating its absorption into the systemic system. 
",CYTOGEN CORP;;ELAN CORP PLC,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA JR BENJAMIN A;;CARTER JOHN M;;CAGNEY GERARD M,ELAN CORPORATION PLC (1998-08-12);;CYTOGEN CORPORATION (1998-10-22),https://lens.org/075-112-247-619-225,Granted Patent,yes,8,27,1,15,407,A61K38/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K7/08;;C07K14/001;;C07K7/08;;C07K5/1016;;C07K5/1013;;A61K38/00;;C07K14/001;;C07K1/047,A61K38/00;;C07K1/04;;C07K5/103;;C07K5/107;;C07K7/08;;C07K14/00,514/12;;514/2;;514/21;;530/300;;530/350;;530/324;;530/387;;424/184.1;;424/185.1;;424/400;;435/69.1;;435/69.2;;436/86,33,30,033-771-696-808-14X;;136-206-156-591-915;;026-623-017-714-89X;;023-581-408-570-254;;010-740-280-665-96X;;009-186-473-238-939;;000-577-316-851-722;;009-069-193-386-694;;014-935-196-346-195;;019-278-757-718-935;;065-117-941-135-263;;060-459-542-715-007;;134-798-310-918-904;;037-412-520-623-943;;011-962-497-035-168;;027-396-041-217-200;;008-721-226-627-596;;013-242-768-882-463;;023-100-238-103-724;;083-771-782-040-353;;020-855-322-534-259;;030-630-100-818-462;;052-798-596-323-654;;042-787-507-181-37X;;058-927-415-617-378;;052-747-811-670-668;;044-798-306-702-833;;181-995-345-726-803;;078-075-414-981-82X;;018-407-315-416-616,1885524;;pmc208258;;10.1128/jb.173.17.5457-5469.1991;;10.1073/pnas.90.22.10638;;pmc47832;;7504273;;10.1002/prot.340080405;;1708882;;10.1016/0014-5793(92)80903-t;;1639197;;1404385;;10.1016/0022-2836(92)90219-a;;10.1073/pnas.87.16.6378;;2201029;;pmc54537;;2450091;;10.1016/s0021-9258(18)68927-6;;2143033;;10.1126/science.2143033;;8961139;;10.1021/js960158a;;1990438;;10.1126/science.1990438;;10.1002/ddr.430330203;;10.1021/jm00035a001;;8176700;;10.1016/0022-2836(91)90354-9;;1880799;;10.1038/354084a0;;1719428;;10.1093/nar/19.15.4133;;pmc328552;;1908075;;10.1073/pnas.88.10.4363;;1903540;;pmc51659;;10.1016/0378-1119(93)90153-t;;8508960;;10.1038/354082a0;;1944576;;10.1074/jbc.270.12.6456;;7896779;;10.1021/bi00109a004;;1932005;;1748994;;10.1016/0022-2836(91)90498-u;;10.1038/348552a0;;2247164;;10.1016/0378-1119(88)90495-7;;3149606;;2481962;;10.1007/978-1-4757-2046-4_21;;10.1242/jcs.102.3.581;;1506435;;2095213;;10.1021/bc00002a001;;9299407;;10.1006/bbrc.1997.7129;;1696028;;10.1126/science.1696028;;4001944;;10.1126/science.4001944;;7504274;;10.1073/pnas.90.22.10643;;pmc47833,"Evans, ""Nucleotide sequence and genetic analysis of the Aotobacter chroococcum nifUSVWZM gene cluster"" 1991, Journal of Bacteriology, vol. 173, No. 17, pp. 5457-5469.*;;Balass et al., 1993, ""Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library"", Proc. Natl. Acad. Sci. USA 90:10638-10642.;;Bass et al., 1990, ""Hormone phage: an enrichment method for variant proteins with altered binding properties"", Proteins: Struct. Func. Genet. 8:309-314.;;Cesareni, 1992, ""Peptide display on filamentous phage capsids"", FEBS Lett. 307:66-70.;;Christian et al., 1992, ""Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage"", J. Mol. Biol. 227:711-718.;;Cwirla et al., 1990, ""Peptides on phage: A vast library of peptides for identifying ligands"", Proc. Natl. Acad. Sci. USA 87:6378-6382.;;Davis and Jllum, 1994, ""Particulate systems for site specific drug delivery"", In: Targeting of Drugs 4 (Eds), Gregoriadis, McCormack and Poste, 183-194.;;De la Cruz et al., 1988, ""Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage"", J. Biol. Chem. 263:4318-4322.;;Devlin et al., 1990, ""Random peptide libraries: a source of specific protein binding molecules"", Science 249:404-406.;;Evers, 1995, Developments in Drug Delivery: Technology and Markets, Financial Times Management Report, p. 1-26.;;Fix, 1996, ""Strategies for delivery of peptides utilizing absorption-enhancing agents"", J. Pharmac. Sci. 85:1282-1285.;;Fodor et al., 1991, ""Light-directed, spatially addressable parallel chemical synthesis"", Science 251:767-773.;;Fong et al., 1994, ""Scanning whole cells with pahge-display libraries: identification of peptide ligands that modulate cell function"", Drug Development Research 33:64-70.;;Gallop et al., 1994, ""Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries"", J. Med. Chem. 37:1233-1251.;;Greenwood et al., 1991, ""Multiple display of foreign peptides on a filamentous bacteriophage"", J. Mol. Biol. 220:821-827.;;Houghten et al., 1991, ""Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery"", Nature 354:84-86.;;Hoogenboom et al., 1991, ""Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains"", Nucleic Acids Res. 19:4133-4137.;;Kang et al., 1991, ""Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces"", Proc. Natl. Acad. Sci. USA 88:4363-4366.;;Kay et al., 1993, ""An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to select targets"", Gene 128:59-65.;;Lam et al, 1991, ""A new type of synthetic peptide library for identifying ligand-binding activity"", Nature 354:82-84.;;Liang et al., 1995, ""Human intestinal H<+>/peptide cotransporter: cloning, functional expression, and chromosomal localization,"" J. Biol. Chem. 270:6456-6463.;;Lowman et al., 1991, ""Selecting high-affinity binding proteins by monovalent pahge display"", Biochemistry 30:10832-10838.;;Marks et al., 1991, ""By-passing immunization: human antibodies from V-gene libraries displayed on phage"", J. Mol. Biol. 222:581-597.;;McCafferty et al., 1990, Phage antibodies: filamentous phage displaying antibody variable domains, Nature 348:552-554.;;Parmley and Smith, 1988, ""Antibody-selectable filamentous fd phage vectors: affinity purification of target genes"", Gene 73:305-318.;;Parmley and Smith, 1989, ""Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines"", Adv. Exp. Med. Biol. 251:215-218.;;Peterson and Mooseker, 1992, ""Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2"", J. Cell Science 102:581-600.;;Pietersz, 1990, ""The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer"", Bioconjugate Chem. 1:89-95.;;Saito et al., 1997, ""Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the H+/peptide cotransporter, PEPT1,"" Biochem. and Biophys. Res. Commun. 237:577-582.;;Scott and Smith, 1990, ""Searching for peptide ligands with an epitope library"", Science 249:386-390.;;Smith, 1985, ""Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface"", Science 228:1315-1317.;;Stevenson et al., 1995, ""Permeability screen for synthetic peptide combinatorial libraries using CACO-2 cell monolayers and LC/MS/MS"", Pharmaceutical Res. 12(9), S94.;;Yayon et al., 1993, ""Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library"", Proc. Natl. Acad. Sci. USA 90:10643-10647.",EXPIRED
125,WO,A2,WO 1998/051325 A2,064-524-326-211-828,1998-11-19,1998,US 9810088 W,1998-05-15,US 4659597 P,1997-05-15,RANDOM PEPTIDES THAT BIND TO GASTRO-INTESTINAL TRACT (GIT) TRANSPORT RECEPTORS AND RELATED METHODS,"This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastro-intestinal tract, thus facilitating its absorption into the systemic system.",CYTOGEN CORP;;ELAN CORP PLC;;ALVAREZ VERNON L;;MAHONY DANIEL J O;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A JR;;CARTER JOHN M;;CAGNEY GERARD M,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A JR;;CARTER JOHN M;;CAGNEY GERARD M,,https://lens.org/064-524-326-211-828,Patent Application,no,0,48,10,15,0,A61K38/09;;A61K9/5153;;A61K38/28;;A61K47/62;;A61K47/6937;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,0,0,,,,PATENTED
126,WO,A3,WO 1998/051325 A3,111-000-026-465-549,1998-12-17,1998,US 9810088 W,1998-05-15,US 4659597 P,1997-05-15,RANDOM PEPTIDES THAT BIND TO GASTRO-INTESTINAL TRACT (GIT) TRANSPORT RECEPTORS AND RELATED METHODS,"This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastro-intestinal tract, thus facilitating its absorption into the systemic system.",CYTOGEN CORP;;ELAN CORP PLC;;ALVAREZ VERNON L;;MAHONY DANIEL J O;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A JR;;CARTER JOHN M;;CAGNEY GERARD M,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A JR;;CARTER JOHN M;;CAGNEY GERARD M,,https://lens.org/111-000-026-465-549,Search Report,yes,2,0,10,15,0,A61K38/09;;A61K9/5153;;A61K38/28;;A61K47/62;;A61K47/6937;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,3,2,044-798-306-702-833;;023-100-238-103-724,9299407;;10.1006/bbrc.1997.7129;;10.1074/jbc.270.12.6456;;7896779,"SAITO H., ET AL.: ""CLONING AND CHARACTERIZATION OF A PH-SENSING REGULATORY FACTOR THAT MODULATES TRANSPORT ACTIVITY OF THE HUMAN H+/PEPTIDE COTRANSPORTER, PEPT1."", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 237., 1 January 1997 (1997-01-01), US, pages 577 - 582., XP002912967, ISSN: 0006-291X, DOI: 10.1006/bbrc.1997.7129;;LIANG R., ET AL.: ""HUMAN INTESTINAL H+/PEPTIDE COTRANSPORTER. CLONING, FUNCTIONAL EXPRESSION, AND CHROMOSOMAL LOCALIZATION."", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 270., no. 12., 24 March 1995 (1995-03-24), US, pages 6456 - 6463., XP002912968, ISSN: 0021-9258, DOI: 10.1074/jbc.270.12.6456;;See also references of EP 1019071A4",PATENTED
127,EP,A2,EP 1019071 A2,168-168-619-260-896,2000-07-19,2000,EP 98922385 A,1998-05-15,US 4659597 P;;US 9810088 W,1997-05-15,RANDOM PEPTIDES THAT BIND TO GASTRO-INTESTINAL TRACT (GIT) TRANSPORT RECEPTORS AND RELATED METHODS,,CYTOGEN CORP;;ELAN CORP PLC,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A JR;;CARTER JOHN M;;CAGNEY GERARD M,,https://lens.org/168-168-619-260-896,Patent Application,yes,0,0,10,15,265,A61K38/09;;A61K9/5153;;A61K38/28;;A61K47/62;;A61K47/6937;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,0,0,,,,DISCONTINUED
128,EP,A4,EP 1019071 A4,078-666-187-802-426,2003-07-30,2003,EP 98922385 A,1998-05-15,US 4659597 P;;US 9810088 W,1997-05-15,RANDOM PEPTIDES THAT BIND TO GASTRO-INTESTINAL TRACT (GIT) TRANSPORT RECEPTORS AND RELATED METHODS,,CYTOGEN CORP;;ELAN CORP PLC,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA BENJAMIN A JR;;CARTER JOHN M;;CAGNEY GERARD M,,https://lens.org/078-666-187-802-426,Search Report,no,2,0,10,15,0,A61K38/09;;A61K9/5153;;A61K38/28;;A61K47/62;;A61K47/6937;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;B82Y5/00;;C07K1/047;;C07K5/1013;;C07K5/1016;;C07K14/001;;C07K14/705;;C07K2319/00,C12N15/09;;A61K9/51;;A61K38/00;;A61K38/09;;A61K38/28;;A61K47/42;;A61P5/48;;A61P7/00;;A61P7/06;;A61P9/12;;A61P19/10;;A61P25/06;;A61P35/00;;A61P43/00;;C07K1/04;;C07K5/04;;C07K5/103;;C07K5/107;;C07K7/04;;C07K14/00;;C07K14/47;;C07K14/705;;C07K16/18;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12P21/02;;C12Q1/68,,8,4,104-895-783-541-306;;022-196-069-374-728;;092-927-808-995-241;;001-350-938-122-508,1353958;;10.1042/bj2850915;;pmc1132882;;pmc288191;;8486766;;10.1172/jci116415;;10.1126/science.8153632;;8153632;;10.1517/14712598.2.1.67;;11772341,"STEVENSON C L ET AL: ""PERMEABILITY SCREEN FOR SYNTHETIC PEPTIDE COMBINATORIAL LIBRARIES USING CACO-2 CELL MONOLAYERS AND LC/MS/MS"", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 12, no. 9, SUPPL, September 1995 (1995-09-01), pages S94,ANBIOTEC2064, XP009000612, ISSN: 0724-8741;;CHANTRET I ET AL: ""SEQUENCE OF THE COMPLETE CDNA AND THE 5' STRUCTURE OF THE HUMAN SUCRASE-ISOMALTASE GENE. POSSIBLE HOMOLOGY WITH A YEAST GLUCOAMYLASE"", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, vol. 285, no. 3, 1992, pages 915 - 923, XP000909979, ISSN: 0264-6021;;LEE W S ET AL: ""CLONING AND CHROMOSOMAL LOCALIZATION OF A HUMAN KIDNEY CDNA INVOLVED IN CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID TRANSPORT"", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 91, no. 5, 1993, pages 1959 - 1963, XP000910010, ISSN: 0021-9738;;DANTZIG ANNE H ET AL: ""Association of intestinal peptide transport with a protein related to the cadherin superfamily."", SCIENCE (WASHINGTON D C), vol. 264, no. 5157, 1994, pages 430 - 433, XP001121129, ISSN: 0036-8075;;LAMBKIN I ET AL: ""IN VITRO SELECTION OF PEPTIDES WHICH FACILITATE TRANSPORT ACROSS ISOLATED RAT COLON MUCOSAE FROM RANDOM PHAGE DISPLAY LIBRARIES"", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 14, no. 11, November 1997 (1997-11-01), pages S - 645, XP000915519, ISSN: 0724-8741;;LAMBKIN I ET AL: ""IDENTIFICATION AND CHARACTERISATION OF PEPTIDES WHICH FACILITATE TRANSPORT ACROSS CACO-2 CELL MONOLAYERS FROM A RANDOM PHAGE DISPLAY LIBRARY"", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 14, no. 11, November 1997 (1997-11-01), pages 667, XP000915523, ISSN: 0724-8741;;LAMBKIN ET PINILLA: ""Targeting approaches to oral drug delivery."", EXPERT OPINION ON BIOLOGICAL THERAPY. ENGLAND JAN 2002, vol. 2, no. 1, January 2002 (2002-01-01), pages 67 - 73, XP002229897, ISSN: 1471-2598;;See also references of WO 9851325A3",DISCONTINUED
129,US,B1,US 7135457 B1,049-106-190-900-396,2006-11-14,2006,US 7981998 A,1998-05-15,US 7981998 A;;US 4659597 P,1997-05-15,Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods,"This invention relates to proteins (e.g., peptides) that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tissue, and derivatives (e.g., fragments) and analogs thereof, and nucleotide sequences coding for said proteins and derivatives. The proteins of the invention have use in facilitating transport of active agents from the lumenal side of the GIT into the systemic blood system, and/or in targeting active agents to the GIT. Thus, for example, by binding (covalently or noncovalently) a protein of the invention to an orally administered drug, the drug can be targeted to specific receptor sites or transport pathways which are known to operate in the human gastrointestinal tract, thus facilitating its absorption into the systemic system.",ELAN CORP PLC,ALVAREZ VERNON L;;O'MAHONY DANIEL J;;LAMBKIN IMELDA J;;PATTERSON CATHERINE A;;SINGLETON JUDITH;;BELINKA JR BENJAMIN A;;CARTER JOHN M;;CAGNEY GERARD M,ELAN CORPORATION PLC (1998-08-12);;CYTOGEN CORPORATION (1998-10-22),https://lens.org/049-106-190-900-396,Granted Patent,yes,10,19,1,15,407,A61K38/28;;A61K38/28;;A61K9/1635;;A61K9/1635;;A61K9/5153;;A61K9/5153;;A61K47/593;;A61K47/593;;A61K47/60;;A61K47/60;;A61K47/62;;A61K47/62;;A61K47/6937;;A61K47/6937;;B82Y5/00;;B82Y5/00;;C07K14/001;;C07K14/001,A61K38/00;;A61K39/00;;C07K5/00;;C07K7/00,514/12;;514/15;;514/21;;530/350;;530/324;;530/327;;424/185.1,32,29,136-206-156-591-915;;026-623-017-714-89X;;023-581-408-570-254;;010-740-280-665-96X;;009-186-473-238-939;;000-577-316-851-722;;009-069-193-386-694;;014-935-196-346-195;;019-278-757-718-935;;065-117-941-135-263;;060-459-542-715-007;;134-798-310-918-904;;037-412-520-623-943;;011-962-497-035-168;;027-396-041-217-200;;008-721-226-627-596;;013-242-768-882-463;;023-100-238-103-724;;083-771-782-040-353;;020-855-322-534-259;;030-630-100-818-462;;052-798-596-323-654;;042-787-507-181-37X;;058-927-415-617-378;;052-747-811-670-668;;044-798-306-702-833;;181-995-345-726-803;;078-075-414-981-82X;;018-407-315-416-616,10.1073/pnas.90.22.10638;;pmc47832;;7504273;;10.1002/prot.340080405;;1708882;;10.1016/0014-5793(92)80903-t;;1639197;;1404385;;10.1016/0022-2836(92)90219-a;;10.1073/pnas.87.16.6378;;2201029;;pmc54537;;2450091;;10.1016/s0021-9258(18)68927-6;;2143033;;10.1126/science.2143033;;8961139;;10.1021/js960158a;;1990438;;10.1126/science.1990438;;10.1002/ddr.430330203;;10.1021/jm00035a001;;8176700;;10.1016/0022-2836(91)90354-9;;1880799;;10.1038/354084a0;;1719428;;10.1093/nar/19.15.4133;;pmc328552;;1908075;;10.1073/pnas.88.10.4363;;1903540;;pmc51659;;10.1016/0378-1119(93)90153-t;;8508960;;10.1038/354082a0;;1944576;;10.1074/jbc.270.12.6456;;7896779;;10.1021/bi00109a004;;1932005;;1748994;;10.1016/0022-2836(91)90498-u;;10.1038/348552a0;;2247164;;10.1016/0378-1119(88)90495-7;;3149606;;2481962;;10.1007/978-1-4757-2046-4_21;;10.1242/jcs.102.3.581;;1506435;;2095213;;10.1021/bc00002a001;;9299407;;10.1006/bbrc.1997.7129;;1696028;;10.1126/science.1696028;;4001944;;10.1126/science.4001944;;7504274;;10.1073/pnas.90.22.10643;;pmc47833,"Balass et al., 1993, ""Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library"", Proc. Natl. Acad. Sci. USA 90:10638-10642.;;Bass et al., 1990, ""Hormone phage: an enrichment method for variant proteins with altered binding properties"", Proteins: Struct. Func. Genet. 8:309-314.;;Cesareni, 1992, ""Peptide display on filamentous phage capsids"", FEBS Lett. 307:66-70.;;Christian et al., 1992, ""Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage"", J. Mol. Biol. 227:711-718.;;Cwirla et al., 1990, ""Peptides on phage: A vast library of peptides for identifying ligands"", Proc. Natl. Acad. Sci. USA 87:6378-6382.;;Davis and Jllum, 1994, ""Particulate systems for site specific drug delivery"", In: Targeting of Drugs 4 (Eds), Gregoriadis, McCormack and Poste, 183-194.;;De la Cruz et al., 1988, ""Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage"", J. Biol. Chem. 263:4318-4322.;;Devlin et al., 1990, ""Random peptide libraries: a source of specific protein binding molecules"", Science 249:404-406.;;Evers, 1995, Developments in Drug Delivery: Technology and Markets, Financial Times Management Report, p. 1-26.;;Fix, 1996, ""Strategies for delivery of peptides utilizing absorption-enhancing agents"", J. Pharmac. Sci. 85:1282-1285.;;Fodor et al., 1991, ""Light-directed, spatially addressable parallel chemical synthesis"", Science 251:767-773.;;Fong et al., 1994, ""Scanning whole cells with phage-display libraries: identification of peptide ligands that modulate cell function"", Drug Development Reseach 33:64-70.;;Gallop et al., 1994, ""Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries"", J. Med. Chem. 37:1233-1251.;;Greenwood et al., 1991, ""Multiple display of foreign peptides on a filamentous bacteriophage"", J. Mol. Biol. 220:821-827.;;Houghton et al., 1991, ""Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery"", Nature 354:84-86.;;Hoogenboom et al., 1991, ""Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains"", Nucleic Acids Res. 19:4133-4137.;;Kang et al., 1991, ""Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage sufaces"", Proc. Natl. Acad. Sci. USA 88:4363-4366.;;Kay et al., 1993, ""An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to select targets"", Gene 128:59-65.;;Lam et al, 1991, ""A new type of synthetic peptide library for identifying ligand-binding activity"", Nature 354:82-84.;;Liang et al., 1995, ""Human intestinal H<SUP>+</SUP>/peptide cotransporter: cloning, functional expression, and chromosomal localization,"" J. Biol. Chem. 270:6456-6463.;;Lowman et al., 1991, ""Selecting high-affinity binding proteins by monovalent phage display"", Biochemistry 30:10832-10838.;;Marks et al., ""By-passing immunization: human antibodies from V-gene libraries displayed on phage"", J. Mol. Biol. 222:581-597.;;McCafferty et al., 1990, ""Phage antibodies: filamentous phage displaying antibody variable domains"", Nature 348:552-554.;;Parmley and Smith, 1988, ""Antibody-selectable filamentous fd phage vectors: affinity purification of target genes"", Gene 73:305-318.;;Parmley and Smith, 1989, ""Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines"", Adv. Exp. Med. Biol. 251:215-218.;;Peterson and Mooseker, 1992, ""Characterization of the enterocyte-like brush border cytoskeleton of the C2<SUB>BBe </SUB>clones of the human intestinal cell line, Caco-2"", J. Cell Science 102:581-600.;;Pietersz, 1990, ""The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer"", Bioconjugate Chem. 1:89-95.;;Saito et al., 1997, ""Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H+/peptide cotransporter, PEPT1,"" Biochem. and Biophys. Res. Commun. 237:577-582.;;Scott and Smith, 1990, ""Searching for peptide ligands with an epitope library"", Science 249:386-390.;;Smith, 1985, ""Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface"", Science 228:1315-1317.;;Stevenson et al., 1995, ""Permeability screen for synthetic peptide combinatorial libraries using CACO-2 cell monolayers and LC/MS/MS"", Pharmaceutical Res. 12(9), S94.;;Yayon et al., 1993, ""Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library"", Proc. Natl. Acad. Sci. USA 90:10643-10647.",EXPIRED
130,US,A1,US 2020/0362119 A1,104-904-185-966-963,2020-11-19,2020,US 201816766904 A,2018-12-04,EP 17290172 A;;US 2018/0063755 W,2017-12-29,METHOD FOR MODIFYING POLYCARBONATE,"Provided is a method of modifying polycarbonate comprising blending the polycarbonate with composite particles, wherein the composite particles comprise (I) a crosslinked polyolefin core, and(II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J,DOW GLOBAL TECHNOLOGIES LLC (2018-11-29);;ROHM AND HAAS COMPANY (2018-11-28),https://lens.org/104-904-185-966-963,Patent Application,yes,1,0,10,10,0,C08L69/00;;C08L69/00;;C08L51/06;;C08J3/20;;C08J3/11;;C08J2323/06;;C08J2333/10;;C08J2369/00;;C08F220/02;;C08F220/14;;C08L33/12;;C08L69/005;;C08L2666/24,C08J3/11,,0,0,,,,ACTIVE
131,KR,A,KR 20200103711 A,137-643-356-480-082,2020-09-02,2020,KR 20207019751 A,2018-12-04,EP 17290172 A;;US 2018/0063755 W,2017-12-29,폴리카보네이트의 개질 방법,"본원은, 폴리카보네이트를 개질하는 방법을 제공하며, 상기 방법은 상기 폴리카보네이트를 복합 입자와 배합하는 단계를 포함하고, 상기 복합 입자는, (I) 가교 폴리올레핀 코어, 및 (II) 하나 이상의 비닐 단량체의 중합 단위를 포함하는 완전한 또는 부분적인 쉘을 포함한다.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT GERARD YANNICK;;HASSO DOUGLAS J,,https://lens.org/137-643-356-480-082,Patent Application,no,0,0,10,10,0,C08L69/00;;C08L69/00;;C08L51/06;;C08J3/20;;C08J3/11;;C08J2323/06;;C08J2333/10;;C08J2369/00;;C08F220/02;;C08F220/14;;C08L33/12;;C08L69/005;;C08L2666/24,C08L69/00;;C08J3/20;;C08L51/06,,0,0,,,,DISCONTINUED
132,EP,A1,EP 3732249 A1,179-825-994-189-40X,2020-11-04,2020,EP 18816470 A,2018-12-04,EP 17290172 A;;US 2018/0063755 W,2017-12-29,METHOD FOR MODIFYING POLYCARBONATE,,DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J,,https://lens.org/179-825-994-189-40X,Patent Application,yes,0,0,10,10,0,C08L69/00;;C08L69/00;;C08L51/06;;C08J3/20;;C08J3/11;;C08J2323/06;;C08J2333/10;;C08J2369/00;;C08F220/02;;C08F220/14;;C08L33/12;;C08L69/005;;C08L2666/24,C08L69/00,,0,0,,,,PENDING
133,US,B2,US 11578177 B2,187-212-263-507-96X,2023-02-14,2023,US 201816766904 A,2018-12-04,EP 17290172 A;;US 2018/0063755 W,2017-12-29,Method for modifying polycarbonate,"Provided is a method of modifying polycarbonate comprising blending the polycarbonate with composite particles, wherein the composite particles comprise (I) a crosslinked polyolefin core, and(II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J,DOW GLOBAL TECHNOLOGIES LLC (2018-11-29);;ROHM AND HAAS COMPANY (2018-11-28),https://lens.org/187-212-263-507-96X,Granted Patent,yes,12,0,10,10,0,C08L69/00;;C08L69/00;;C08L51/06;;C08J3/20;;C08J3/11;;C08J2323/06;;C08J2333/10;;C08J2369/00;;C08F220/02;;C08F220/14;;C08L33/12;;C08L69/005;;C08L2666/24,C08F220/02;;C08F220/14;;C08J3/11;;C08L33/12;;C08L69/00,,1,1,012-499-893-882-312,10.1002/app.21252,"Kilwon, “Toughening of polycarbonate: Effect pf patic;e size and rubber phase contents of the core-shell impact modifier.” Journal of Applied Polymer Science. 2004, p. 748-755, vol. 95, No. 3.",ACTIVE
134,CN,A,CN 111527148 A,041-000-189-616-818,2020-08-11,2020,CN 201880079543 A,2018-12-04,EP 17290172 A;;US 2018/0063755 W,2017-12-29,Method for modifying polycarbonate,"Provided is a method of modifying polycarbonate comprising blending the polycarbonate with composite particles, wherein the composite particles comprise (I) a crosslinked polyolefin core, and (II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J,,https://lens.org/041-000-189-616-818,Patent Application,no,4,0,10,10,0,C08L69/00;;C08L69/00;;C08L51/06;;C08J3/20;;C08J3/11;;C08J2323/06;;C08J2333/10;;C08J2369/00;;C08F220/02;;C08F220/14;;C08L33/12;;C08L69/005;;C08L2666/24,C08L69/00,,0,0,,,,ACTIVE
135,BR,A2,BR 112020011047 A2,075-090-391-628-500,2020-11-17,2020,BR 112020011047 A,2018-12-04,US 2018/0063755 W;;EP 17290172 A,2017-12-29,método para modificar policarbonato,"é fornecido um método para modificar policarbonato compreendendo misturar policarbonato com partículas compósitas, em que as partículas compósitas compreendem (i) um núcleo de poliolefina reticulado, e (ii) uma casca total ou parcial compreendendo unidades polimerizadas de um ou mais monômeros de vinil.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,ANDY JUN LI;;CARLOS A CRUZ;;DOUGLAS J HASSO;;JOHN F KOHN;;LIANG CHEN;;MATTHEW CARTER;;RALPH C EVEN;;ROBERT S MOGLIA;;YANNICK SAINT-GERARD,,https://lens.org/075-090-391-628-500,Patent Application,no,0,0,10,10,0,C08L69/00;;C08L69/00;;C08L51/06;;C08J3/20;;C08J3/11;;C08J2323/06;;C08J2333/10;;C08J2369/00;;C08F220/02;;C08F220/14;;C08L33/12;;C08L69/005;;C08L2666/24,C08L69/00,,0,0,,,,PENDING
136,WO,A1,WO 2019/133196 A1,114-929-905-011-422,2019-07-04,2019,US 2018/0063755 W,2018-12-04,EP 17290172 A,2017-12-29,METHOD FOR MODIFYING POLYCARBONATE,"Provided is a method of modifying polycarbonate comprising blending the polycarbonate with composite particles, wherein the composite particles comprise (I) a crosslinked polyolefin core, and (II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J,,https://lens.org/114-929-905-011-422,Patent Application,yes,5,2,10,10,0,C08L69/00;;C08L69/00;;C08L51/06;;C08J3/20;;C08J3/11;;C08J2323/06;;C08J2333/10;;C08J2369/00;;C08F220/02;;C08F220/14;;C08L33/12;;C08L69/005;;C08L2666/24,C08L69/00,,1,1,012-499-893-882-312,10.1002/app.21252,"KILWON CHO ET AL: ""Toughening of polycarbonate: Effect of particle size and rubber phase contents of the core-shell impact modifier"", JOURNAL OF APPLIED POLYMER SCIENCE, vol. 95, no. 3, 1 January 2004 (2004-01-01), pages 748 - 755, XP055240284, ISSN: 0021-8995, DOI: 10.1002/app.21252",PENDING
137,US,A1,US 2020/0332098 A1,073-663-921-120-302,2020-10-22,2020,US 201816765938 A,2018-11-29,EP 17290171 A;;US 2018/0062995 W,2017-12-29,POLYOLEFIN-ACRYLIC PARTICLES,"Provided is a dispersion of composite particles in an aqueous medium, wherein the composite particles comprise (I) a crosslinked polyolefin core, and(II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J;;JANCO MIROSLAV,DOW GLOBAL TECHNOLOGIES LLC (2018-11-29);;ROHM AND HAAS COMPANY (2018-11-28),https://lens.org/073-663-921-120-302,Patent Application,yes,0,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/44;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815;;C08L2201/50;;C08L2205/025;;C08L2205/03;;C08L2207/53,C08L23/08,,0,0,,,,ACTIVE
138,WO,A1,WO 2019/133169 A1,170-170-491-757-960,2019-07-04,2019,US 2018/0062995 W,2018-11-29,EP 17290171 A,2017-12-29,POLYOLEFIN-ACRYLIC PARTICLES,"Provided is a dispersion of composite particles in an aqueous medium, wherein the composite particles comprise (I) a crosslinked polyolefin core, and (II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J;;JANCO MIROSLAV,,https://lens.org/170-170-491-757-960,Patent Application,yes,5,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/44;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815;;C08L2201/50;;C08L2205/025;;C08L2205/03;;C08L2207/53,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,PENDING
139,EP,A1,EP 3732207 A1,033-214-036-021-243,2020-11-04,2020,EP 18815094 A,2018-11-29,EP 17290171 A;;US 2018/0062995 W,2017-12-29,POLYOLEFIN-ACRYLIC PARTICLES,,DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J;;JANCO MIROSLAV,,https://lens.org/033-214-036-021-243,Patent Application,yes,0,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/44;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815;;C08L2201/50;;C08L2205/025;;C08L2205/03;;C08L2207/53,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,PENDING
140,KR,A,KR 20200104862 A,181-814-493-141-81X,2020-09-04,2020,KR 20207017940 A,2018-11-29,EP 17290171 A;;US 2018/0062995 W,2017-12-29,폴리올레핀 아크릴 입자,"본원은, 수성 매질 중의 복합 입자의 분산액을 제공하며, 상기 복합 입자는, (I) 가교 폴리올레핀 코어, 및 (II) 하나 이상의 비닐 단량체의 중합 단위를 포함하는 완전한 또는 부분적인 쉘을 포함한다.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT GERARD YANNICK;;HASSO DOUGLAS J;;JANCO MIROSLAV,,https://lens.org/181-814-493-141-81X,Patent Application,no,1,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/44;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815;;C08L2201/50;;C08L2205/025;;C08L2205/03;;C08L2207/53,C08F285/00;;C08F2/44;;C08F220/18;;C08F299/00;;C08K5/3492;;C08L23/08;;C08L51/06;;C08L69/00,,0,0,,,,ACTIVE
141,CN,A,CN 111741982 A,181-898-531-442-818,2020-10-02,2020,CN 201880079776 A,2018-11-29,EP 17290171 A;;US 2018/0062995 W,2017-12-29,POLYOLEFIN-ACRYLIC PARTICLES,"Provided is a dispersion of composite particles in an aqueous medium, wherein the composite particles comprise (I) a crosslinked polyolefin core, and (II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J;;JANCO MIROSLAV,,https://lens.org/181-898-531-442-818,Patent Application,no,5,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/44;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815;;C08L2201/50;;C08L2205/025;;C08L2205/03;;C08L2207/53,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,ACTIVE
142,BR,A2,BR 112020011032 A2,045-211-405-100-599,2020-11-17,2020,BR 112020011032 A,2018-11-29,US 2018/0062995 W;;EP 17290171 A,2017-12-29,dispersão de partículas compósitas em um meio aquoso,"trata-se de uma dispersão de partículas compósitas em um meio aquoso, em que as partículas compósitas compreendem (i) um núcleo de poliolefina reticulada, e (ii) invólucro total ou parcial que compreende unidades polimerizadas de um ou mais monômeros de vinila.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,ANDY JUN LI;;CARLOS A CRUZ;;DOUGLAS J HASSO;;JOHN F KOHN;;LIANG CHEN;;MATTHEW CARTER;;MIROSLAV JANCO;;RALPH C EVEN;;ROBERT S MOGLIA;;YANNICK SAINT-GERARD,,https://lens.org/045-211-405-100-599,Patent Application,no,0,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/44;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815;;C08L2201/50;;C08L2205/025;;C08L2205/03;;C08L2207/53,C08F2/24;;C08F255/02;;C08F285/00;;C08L51/06;;C08L69/00,,0,0,,,,ACTIVE
143,US,B2,US 11499040 B2,085-016-016-263-025,2022-11-15,2022,US 201816765938 A,2018-11-29,EP 17290171 A;;US 2018/0062995 W,2017-12-29,Polyolefin-acrylic particles,"Provided is a dispersion of composite particles in an aqueous medium, wherein the composite particles comprise (I) a crosslinked polyolefin core, and(II) a full or partial shell comprising polymerized units of one of more vinyl monomers.",DOW GLOBAL TECHNOLOGIES LLC;;ROHM & HAAS,CHEN LIANG;;LI ANDY JUN;;CARTER MATTHEW;;MOGLIA ROBERT S;;EVEN RALPH C;;KOHN JOHN F;;CRUZ CARLOS A;;SAINT-GERARD YANNICK;;HASSO DOUGLAS J;;JANCO MIROSLAV,DOW GLOBAL TECHNOLOGIES LLC (2018-11-29);;ROHM AND HAAS COMPANY (2018-11-28),https://lens.org/085-016-016-263-025,Granted Patent,yes,25,0,11,11,0,C08F2/24;;C08F285/00;;C08F299/00;;C08L23/0815;;C08L69/00;;C08F285/00;;C08F299/00;;C08F220/1804;;C08F2/44;;C08L23/0815;;C08L69/00;;C08L51/06;;C08K5/34924;;C08L23/0815;;C08L2201/50;;C08L2205/025;;C08L2205/03;;C08L2207/53,C08L23/08,,3,2,151-030-940-447-404;;083-508-159-451-988,10.1080/01932690903224730;;10.1002/macp.200500255,"Hussain, “High Performance Emulsified EPDM grafted with vinyl acetate as Compatibilizer for EPDM with Polar Rubber.,” Nature and Science 2010, p. 348-357, vol. 8.;;Hussain, “Evaluation of the Stability of Emulsified Ethylene-Propylene-Diene-Monomer Using Novel Technique.,” Journal of Dispersion Science and Technology, 2010, p. 1278-1284, vol. 31.;;Kangwansupamonkon, “Modification of Natural Rubber by Grafting with Hydrophilic Vinyl Monomers.,” Macromol. Chem. Phys. 2005, p. 2450-2460, vol. 206.",ACTIVE
144,CN,A,CN 116583382 A,073-736-177-286-033,2023-08-11,2023,CN 202180074365 A,2021-09-01,US 202017009620 A;;US 2021/0048606 W,2020-09-01,System and method for automated operation and manipulation of autonomous trucks and trailers towed therewith,"A system and method for operating an autonomous vehicle (AV) yard truck is provided. The processor facilitates autonomous movement of the AV yard truck and connection and disconnection with the trailer. A plurality of sensors are interconnected with the processor, the sensors sensing terrain/objects and assisting in automatic connection/disconnection with the trailer. A server wirelessly interconnected with the processor tracks the movement of the truck and determines the location of trailer connections and disconnections. The door station unlocks/opens the rear door when adjacent to the rear door of the trailer, and fastens the rear door in the open position via a clamp or the like. The system calculates the height of the trailer, and/or whether the landing gear of the trailer is on the ground and interacts with the fifth wheel to change the height, and whether the docking is safe, thereby allowing the user to take manual control and optimal charging time. Reversing sensor/safe automatic blocking and intermodal container organization are also provided.",OLTRIDE TECH CORPORATION,SMITH AMY FRANCES;;KLEIN LAWRENCE S;;LANGENDERFER SCOTT A;;SOTOLA MICHAEL E;;BAR VIVEK;;ROSENBLUM MICHAEL H;;JAMES PETER;;ROWLEY DONALD D;;JOHANNES MICHAEL S;;SEMINARA GERARD M;;KNIGHT JAMES N;;BETT CHRISTOPHER T;;CARTER MICHAEL P,,https://lens.org/073-736-177-286-033,Patent Application,no,0,0,6,38,0,B60D1/64;;B25J9/1679;;B60D1/62;;B60D1/015;;B62D53/125;;B62D53/0821,B25J9/16,,0,0,,,,PENDING
